{ "version": "2.2", "instance": { "vsees1091726.htm": { "nsprefix": "vsee", "nsuri": "http://vseehealth.com/20260630", "dts": { "schema": { "local": [ "vsee-20260630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd", "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd", "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd", "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd", "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd", "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd", "https://xbrl.sec.gov/country/2026/country-2026.xsd", "https://xbrl.sec.gov/dei/2026/dei-2026.xsd", "https://xbrl.sec.gov/sic/2026/sic-2026.xsd", "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd" ] }, "calculationLink": { "local": [ "vsee-20260630_cal.xml" ] }, "definitionLink": { "local": [ "vsee-20260630_def.xml" ] }, "labelLink": { "local": [ "vsee-20260630_lab.xml" ] }, "presentationLink": { "local": [ "vsee-20260630_pre.xml" ] }, "inline": { "local": [ "vsees1091726.htm" ] } }, "keyStandard": 472, "keyCustom": 403, "axisStandard": 50, "axisCustom": 5, "memberStandard": 66, "memberCustom": 179, "hidden": { "total": 37, "http://xbrl.sec.gov/dei/2026": 2, "http://vseehealth.com/20260630": 24, "http://fasb.org/us-gaap/2026": 11 }, "contextCount": 1414, "entityCount": 1, "segmentCount": 307, "elementCount": 1394, "unitCount": 15, "baseTaxonomies": { "http://fasb.org/us-gaap/2026": 2824, "http://xbrl.sec.gov/dei/2026": 25, "http://fasb.org/srt/2026": 2 }, "report": { "R1": { "role": "http://vseehealth.com/role/DocumentAndEntityInformation", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R2": { "role": "http://vseehealth.com/role/ConsolidatedBalanceSheet", "longName": "001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R3": { "role": "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "longName": "002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c2", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R4": { "role": "http://vseehealth.com/role/ConsolidatedIncomeStatement", "longName": "003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c39", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R5": { "role": "http://vseehealth.com/role/ShareholdersEquityType2or3", "longName": "004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT)", "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c107", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c107", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R6": { "role": "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals", "longName": "005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Parentheticals)", "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Parentheticals)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c115", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R7": { "role": "http://vseehealth.com/role/ConsolidatedCashFlow", "longName": "006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R8": { "role": "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "longName": "007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)", "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c115", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://vseehealth.com/role/OrganizationandDescriptionofBusiness", "longName": "008 - Disclosure - Organization and Description of Business", "shortName": "Organization and Description of Business", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R10": { "role": "http://vseehealth.com/role/SummaryofSignificantAccountingPolicies", "longName": "009 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R11": { "role": "http://vseehealth.com/role/DiscontinuedOperations", "longName": "010 - Disclosure - Discontinued Operations", "shortName": "Discontinued Operations", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R12": { "role": "http://vseehealth.com/role/Leases", "longName": "011 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c0", "name": "vsee:LeaseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:LeaseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R13": { "role": "http://vseehealth.com/role/AccountsPayableandAccruedLiabilities", "longName": "012 - Disclosure - Accounts Payable and Accrued Liabilities", "shortName": "Accounts Payable and Accrued Liabilities", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R14": { "role": "http://vseehealth.com/role/FactoringPayable", "longName": "013 - Disclosure - Factoring Payable", "shortName": "Factoring Payable", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c0", "name": "vsee:FactoringPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:FactoringPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R15": { "role": "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscount", "longName": "014 - Disclosure - Line of Credit and Notes Payable, net of discount", "shortName": "Line of Credit and Notes Payable, net of discount", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R16": { "role": "http://vseehealth.com/role/Convertiblenotesatfairvalue", "longName": "015 - Disclosure - Convertible notes, at fair value", "shortName": "Convertible notes, at fair value", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c0", "name": "vsee:ConvertibleNotesAtFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:ConvertibleNotesAtFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R17": { "role": "http://vseehealth.com/role/StandbyEquityPurchaseAgreement", "longName": "016 - Disclosure - Standby Equity Purchase Agreement", "shortName": "Standby Equity Purchase Agreement", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c0", "name": "vsee:DisclosureOfStandbyEquityPurchaseAgreementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:DisclosureOfStandbyEquityPurchaseAgreementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R18": { "role": "http://vseehealth.com/role/RelatedParty", "longName": "017 - Disclosure - Related Party", "shortName": "Related Party", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R19": { "role": "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRisk", "longName": "018 - Disclosure - Commitments, Contingencies, and Concentration Risk", "shortName": "Commitments, Contingencies, and Concentration Risk", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c0", "name": "vsee:CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R20": { "role": "http://vseehealth.com/role/IncomeTaxes", "longName": "019 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R21": { "role": "http://vseehealth.com/role/Equity", "longName": "020 - Disclosure - Equity", "shortName": "Equity", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R22": { "role": "http://vseehealth.com/role/Warrants", "longName": "021 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c0", "name": "vsee:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R23": { "role": "http://vseehealth.com/role/Reportablesegment", "longName": "022 - Disclosure - Reportable segment", "shortName": "Reportable segment", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R24": { "role": "http://vseehealth.com/role/FairValueMeasurements", "longName": "023 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R25": { "role": "http://vseehealth.com/role/SubsequentEvents", "longName": "024 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R26": { "role": "http://vseehealth.com/role/BusinessCombination", "longName": "025 - Disclosure - Business Combination", "shortName": "Business Combination", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c54", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R27": { "role": "http://vseehealth.com/role/FixedAssets", "longName": "026 - Disclosure - Fixed Assets", "shortName": "Fixed Assets", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c54", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R28": { "role": "http://vseehealth.com/role/AccountingPoliciesByPolicy", "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)", "shortName": "Accounting Policies, by Policy (Policies)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "policies", "menuCat": "Policies", "order": "28", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R29": { "role": "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables", "longName": "996001 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R30": { "role": "http://vseehealth.com/role/DiscontinuedOperationsTables", "longName": "996002 - Disclosure - Discontinued Operations (Tables)", "shortName": "Discontinued Operations (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c0", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R31": { "role": "http://vseehealth.com/role/LeasesTables", "longName": "996003 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c0", "name": "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R32": { "role": "http://vseehealth.com/role/AccountsPayableandAccruedLiabilitiesTables", "longName": "996004 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R33": { "role": "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountTables", "longName": "996005 - Disclosure - Line of Credit and Notes Payable, net of discount (Tables)", "shortName": "Line of Credit and Notes Payable, net of discount (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R34": { "role": "http://vseehealth.com/role/IncomeTaxesTables", "longName": "996006 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R35": { "role": "http://vseehealth.com/role/EquityTables", "longName": "996007 - Disclosure - Equity (Tables)", "shortName": "Equity (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c54", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R36": { "role": "http://vseehealth.com/role/WarrantsTables", "longName": "996008 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R37": { "role": "http://vseehealth.com/role/ReportablesegmentTables", "longName": "996009 - Disclosure - Reportable segment (Tables)", "shortName": "Reportable segment (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R38": { "role": "http://vseehealth.com/role/FairValueMeasurementsTables", "longName": "996010 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R39": { "role": "http://vseehealth.com/role/BusinessCombinationTables", "longName": "996011 - Disclosure - Business Combination (Tables)", "shortName": "Business Combination (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c54", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R40": { "role": "http://vseehealth.com/role/FixedAssetsTables", "longName": "996012 - Disclosure - Fixed Assets (Tables)", "shortName": "Fixed Assets (Tables)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c54", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R41": { "role": "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "longName": "996013 - Disclosure - Organization and Description of Business (Details)", "shortName": "Organization and Description of Business (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c169", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R42": { "role": "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails", "longName": "996014 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "link:footnote", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:CashEquivalentsAtCarryingValue", "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R43": { "role": "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable", "longName": "996015 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Timing of Revenue Recognition (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Timing of Revenue Recognition (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R44": { "role": "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "longName": "996016 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic and Diluted Earnings Per Share Attributable to Continuing Operations (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Basic and Diluted Earnings Per Share Attributable to Continuing Operations (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c191", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c191", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R45": { "role": "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable", "longName": "996017 - Disclosure - Summary of Significant Accounting Policies - Schedule of Allowance for Credit Losses (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Allowance for Credit Losses (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R46": { "role": "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "longName": "996018 - Disclosure - Summary of Significant Accounting Policies - Schedule of Identifiable Intangible Assets Subject to Amortization (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Identifiable Intangible Assets Subject to Amortization (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R47": { "role": "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "longName": "996019 - Disclosure - Summary of Significant Accounting Policies - Schedule of Expected Amortization Expense (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Expected Amortization Expense (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c2", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R48": { "role": "http://vseehealth.com/role/DiscontinuedOperationsDetails", "longName": "996020 - Disclosure - Discontinued Operations (Details)", "shortName": "Discontinued Operations (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c319", "name": "vsee:CommonStockNumberOfSharesOwned", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R49": { "role": "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable", "longName": "996021 - Disclosure - Discontinued Operations - Schedule of Balance sheet - Discontinued operations (Details)", "shortName": "Discontinued Operations - Schedule of Balance sheet - Discontinued operations (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R50": { "role": "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable_Parentheticals", "longName": "996022 - Disclosure - Discontinued Operations - Schedule of Balance sheet - Discontinued operations (Parentheticals) (Details)", "shortName": "Discontinued Operations - Schedule of Balance sheet - Discontinued operations (Parentheticals) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "parenthetical", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R51": { "role": "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable", "longName": "996023 - Disclosure - Discontinued Operations - Schedule of Statement of Operations - Discontinued Operations (Details)", "shortName": "Discontinued Operations - Schedule of Statement of Operations - Discontinued Operations (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c39", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R52": { "role": "http://vseehealth.com/role/LeasesDetails", "longName": "996024 - Disclosure - Leases (Details)", "shortName": "Leases (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c333", "name": "vsee:PaymentsForSettlementOfFrostBankObligations", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c333", "name": "vsee:FinanceLeaseLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R53": { "role": "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable", "longName": "996025 - Disclosure - Leases - Schedule of Operating Lease Right-of-Use Assets (Details)", "shortName": "Leases - Schedule of Operating Lease Right-of-Use Assets (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c2", "name": "vsee:OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R54": { "role": "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable", "longName": "996026 - Disclosure - Leases - Schedule of Operating Lease Liabilities (Details)", "shortName": "Leases - Schedule of Operating Lease Liabilities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:OperatingLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeOperatingLeaseLiabilitiesTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable", "longName": "996027 - Disclosure - Leases - Schedule of Future Minimum Rent Payments Under the Operating Lease (Details)", "shortName": "Leases - Schedule of Future Minimum Rent Payments Under the Operating Lease (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c2", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R56": { "role": "http://vseehealth.com/role/ScheduleofExpensesIncurredforOperatingLeasesTable", "longName": "996028 - Disclosure - Leases - Schedule of Expenses Incurred for Operating Leases (Details)", "shortName": "Leases - Schedule of Expenses Incurred for Operating Leases (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R57": { "role": "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable", "longName": "996029 - Disclosure - Leases - Schedule of Weighted Average Remaining Lease Term and Discount Rate on Finance Leases (Details)", "shortName": "Leases - Schedule of Weighted Average Remaining Lease Term and Discount Rate on Finance Leases (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseSupplementalInformationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R58": { "role": "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable", "longName": "996030 - Disclosure - Leases - Schedule of Finance Leased Equipment (Details)", "shortName": "Leases - Schedule of Finance Leased Equipment (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseRightOfUseAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R59": { "role": "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable", "longName": "996031 - Disclosure - Leases - Schedule of Finance Lease Liabilities (Details)", "shortName": "Leases - Schedule of Finance Lease Liabilities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:FinanceLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R60": { "role": "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable", "longName": "996032 - Disclosure - Leases - Schedule of Expenses Incurred with Respect to Finance Leases (Details)", "shortName": "Leases - Schedule of Expenses Incurred with Respect to Finance Leases (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:FinanceLeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R61": { "role": "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "longName": "996033 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)", "shortName": "Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c334", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R62": { "role": "http://vseehealth.com/role/FactoringPayableDetails", "longName": "996034 - Disclosure - Factoring Payable (Details)", "shortName": "Factoring Payable (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c0", "name": "vsee:FutureReceiptsSaleAgreementInterestRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "span", "p", "vsee:FactoringPayableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:FutureReceiptsSaleAgreementInterestRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "span", "p", "vsee:FactoringPayableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R63": { "role": "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "longName": "996035 - Disclosure - Line of Credit and Notes Payable, net of discount (Details)", "shortName": "Line of Credit and Notes Payable, net of discount (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c333", "name": "vsee:SubsequentSettlementAgreementPaid", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R64": { "role": "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "longName": "996036 - Disclosure - Line of Credit and Notes Payable, net of discount - Schedule of Line of Credit and Notes Payable, Net of Discount (Details)", "shortName": "Line of Credit and Notes Payable, net of discount - Schedule of Line of Credit and Notes Payable, Net of Discount (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:LongTermDebt", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c438", "name": "us-gaap:LongTermDebt", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R65": { "role": "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable", "longName": "996037 - Disclosure - Line of Credit and Notes Payable, net of discount - Schedule of Required Principal Payments (Details)", "shortName": "Line of Credit and Notes Payable, net of discount - Schedule of Required Principal Payments (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c2", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R66": { "role": "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "longName": "996038 - Disclosure - Convertible notes, at fair value (Details)", "shortName": "Convertible notes, at fair value (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "link:footnote", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c474", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R67": { "role": "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails", "longName": "996039 - Disclosure - Standby Equity Purchase Agreement (Details)", "shortName": "Standby Equity Purchase Agreement (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c2", "name": "vsee:SEPALiability", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c548", "name": "vsee:SaleOfStockMaximumCommitmentAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "vsee:DisclosureOfStandbyEquityPurchaseAgreementTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R68": { "role": "http://vseehealth.com/role/RelatedPartyDetails", "longName": "996040 - Disclosure - Related Party (Details)", "shortName": "Related Party (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c18", "name": "us-gaap:OtherReceivablesNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c558", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R69": { "role": "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "longName": "996041 - Disclosure - Commitments, Contingencies, and Concentration Risk (Details)", "shortName": "Commitments, Contingencies, and Concentration Risk (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c596", "name": "us-gaap:LossContingencyDamagesSoughtValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c596", "name": "us-gaap:LossContingencyDamagesSoughtValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R70": { "role": "http://vseehealth.com/role/IncomeTaxesDetails", "longName": "996042 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c39", "name": "us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R71": { "role": "http://vseehealth.com/role/ScheduleofIncomeLossIncomeTaxesTable", "longName": "996043 - Disclosure - Income Taxes - Schedule of Income/ (Loss) Income Taxes (Details)", "shortName": "Income Taxes - Schedule of Income/ (Loss) Income Taxes (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c39", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R72": { "role": "http://vseehealth.com/role/ScheduleofIncomeTaxExpenseBenefitTable", "longName": "996044 - Disclosure - Income Taxes - Schedule of Income Tax Expense (Benefit) (Details)", "shortName": "Income Taxes - Schedule of Income Tax Expense (Benefit) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c39", "name": "vsee:IncomeTaxExpenseBenefitContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:ScheduleOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c39", "name": "vsee:IncomeTaxExpenseBenefitContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:ScheduleOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R73": { "role": "http://vseehealth.com/role/EquityDetails", "longName": "996045 - Disclosure - Equity (Details)", "shortName": "Equity (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c54", "name": "vsee:ConversionOfStockEquivalentCommonStockSharesUponConversion", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R74": { "role": "http://vseehealth.com/role/WarrantsDetails", "longName": "996046 - Disclosure - Warrants (Details)", "shortName": "Warrants (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c0", "name": "vsee:ClassOfWarrantOrRightIssuedDuringPeriod", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c1205", "name": "vsee:SecuritiesSoldCombinedPurchasePrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R75": { "role": "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "longName": "996047 - Disclosure - Warrants - Schedule of Warrants Issued and Outstanding (Details)", "shortName": "Warrants - Schedule of Warrants Issued and Outstanding (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c687", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R76": { "role": "http://vseehealth.com/role/ReportablesegmentDetails", "longName": "996048 - Disclosure - Reportable segment (Details)", "shortName": "Reportable segment (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c54", "name": "vsee:NumberOfLegacyOperatingEntities", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R77": { "role": "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "longName": "996049 - Disclosure - Reportable segment - Schedule of Reconciliation of Consolidated Segment (Details)", "shortName": "Reportable segment - Schedule of Reconciliation of Consolidated Segment (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c694", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c694", "name": "us-gaap:OtherOperatingIncomeExpenseNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R78": { "role": "http://vseehealth.com/role/FairValueMeasurementsDetails", "longName": "996050 - Disclosure - Fair Value Measurements (Details)", "shortName": "Fair Value Measurements (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R79": { "role": "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "longName": "996051 - Disclosure - Fair Value Measurements - Schedule of Fair Value Information on Recurring Basis (Details)", "shortName": "Fair Value Measurements - Schedule of Fair Value Information on Recurring Basis (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c698", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c698", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R80": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable", "longName": "996052 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c731", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c731", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R81": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "longName": "996053 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c740", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R82": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "longName": "996054 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c749", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c749", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R83": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "longName": "996055 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c758", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c758", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R84": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "longName": "996056 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c767", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c767", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R85": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "longName": "996057 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c776", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c776", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R86": { "role": "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "longName": "996058 - Disclosure - Fair Value Measurements - Schedule of Changes in the Fair Value of Financial Liabilities (Details)", "shortName": "Fair Value Measurements - Schedule of Changes in the Fair Value of Financial Liabilities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInitialFairValueAtIssuance", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R87": { "role": "http://vseehealth.com/role/SubsequentEventsDetails", "longName": "996059 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c813", "name": "vsee:DebtInstrumentMinimumBidPrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c813", "name": "vsee:DebtInstrumentMinimumBidPrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R88": { "role": "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable0", "longName": "996060 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Timing of Revenue Recognition (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Timing of Revenue Recognition (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R89": { "role": "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "longName": "996061 - Disclosure - Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c869", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R90": { "role": "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable0", "longName": "996062 - Disclosure - Summary of Significant Accounting Policies - Schedule of Allowance for Credit Losses (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Allowance for Credit Losses (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R91": { "role": "http://vseehealth.com/role/ScheduleofDeferredRevenueActivitiesTable", "longName": "996063 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Revenue Activities (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Deferred Revenue Activities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "c18", "name": "us-gaap:DeferredRevenueCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DeferredRevenueByArrangementDisclosureTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c111", "name": "us-gaap:DeferredRevenueCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DeferredRevenueByArrangementDisclosureTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R92": { "role": "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "longName": "996064 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "c893", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "vsee:ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssets", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c893", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "vsee:ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssets", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R93": { "role": "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0", "longName": "996065 - Disclosure - Summary of Significant Accounting Policies - Schedule of Identifiable Intangible Assets Subject to Amortization (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Identifiable Intangible Assets Subject to Amortization (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R94": { "role": "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0", "longName": "996066 - Disclosure - Summary of Significant Accounting Policies - Schedule of Expected Amortization Expense (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Expected Amortization Expense (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R95": { "role": "http://vseehealth.com/role/BusinessCombinationDetails", "longName": "996067 - Disclosure - Business Combination (Details)", "shortName": "Business Combination (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "c0", "name": "vsee:BusinessAcquisitionCommonStockIssuedOrIssuableNumberOfShares", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c852", "name": "vsee:EstimatedValueOfSharesAndOptionsGranted", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R96": { "role": "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "longName": "996068 - Disclosure - Business Combination - Schedule of Purchase Consideration (Details)", "shortName": "Business Combination - Schedule of Purchase Consideration (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "c903", "name": "vsee:BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c903", "name": "vsee:BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R97": { "role": "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "longName": "996069 - Disclosure - Business Combination - Schedule of Purchase Consideration (Parentheticals) (Details)", "shortName": "Business Combination - Schedule of Purchase Consideration (Parentheticals) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "parenthetical", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "c903", "name": "vsee:BusinessAcquisitionCommonStockIssuedOrIssuableNumberOfShares", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R98": { "role": "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "longName": "996070 - Disclosure - Business Combination - Schedule of Allocation of Total Purchase Consideration (Details)", "shortName": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "c903", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c903", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R99": { "role": "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals", "longName": "996071 - Disclosure - Business Combination - Schedule of Allocation of Total Purchase Consideration (Parentheticals) (Details)", "shortName": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Parentheticals) (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "parenthetical", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "c903", "name": "us-gaap:CashAcquiredFromAcquisition", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c903", "name": "us-gaap:CashAcquiredFromAcquisition", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R100": { "role": "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable", "longName": "996072 - Disclosure - Business Combination - Schedule of Pro forma Financial Information (Details)", "shortName": "Business Combination - Schedule of Pro forma Financial Information (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "c55", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c55", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R101": { "role": "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "longName": "996073 - Disclosure - Business Combination - Schedule of Common Stock Business Combination (Details)", "shortName": "Business Combination - Schedule of Common Stock Business Combination (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "c817", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "vsee:ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c924", "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "vsee:ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R102": { "role": "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable", "longName": "996074 - Disclosure - Business Combination - Schedule of the Recapitalization and Net Equity Impact on Business Combination (Details)", "shortName": "Business Combination - Schedule of the Recapitalization and Net Equity Impact on Business Combination (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "c843", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:SummaryOfRecapitalizationAndEquityImpactTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c843", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:SummaryOfRecapitalizationAndEquityImpactTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R103": { "role": "http://vseehealth.com/role/FixedAssetsDetails", "longName": "996075 - Disclosure - Fixed Assets (Details)", "shortName": "Fixed Assets (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "c54", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R104": { "role": "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "longName": "996076 - Disclosure - Fixed Assets - Schedule of Components of Fixed Assets (Details)", "shortName": "Fixed Assets - Schedule of Components of Fixed Assets (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R105": { "role": "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable0", "longName": "996077 - Disclosure - Leases - Schedule of Operating Lease Right-of-Use Assets (Details)", "shortName": "Leases - Schedule of Operating Lease Right-of-Use Assets (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "c2", "name": "vsee:OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R106": { "role": "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable0", "longName": "996078 - Disclosure - Leases - Schedule of Operating Lease Liabilities (Details)", "shortName": "Leases - Schedule of Operating Lease Liabilities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:OperatingLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeOperatingLeaseLiabilitiesTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R107": { "role": "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable0", "longName": "996079 - Disclosure - Leases - Schedule of Future Minimum Rent Payments Under the Operating Lease (Details)", "shortName": "Leases - Schedule of Future Minimum Rent Payments Under the Operating Lease (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R108": { "role": "http://vseehealth.com/role/ScheduleofExpensesIncurredforOperatingLeasesTable0", "longName": "996080 - Disclosure - Leases - Schedule of Expenses Incurred for Operating Leases (Details)", "shortName": "Leases - Schedule of Expenses Incurred for Operating Leases (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R109": { "role": "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable0", "longName": "996081 - Disclosure - Leases - Schedule of Weighted Average Remaining Lease Term and Discount Rate on Finance Leases (Details)", "shortName": "Leases - Schedule of Weighted Average Remaining Lease Term and Discount Rate on Finance Leases (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseSupplementalInformationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R110": { "role": "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable0", "longName": "996082 - Disclosure - Leases - Schedule of Finance Leased Equipment (Details)", "shortName": "Leases - Schedule of Finance Leased Equipment (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseRightOfUseAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R111": { "role": "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable0", "longName": "996083 - Disclosure - Leases - Schedule of Finance Lease Liabilities (Details)", "shortName": "Leases - Schedule of Finance Lease Liabilities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:FinanceLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R112": { "role": "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable", "longName": "996084 - Disclosure - Leases - Schedule of Future Minimum Payments Under Finance Lease (Details)", "shortName": "Leases - Schedule of Future Minimum Payments Under Finance Lease (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R113": { "role": "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable0", "longName": "996085 - Disclosure - Leases - Schedule of Expenses Incurred with Respect to Finance Leases (Details)", "shortName": "Leases - Schedule of Expenses Incurred with Respect to Finance Leases (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "c39", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:FinanceLeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R114": { "role": "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0", "longName": "996086 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)", "shortName": "Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "114", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c18", "name": "us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R115": { "role": "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0", "longName": "996087 - Disclosure - Line of Credit and Notes Payable, net of discount - Schedule of Line of Credit and Notes Payable, Net of Discount (Details)", "shortName": "Line of Credit and Notes Payable, net of discount - Schedule of Line of Credit and Notes Payable, Net of Discount (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "115", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:LongTermDebt", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c16", "name": "us-gaap:LongTermDebtCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R116": { "role": "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0", "longName": "996088 - Disclosure - Line of Credit and Notes Payable, net of discount - Schedule of Required Principal Payments (Details)", "shortName": "Line of Credit and Notes Payable, net of discount - Schedule of Required Principal Payments (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "116", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R117": { "role": "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable", "longName": "996089 - Disclosure - Income Taxes - Schedule of Income Tax Provision (Details)", "shortName": "Income Taxes - Schedule of Income Tax Provision (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "117", "firstAnchor": { "contextRef": "c54", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R118": { "role": "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable", "longName": "996090 - Disclosure - Income Taxes - Schedule of Reconciliation of Federal Income Tax Rate to Company's Effective Tax Rate (Details)", "shortName": "Income Taxes - Schedule of Reconciliation of Federal Income Tax Rate to Company's Effective Tax Rate (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "118", "firstAnchor": { "contextRef": "c54", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R119": { "role": "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable", "longName": "996091 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "119", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R120": { "role": "http://vseehealth.com/role/ScheduleofStockOptionsTable", "longName": "996092 - Disclosure - Equity - Schedule of Stock Options (Details)", "shortName": "Equity - Schedule of Stock Options (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "120", "firstAnchor": { "contextRef": "c18", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c18", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R121": { "role": "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "longName": "996093 - Disclosure - Equity - Schedule of Key Assumptions Used in Valuing Unvested Options (Details)", "shortName": "Equity - Schedule of Key Assumptions Used in Valuing Unvested Options (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "121", "firstAnchor": { "contextRef": "c817", "name": "us-gaap:SharePrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c817", "name": "us-gaap:SharePrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R122": { "role": "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "longName": "996094 - Disclosure - Warrants - Schedule of Warrants Issued and outstanding (Details)", "shortName": "Warrants - Schedule of Warrants Issued and outstanding (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "122", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c55", "name": "vsee:ClassOfWarrantOrRightAssumed", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R123": { "role": "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "longName": "996095 - Disclosure - Reportable segments - Schedule of Reconciliation of Consolidated Segment (Details)", "shortName": "Reportable segments - Schedule of Reconciliation of Consolidated Segment (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "123", "firstAnchor": { "contextRef": "c694", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c1275", "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R124": { "role": "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable", "longName": "996096 - Disclosure - Reportable segments - Schedule of Total Assets by Segment (Details)", "shortName": "Reportable segments - Schedule of Total Assets by Segment (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "124", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c1277", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R125": { "role": "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "longName": "996097 - Disclosure - Reportable segments - Schedule of Reportable Segment Depreciation and Amortization and Capital Expenditures (Details)", "shortName": "Reportable segments - Schedule of Reportable Segment Depreciation and Amortization and Capital Expenditures (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "125", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:SegmentExpenditureAdditionToLongLivedAssets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R126": { "role": "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0", "longName": "996098 - Disclosure - Fair Value Measurements - Schedule of Fair Value Information on Recurring Basis (Details)", "shortName": "Fair Value Measurements - Schedule of Fair Value Information on Recurring Basis (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "126", "firstAnchor": { "contextRef": "c718", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c1287", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } }, "R127": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "longName": "996099 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "127", "firstAnchor": { "contextRef": "c1308", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c1308", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R128": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable6", "longName": "996100 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "128", "firstAnchor": { "contextRef": "c1319", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c1319", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R129": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "longName": "996101 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "129", "firstAnchor": { "contextRef": "c1321", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c1321", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R130": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable8", "longName": "996102 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "130", "firstAnchor": { "contextRef": "c1337", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c1337", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R131": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable9", "longName": "996103 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "131", "firstAnchor": { "contextRef": "c1348", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c1348", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R132": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "longName": "996104 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "132", "firstAnchor": { "contextRef": "c1357", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c1357", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R133": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "longName": "996105 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "133", "firstAnchor": { "contextRef": "c1368", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c1368", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true, "unique": true } }, "R134": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "longName": "996106 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "134", "firstAnchor": { "contextRef": "c740", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": null }, "R135": { "role": "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "longName": "996107 - Disclosure - Fair Value Measurements - Schedule of Changes in the Fair Value of Financial Liabilities (Details)", "shortName": "Fair Value Measurements - Schedule of Changes in the Fair Value of Financial Liabilities (Details)", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "details", "menuCat": "Details", "order": "135", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "first": true }, "uniqueAnchor": { "contextRef": "c1388", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsees1091726.htm", "unique": true } } }, "tag": { "vsee_ADIFundingConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ADIFundingConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Convertible Note, related party [Member]", "verboseLabel": "ADI Funding Convertible Note [Member]", "label": "ADIFunding Convertible Note Member" } } }, "auth_ref": [] }, "vsee_ADIFundingLLCConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ADIFundingLLCConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable1" ], "lang": { "en-us": { "role": { "terseLabel": "ADI Funding LLC Convertible Note [Member]", "label": "ADIFunding LLCConvertible Note Member" } } }, "auth_ref": [] }, "vsee_AGPAllianceGlobalPartnersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AGPAllianceGlobalPartnersMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "A.G.P./Alliance Global Partners [Member]", "label": "AGPAlliance Global Partners Member" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Total accounts payable and accrued liabilities", "terseLabel": "Accounts payable and accrued liabilities", "label": "Accounts Payable and Accrued Liabilities, Current", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r1431" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Accounts Payable and Accrued Liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r932", "r933", "r941" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/AccountsPayableandAccruedLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Payable and Accrued Liabilities", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r1653" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsPayableAndAccruedLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Accounts Payable and Accrued Liabilities, Noncurrent", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r1424" ] }, "vsee_AccountsPayableAndAccruedLiabilitiesOneMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AccountsPayableAndAccruedLiabilitiesOneMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Payable And Accrued Liabilities [Member]", "label": "Accounts Payable And Accrued Liabilities One Member" } } }, "auth_ref": [] }, "vsee_AccountsPayableAndAccruedLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AccountsPayableAndAccruedLiabilityMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Payable and Accrued Liability [Member]", "label": "Accounts Payable And Accrued Liability Member" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r1315", "r1415", "r1420" ] }, "vsee_AccountsPayableandAccruedLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AccountsPayableandAccruedLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_AccountsPayableandAccruedLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AccountsPayableandAccruedLiabilitiesScheduleofAccountsPayableandAccruedLiabilitiesDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) [Table]" } } }, "auth_ref": [] }, "vsee_AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable0", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Add: Allowance for credit losses, due to acquisition", "verboseLabel": "Allowance for credit losses, due to acquisition", "documentation": "Amount of allowance for credit loss on accounts receivable raised from business acquisition.", "label": "Accounts Receivable Allowance For Credit Loss Increase From Acquisition" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Allowance for Credit Losses", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r1554" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsReceivableMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable [Member]", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r1160", "r1520" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r1541" ] }, "vsee_AccountsReceivableWriteOffIncludedInAllowanceForCreditLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AccountsReceivableWriteOffIncludedInAllowanceForCreditLosses", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable", "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accounts receivable write-off included in allowance for credit losses above", "negatedTerseLabel": "(Less)/Add: Accounts receivable write-off included in allowance for credit losses above", "documentation": "Accounts receivable write-off included in allowance for credit losses.", "label": "Accounts Receivable Write Off Included In Allowance For Credit Losses" } } }, "auth_ref": [] }, "vsee_AccruedLiabilitiesCommonStockIssuableToRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AccruedLiabilitiesCommonStockIssuableToRelatedParty", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock issuances to the related party", "documentation": "Carrying amount as of the balance sheet date relating to future stock issuances to the related party as part of the consulting agreement.", "label": "Accrued Liabilities Common Stock Issuable To Related Party" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated depreciation", "label": "Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization", "documentation": "Amount of accumulated depreciation, depletion, and amortization of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r151", "r407", "r417", "r976", "r977", "r994", "r1572" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r385", "r386", "r387", "r389", "r1036", "r1173" ] }, "vsee_AdditionalAdvanceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AdditionalAdvanceAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional advance amount", "documentation": "Additional advance amount.", "label": "Additional Advance Amount" } } }, "auth_ref": [] }, "vsee_AdditionalBridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AdditionalBridgeNotesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Bridge Notes", "verboseLabel": "Additional Bridge Notes [Member]", "documentation": "Represents information pertaining to additional bridge note.", "label": "Additional Bridge Notes Member" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r176", "r514", "r932", "r933", "r947", "r1315", "r1813" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "verboseLabel": "Additional Paid- In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r978", "r1055", "r1506", "r1507", "r1508", "r1511", "r1706", "r1818" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "AddressTypeDomain", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "vsee_AdjustmentToIncreaseCompensationAndRelatedBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AdjustmentToIncreaseCompensationAndRelatedBenefits", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation and related benefits", "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Adjustment To Increase Compensation And Related Benefits" } } }, "auth_ref": [] }, "vsee_AdjustmentsToAdditionalPaidInCapitalConversionOfDebtGainLossOnRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AdjustmentsToAdditionalPaidInCapitalConversionOfDebtGainLossOnRestructuring", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional reduction in the carrying value representing as gain on restructuring", "verboseLabel": "Additional reduction in the carrying value representing as gain on restructuring (in Dollars)", "documentation": "Amount of increase (decrease) in adjustments to additional paid-in capital (APIC) resulting from the gain (loss) on restructuring.", "label": "Adjustments To Additional Paid In Capital Conversion Of Debt Gain Loss On Restructuring" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from pre-funded warrants, net of issuance cost", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration." } } }, "auth_ref": [ "r1608", "r1614", "r1617" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:", "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]" } } }, "auth_ref": [] }, "vsee_AdministratorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AdministratorMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Administrator [Member]", "documentation": "Represents the member information pertaining to administrator.", "label": "Administrator Member" } } }, "auth_ref": [] }, "vsee_AffiliateOfSponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AffiliateOfSponsorMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Affiliate Of The Sponsor [Member]", "documentation": "This member stands for an affiliate of the sponsor.", "label": "Affiliate Of Sponsor Member" } } }, "auth_ref": [] }, "vsee_AggregateAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AggregateAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount (in Dollars)", "documentation": "The amount of aggregate amount.", "label": "Aggregate Amount" } } }, "auth_ref": [] }, "vsee_AggregateShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AggregateShares", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate shares", "documentation": "Shares of aggregate.", "label": "Aggregate Shares" } } }, "auth_ref": [] }, "vsee_AgreedToPurchaseSharesOfCommonStockAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AgreedToPurchaseSharesOfCommonStockAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreed to purchase shares of common stock amount", "documentation": "Agreed to purchase shares of common stock amount.", "label": "Agreed To Purchase Shares Of Common Stock Amount" } } }, "auth_ref": [] }, "vsee_AgreementAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AgreementAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreement amount", "documentation": "Agreement amount.", "label": "Agreement Amount" } } }, "auth_ref": [] }, "vsee_AgreementAxis": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AgreementAxis", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreement [Axis]", "label": "Agreement Axis" } } }, "auth_ref": [] }, "vsee_AgreementDomainDomain": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AgreementDomainDomain", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "label": "AgreementDomain [Domain]" } } }, "auth_ref": [] }, "vsee_AgreementTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AgreementTypeAxis", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreement Type [Axis]", "label": "Agreement Type Axis" } } }, "auth_ref": [] }, "vsee_AgreementTypeDomainDomain": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AgreementTypeDomainDomain", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "AgreementTypeDomain [Domain]" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "verboseLabel": "Share-based compensation expense", "netLabel": "Share-based compensation expense (in Dollars)", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r587", "r590", "r599" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable", "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable0", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning allowance for credit losses", "periodEndLabel": "Ending allowance for credit losses", "terseLabel": "Allowance for credit losses", "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r181", "r310", "r349", "r351", "r353", "r1767" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for credit losses", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r181", "r310", "r349" ] }, "vsee_AltaMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AltaMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alta [Member]", "label": "Alta Member" } } }, "auth_ref": [] }, "vsee_AltaWarrantsExercisableCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AltaWarrantsExercisableCommonStockMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alta warrants Exercisable Common Stock [Member]", "label": "Alta Warrants Exercisable Common Stock Member" } } }, "auth_ref": [] }, "vsee_AmendedAndRestatedConversionSecuritiesPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AmendedAndRestatedConversionSecuritiesPurchaseAgreementsMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amended And Restated Conversion Securities Purchase Agreements [Member]", "documentation": "Represents information related to amended and restated conversion conversion securities purchase agreement.", "label": "Amended And Restated Conversion Securities Purchase Agreements Member" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "AmendmentFlag", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of discount on note payable", "label": "Amortization of Debt Discount (Premium)", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r4", "r34", "r465", "r1732" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Intangible Asset, Finite-Lived, Amortization Expense", "documentation": "Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r4", "r198", "r384", "r391", "r1176", "r1194", "r1195", "r1197", "r1199", "r1572" ] }, "vsee_AmortizationOfRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AmortizationOfRightOfUseAsset", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of right-of-use assets", "documentation": "Amount of amortization expense attributable to right-of-use asset.", "label": "Amortization Of Right Of Use Asset" } } }, "auth_ref": [] }, "vsee_AmountDue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AmountDue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount due", "documentation": "Amount due.", "label": "Amount Due" } } }, "auth_ref": [] }, "vsee_AmountPaidByInvestor": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AmountPaidByInvestor", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount paid by investor", "documentation": "The amount paid by an accredited investor in a partnership agreement with the company.", "label": "Amount Paid By Investor" } } }, "auth_ref": [] }, "vsee_AmountSettledThroughPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AmountSettledThroughPayment", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount settled through payment", "documentation": "Amount settled through payment.", "label": "Amount Settled Through Payment" } } }, "auth_ref": [] }, "vsee_AnnualPercentageRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AnnualPercentageRate", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual percentage rate", "documentation": "Annual percentage rate.", "label": "Annual Percentage Rate" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Anti-dilutive shares outstanding", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r253" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r253" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r253" ] }, "vsee_April2025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "April2025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "April 2025 Promissory Note [Member]", "label": "April2025 Promissory Note Member" } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r710" ] }, "us-gaap_AssetAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetAcquisitionAxis", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Axis]", "documentation": "Information by asset acquisition." } } }, "auth_ref": [ "r381", "r385", "r386", "r387", "r388", "r389", "r1036", "r1683" ] }, "us-gaap_AssetAcquisitionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetAcquisitionDomain", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Domain]", "documentation": "Asset acquisition." } } }, "auth_ref": [ "r381", "r385", "r386", "r387", "r388", "r389", "r1036", "r1683" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Assets", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "terseLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r129", "r135", "r154", "r212", "r215", "r216", "r256", "r270", "r296", "r300", "r344", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r517", "r712", "r717", "r804", "r932", "r933", "r936", "r953", "r954", "r983", "r1096", "r1212", "r1213", "r1230", "r1315", "r1336", "r1337", "r1349", "r1594", "r1595", "r1746" ] }, "vsee_AssetsAbstract0": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AssetsAbstract0", "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets Abstract0" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r129", "r135", "r182", "r212", "r215", "r216", "r344", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r517", "r712", "r717", "r804", "r1315", "r1412", "r1594", "r1595", "r1746" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsCurrentAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "verboseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current assets", "label": "Assets, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets from discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Assets", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r121", "r132", "r404", "r415", "r1182", "r1401", "r1407", "r1408" ] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Current assets from discontinued operations", "terseLabel": "Current assets from discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r121", "r132", "r404", "r415", "r1401", "r1407", "r1408" ] }, "vsee_AssignmentOfALoanLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AssignmentOfALoanLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assignment of a loan liability", "documentation": "Assignment of a loan liability.", "label": "Assignment Of ALoan Liability" } } }, "auth_ref": [] }, "vsee_AssumesFloorConversionPriceMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "AssumesFloorConversionPriceMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assumes Floor Conversion Price [Member]", "label": "Assumes Floor Conversion Price Member" } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AwardTypeAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r558", "r559", "r560", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r582", "r583", "r584", "r585", "r586" ] }, "vsee_BearsInterestRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BearsInterestRatePercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bears interest rate percent", "documentation": "Percentage of bears interest rate.", "label": "Bears Interest Rate Percentage" } } }, "auth_ref": [] }, "vsee_BeneficialOwnershipPercent": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BeneficialOwnershipPercent", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Beneficial ownership", "documentation": "Percentage of beneficial ownership.", "label": "Beneficial Ownership Percent" } } }, "auth_ref": [] }, "vsee_BeneficiallyOwnPercent": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BeneficiallyOwnPercent", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Beneficially own percent", "documentation": "Beneficially own percent.", "label": "Beneficially Own Percent" } } }, "auth_ref": [] }, "vsee_BidPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BidPricePerShare", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bid price per share", "documentation": "It represents the bid price per share regained by the entity.", "label": "Bid Price Per Share" } } }, "auth_ref": [] }, "vsee_BridgeExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BridgeExchangeAgreementMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Exchange Agreement", "verboseLabel": "Bridge Exchange Agreement [Member]", "documentation": "Represents the information pertaining to bridge exchange agreement.", "label": "Bridge Exchange Agreement Member" } } }, "auth_ref": [] }, "vsee_BridgeInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BridgeInvestorMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Investor [Member]", "documentation": "Represents information related to Bridge Investor.", "label": "Bridge Investor Member" } } }, "auth_ref": [] }, "vsee_BridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BridgeNotesMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Notes [Member]", "documentation": "Represents information relating to the bridge notes issued by the entity.", "label": "Bridge Notes Member" } } }, "auth_ref": [] }, "vsee_BridgeSecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BridgeSecuritiesPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Securities Purchase Agreement [Member]", "documentation": "It represents bridge securities purchase agreement.", "label": "Bridge Securities Purchase Agreement Member" } } }, "auth_ref": [] }, "vsee_BridgeWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BridgeWarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Warrants [Member]", "verboseLabel": "Bridge [Member]", "documentation": "Represents information pertaining to Bridge Warrants.", "label": "Bridge Warrants Member" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Business Combination [Domain]", "documentation": "Business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r381", "r385", "r386", "r387", "r388", "r389", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r682", "r683", "r684", "r685", "r686", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r704", "r705", "r706", "r1036", "r1173", "r1245", "r1246", "r1670", "r1675", "r1677" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Business Combination [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r381", "r385", "r386", "r387", "r388", "r389", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r682", "r683", "r684", "r685", "r686", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r704", "r705", "r706", "r1036", "r1173", "r1245", "r1246", "r1670", "r1675", "r1677" ] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock issued to seller (in Shares)", "verboseLabel": "Number of shares of common stock issued to seller", "documentation": "Number of common shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition Common Stock Issued Or Issuable Number Of Shares" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock issued upon conversion of debt (in Shares)", "verboseLabel": "Number of shares of common stock issued upon conversion of debt", "documentation": "Number of common shares of equity interests issued or issuable upon debt conversion to acquire entity.", "label": "Business Acquisition Common Stock Issued Or Issuable Upon Debt Conversion Number Of Shares" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "3,656 shares of common stock issued upon conversion of debt at $968.80 per share", "documentation": "Amount of common stock issued or issuable upon debt conversion in consideration for the business combination.", "label": "Business Acquisition Common Stock Issued Or Issuable Upon Debt Conversion Value Assigned" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "61,875 shares of common stock issued to sellers at $968.80 per share", "documentation": "Amount of common stock issued or issuable in consideration for the business combination.", "label": "Business Acquisition Common Stock Issued Or Issuable Value Assigned" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionEquityInterestConvertedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionEquityInterestConvertedValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes converted (in Dollars)", "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) converted to acquire the entity.", "label": "Business Acquisition Equity Interest Converted Value" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionEquityInterestIssuableNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionEquityInterestIssuableNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity interests issuable", "documentation": "Number of shares of equity interests issuable to acquire entity.", "label": "Business Acquisition Equity Interest Issuable Number Of Shares" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total purchase consideration", "verboseLabel": "Total purchase consideration (in Dollars)", "label": "Business Combination, Consideration Transferred, Equity Interest, Share Issued, Value", "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity." } } }, "auth_ref": [ "r1680", "r1681" ] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued for business combination", "label": "Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares", "documentation": "Number of shares of equity interest issued or issuable by acquirer as part of consideration transferred in business combination." } } }, "auth_ref": [ "r1251", "r1256", "r1257", "r1291", "r1292" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Business Combination", "terseLabel": "Organization and Description of Business", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r381", "r646", "r647", "r648", "r649", "r655", "r656", "r657", "r658", "r664", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r682", "r683", "r684", "r685", "r686", "r689", "r690", "r691", "r692", "r693", "r694", "r700", "r701", "r702", "r706", "r1251", "r1261", "r1670", "r1675", "r1677" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business acquisition percentage of voting interests acquired", "label": "Business Combination, Voting Equity Interest Acquired, Percentage", "documentation": "Percentage of voting equity interest acquired in business combination." } } }, "auth_ref": [ "r648", "r1251", "r1254" ] }, "vsee_BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionSharesAssigned": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionSharesAssigned", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issuable upon conversion (in Shares)", "verboseLabel": "Common stock issuable upon conversion", "documentation": "Shares of preferred stock issued or issuable to acquire the entity.", "label": "Business Acquisition Preferred Stock Issued Or Issuable Upon Debt Conversion Shares Assigned" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "300 shares of series A preferred stock issued upon conversion of debt, of which upon conversion, 1,875 shares of common stock are issuable, at $968.80 per share", "documentation": "Amount of preferred stock issued or issuable upon debt conversion in consideration for the business combination.", "label": "Business Acquisition Preferred Stock Issued Or Issuable Upon Debt Conversion Value Assigned" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share, basic (in Dollars per share)", "label": "Business Combination, Pro Forma Information, Pro Forma Earnings Per Share, Basic", "documentation": "Per basic share amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r1379", "r1380", "r1671" ] }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share, diluted (in Dollars per share)", "label": "Business Combination, Pro Forma Information, Pro Forma Earnings Per Share, Diluted", "documentation": "Per diluted share amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r1379", "r1380", "r1671" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Pro forma Financial Information", "label": "Business Combination, Pro Forma Information [Table Text Block]", "documentation": "Tabular disclosure of pro forma revenue and earnings for business combination or aggregate of series of individually immaterial business combinations." } } }, "auth_ref": [ "r1251", "r1262", "r1379", "r1380", "r1671" ] }, "vsee_BusinessAcquisitionProFormaOperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionProFormaOperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "documentation": "The pro forma operating lease expense.", "label": "Business Acquisition Pro Forma Operating Lease Expense" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaTransactionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionProFormaTransactionExpenses", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction expenses", "documentation": "The pro forma transaction expenses for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition Pro Forma Transaction Expenses" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares, basic (in Shares)", "documentation": "The pro forma basic weighted average shares outstanding for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares, diluted (in Shares)", "documentation": "The pro forma diluted weighted average shares outstanding for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition Pro Forma Weighted Average Shares Outstanding Diluted" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Share price per share (in Dollars per share)", "label": "Business Combination, Price Per Share", "documentation": "Per share price of saleable stock paid or offered to be paid by acquirer in business combination." } } }, "auth_ref": [ "r1293", "r1673", "r1674", "r1680", "r1681" ] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss", "label": "Business Combination, Pro Forma Information, Pro Forma Income (Loss), after Tax", "documentation": "Amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r661", "r662", "r664", "r1251", "r1262", "r1263" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenues", "label": "Business Combination, Pro Forma Information, Pro Forma Revenue", "documentation": "Amount of pro forma revenue of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r661", "r662", "r664", "r1251", "r1262" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction expenses", "label": "Business Combination, Acquisition-Related Cost, Expense", "documentation": "Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department." } } }, "auth_ref": [ "r1668", "r1672" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total purchase price consideration, net of cash acquired of $29,123", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r690", "r702", "r1251", "r1256" ] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount of outstanding notes (in Dollars)", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r693", "r1251", "r1256", "r1292" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r695", "r702", "r776", "r777", "r778", "r1251", "r1258" ] }, "vsee_BusinessCombinationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationDetailsLineItems", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationDetailsTable", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombination" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination", "label": "Business Combination [Text Block]", "documentation": "The entire disclosure for business combination." } } }, "auth_ref": [ "r643", "r646", "r650", "r659", "r663", "r664", "r665", "r666", "r667", "r668", "r670", "r671", "r677", "r680", "r681", "r687", "r688", "r689", "r697", "r701", "r702", "r703", "r705", "r707", "r1251", "r1252", "r1253", "r1254", "r1258", "r1259", "r1260" ] }, "vsee_BusinessCombinationNotesAssumedFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationNotesAssumedFairValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate fair value of notes (in Dollars)", "documentation": "Fair value of notes payable assumed which have been recognized as of the acquisition date.", "label": "Business Combination Notes Assumed Fair Value" } } }, "auth_ref": [] }, "vsee_BusinessCombinationNumberOfSharesCalledByEachRightsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationNumberOfSharesCalledByEachRightsIssued", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock called by each rights issued (in Shares)", "documentation": "The number of shares or fractional shares that each right entitles the holder, issued pursuant to business combination transaction.", "label": "Business Combination Number Of Shares Called By Each Rights Issued" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss since the date of acquisition (in Dollars)", "label": "Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual", "documentation": "Amount of acquiree's earnings (loss) since acquisition date of business combination included in consolidated statement of income." } } }, "auth_ref": [ "r660", "r664", "r1251", "r1262" ] }, "vsee_BusinessCombinationProFormaInformationGoodwillImpairmentChargeOfAcquireeActual": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationProFormaInformationGoodwillImpairmentChargeOfAcquireeActual", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment since the date of acquisition (in Dollars)", "documentation": "This element represents the amount of goodwill impairment of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination Pro Forma Information Goodwill Impairment Charge Of Acquiree Actual" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue since the date of acquisition (in Dollars)", "label": "Business Combination, Acquiree's Revenue since Acquisition Date, Actual", "documentation": "Amount of acquiree's revenue since acquisition date of business combination included in consolidated statement of income." } } }, "auth_ref": [ "r660", "r664", "r1251", "r1262" ] }, "vsee_BusinessCombinationPurchaseConsiderationPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationPurchaseConsiderationPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Encompass Purchase Liability", "verboseLabel": "Encompass purchase liability", "documentation": "Carrying value as of the balance sheet date of business combination purchase consideration due within one year or the operating cycle.", "label": "Business Combination Purchase Consideration Payable Current" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedFinanceLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedFinanceLeaseObligation", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities - finance", "documentation": "Amount of finance lease obligation assumed in business combination.", "label": "Business Combination Recognized Identifiable Asset Acquired And Liability Assumed Finance Lease Obligation" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities - operating", "documentation": "Amount of operating lease obligation assumed in business combination.", "label": "Business Combination Recognized Identifiable Asset Acquired And Liability Assumed Operating Lease Obligation" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets acquired", "label": "Business Combination, Recognized Asset Acquired, Asset", "documentation": "Amount of asset acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r675", "r680" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cash - Trust and cash", "label": "Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1676", "r1678" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivables", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "documentation": "Amount of accounts receivables, that have been delivered or sold in the normal course of business, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Accounts Receivables" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesGross", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross contractual accounts receivable (in Dollars)", "documentation": "Amount of gross accounts receivables, that have been delivered or sold in the normal course of business, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Accounts Receivables Gross" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesNotExpectedToBeCollected": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesNotExpectedToBeCollected", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross contractual accounts receivable not expected to be collected (in Dollars)", "documentation": "Amount of gross accounts receivables that are not expected to be collected from customers.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Accounts Receivables Not Expected To Be Collected" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivables", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Note receivable, related party", "documentation": "Amount of notes receivables, that have been delivered or sold in the normal course of business, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Notes Receivables" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current", "documentation": "Amount of prepaid expense and asset classified as other, acquired in business combination and recognized at acquisition date, classified as current." } } }, "auth_ref": [ "r1676", "r1678" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesFromRelatedParties", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Due from related party", "documentation": "Amount due from customers or clients for goods or services, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables From Related Parties" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable, accrued expenses and other current liabilities", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, accrued liabilities and other liabilities, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Accrued Liabilities And Other Liabilities" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Accrued Expenses", "documentation": "Amount of expenses of taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. used in an entity's business assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDerivativeLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Extension Note - Embedded Derivative", "documentation": "Amount of derivative liability due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Derivative Liability" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesExchangeNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesExchangeNotesPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Exchange Note", "documentation": "Amount of exchange notes payables due within one year or within the normal operating cycle, if longer assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Exchange Notes Payable" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLineOfCredit", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "ELOC", "documentation": "Amount of line of credit payables due within one year or within the normal operating cycle, if longer assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Line Of Credit" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableExtensionLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableExtensionLoan", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Promissory Note - Extension Note", "documentation": "Amount of extension notes payables due within one year or within the normal operating cycle, if longer assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Extension Loan" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartyOther": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartyOther", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Promissory Note - SCS Capital Partners LLC", "documentation": "Amount of notes payables to the related party due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Related Party Other" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartySponsor": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartySponsor", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Promissory Note - Related Party", "documentation": "Amount of notes payables to the sponsor due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Related Party Sponsor" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Due to Sponsor", "label": "Business Combination, Recognized Liability Assumed, Other Liability, Current", "documentation": "Amount of liability assumed in business combination and recognized at acquisition date, classified as other and current." } } }, "auth_ref": [ "r1676", "r1678" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesPromissoryNotesPayableAdditionalBridgeLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesPromissoryNotesPayableAdditionalBridgeLoans", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Additional Bridge Notes", "documentation": "Amount of notes payable related to additional bridge loans due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Promissory Notes Payable Additional Bridge Loans" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Business Combination, Recognized Liability Assumed, Deferred Tax Liability", "documentation": "Amount of deferred tax liability assumed in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1676", "r1678" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets", "label": "Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill", "documentation": "Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset." } } }, "auth_ref": [ "r1251", "r1256", "r1259", "r1676", "r1678" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Finite-Lived", "documentation": "Amount of identifiable finite-lived intangible asset acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1676", "r1678" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities assumed", "negatedTotalLabel": "Total liabilities assumed", "label": "Business Combination, Recognized Liability Assumed, Liability", "documentation": "Amount of liability assumed in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r675", "r680" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net liabilities assumed", "verboseLabel": "Net liabilities assumed (in Dollars)", "label": "Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)", "documentation": "Amount of asset acquired in excess of (less than) liability assumed in business combination and recognized at acquisition date. Excludes goodwill." } } }, "auth_ref": [ "r1251", "r1256", "r1676", "r1678" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredOfferingCosts", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred Underwriting Fee Payable", "documentation": "Amount of deferred offering costs due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Deferred Offering Costs" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit and notes payable", "label": "Business Combination, Recognized Liability Assumed, Long-Term Debt, Noncurrent", "documentation": "Amount of long-term debt assumed in business combination and recognized at acquisition date, classified as noncurrent." } } }, "auth_ref": [ "r1676", "r1678" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed assets", "verboseLabel": "Property and equipment", "label": "Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment", "documentation": "Amount of property, plant, and equipment acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1251", "r1256", "r1676", "r1678" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets", "documentation": "The amount of right of use assets recognized as of the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Right Of Use Assets" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Details) [Table]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationParentheticalsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationParentheticalsDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Parentheticals) (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationParentheticalsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationParentheticalsDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Parentheticals) (Details) [Table]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofCommonStockBusinessCombinationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationScheduleofCommonStockBusinessCombinationDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Common Stock Business Combination (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofCommonStockBusinessCombinationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationScheduleofCommonStockBusinessCombinationDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Common Stock Business Combination (Details) [Table]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of the Recapitalization and Net Equity Impact on Business Combination (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "BusinessCombinationScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of the Recapitalization and Net Equity Impact on Business Combination (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of equity interest to obtain in acquisition", "label": "Business Combination, Achieved in Stages, Preacquisition and Acquired Equity Interests in Acquiree, Percentage", "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date." } } }, "auth_ref": [ "r1669", "r1670", "r1671" ] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combination [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction Expenses", "label": "Business Combination [Policy Text Block]", "documentation": "Disclosure of accounting policy for business combination." } } }, "auth_ref": [ "r644", "r645", "r651", "r653", "r664", "r676", "r680", "r1251", "r1257", "r1291", "r1292" ] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "BusinessContactMember", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Business Contact [Member]", "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r1351", "r1352" ] }, "vsee_CapitalExpendituresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CapitalExpendituresAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Capital Expenditures:", "label": "Capital Expenditures Abstract" } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Cash", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r58", "r204", "r208", "r987", "r1067", "r1091", "r1315", "r1336", "r1337", "r1349", "r1417", "r1753", "r1754", "r1755" ] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Cash acquired from Business Combination- iDoc", "verboseLabel": "Cash acquired in Business Combination - iDoc", "label": "Cash Acquired from Acquisition", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r9" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r148", "r204", "r208", "r1184", "r1748" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r205" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, Beginning of Period", "periodEndLabel": "CASH, END OF THE PERIOD", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r40", "r204", "r208" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "NET CHANGE IN CASH", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation", "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r0", "r40" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r204", "r208", "r1417", "r1766" ] }, "vsee_CashPaymentSettled": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CashPaymentSettled", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payment settled", "documentation": "Cash payment settled.", "label": "Cash Payment Settled" } } }, "auth_ref": [] }, "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash used in financing activities - discontinued operations", "label": "Cash Provided by (Used in) Financing Activity, Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from financing activity attributable to discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r40" ] }, "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash used in investing activities- discontinued operations", "label": "Cash Provided by (Used in) Investing Activity, Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from investing activity attributable to discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r40", "r131" ] }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash (used in) provided by operating activities - discontinued operations", "label": "Cash Provided by (Used in) Operating Activity, Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from operating activity attributable to discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r40", "r131" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Executive Officer [Member]", "label": "Chief Executive Officer [Member]", "documentation": "Person with designation of chief executive officer." } } }, "auth_ref": [ "r1540" ] }, "srt_ChiefFinancialOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ChiefFinancialOfficerMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Financial Officer [Member]", "label": "Chief Financial Officer [Member]", "documentation": "Person with designation of chief financial officer." } } }, "auth_ref": [ "r1540", "r1753", "r1754", "r1756" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "CityAreaCode", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfStockDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r66", "r141", "r142", "r170", "r171", "r172", "r173", "r174", "r175", "r212", "r216", "r247", "r248", "r250", "r252", "r258", "r259", "r344", "r432", "r435", "r436", "r437", "r441", "r442", "r477", "r478", "r480", "r481", "r483", "r486", "r489", "r490", "r492", "r493", "r494", "r495", "r496", "r497", "r499", "r502", "r506", "r507", "r508", "r509", "r510", "r512", "r513", "r516", "r517", "r518", "r804", "r932", "r933", "r944", "r945", "r946", "r978", "r1044", "r1045", "r1046", "r1047", "r1055", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1068", "r1083", "r1104", "r1126", "r1147", "r1148", "r1149", "r1150", "r1151", "r1366", "r1498", "r1500", "r1516", "r1615", "r1621" ] }, "vsee_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnGreaterOfMarketValueAndNewlyShareIssuedPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnGreaterOfMarketValueAndNewlyShareIssuedPrice", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment percentage of Exercise price of warrants", "documentation": "Represents the percentage of adjustment to exercise price of warrants based on the greater of market value and newly issued share price.", "label": "Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Greater Of Market Value And Newly Share Issued Price" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketPrice", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment percentage of Redemption price of warrants", "documentation": "Represents the percentage of adjustment to redemption price of warrants or rights based on market value.", "label": "Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Price" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightAssumed": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightAssumed", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Assumed at June 24, 2024", "documentation": "Number of warrants or rights assumed during the period.", "label": "Class Of Warrant Or Right Assumed" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r1609" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [ "r1609" ] }, "vsee_ClassOfWarrantOrRightExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightExercisable", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable", "documentation": "Number of warrants or rights exercisable.", "label": "Class Of Warrant Or Right Exercisable" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price (in Dollars per share)", "verboseLabel": "Exercise price of warrants (in Dollars per share)", "netLabel": "Warrant shares per share (in Dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r212", "r219", "r507" ] }, "vsee_ClassOfWarrantOrRightExercisedDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightExercisedDuringPeriod", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised", "documentation": "Class of Warrant or right exercised during period.", "label": "Class Of Warrant Or Right Exercised During Period" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightIssued": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightIssued", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of warrant or right, issued", "documentation": "Number of warrants or rights issued.", "label": "Class Of Warrant Or Right Issued" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightIssuedDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightIssuedDuringPeriod", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued", "verboseLabel": "Warrants issued during period (in Shares)", "netLabel": "Warrants issued during period", "documentation": "Number of warrants or rights issued during the period.", "label": "Class Of Warrant Or Right Issued During Period" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Warrants", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1609" ] }, "vsee_ClassOfWarrantOrRightNumberOfPreFundedWarrantsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightNumberOfPreFundedWarrantsExercised", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-funded warrants exercised", "documentation": "Exercised warrants (in shares).", "label": "Class Of Warrant Or Right Number Of Pre Funded Warrants Exercised" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock per warrant or right (in Shares)", "verboseLabel": "Number of shares of common stock per warrant or right", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [ "r507" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants to purchase common stock (in Shares)", "verboseLabel": "Warrant shares", "netLabel": "Purchase an aggregate shares", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r1609" ] }, "vsee_ClassOfWarrantOrRightNumberOfTotalWarrantsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightNumberOfTotalWarrantsExercised", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total warrants", "documentation": "Class Of Warrant Or Right, Number Of Total Warrants Exercised.", "label": "Class Of Warrant Or Right Number Of Total Warrants Exercised" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightNumberOfTradingDaysConsideredForDeterminationOfFairMarketValue": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightNumberOfTradingDaysConsideredForDeterminationOfFairMarketValue", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days considered for determination of fair market value of warrants (in tradingdays)", "documentation": "Number of trading days over which average reported last sale price of the shares of common stock is considered for determination of Fair Market Value of warrants.", "label": "Class Of Warrant Or Right Number Of Trading Days Considered For Determination Of Fair Market Value" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding, Balance", "periodEndLabel": "Outstanding, Balance", "terseLabel": "Class of warrant or right, outstanding", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock price trigger for redemption of warrants (in Dollars per share)", "documentation": "Price of the entity's common stock which would be required to be attained for triggering redemption of warrants.", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold consecutive trading days considered for redemption of warrants", "documentation": "Represents the threshold consecutive trading days over which the stock price is considered for redemption of warrants.", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold trading days considered for redemption of warrants", "documentation": "Represents the threshold trading days over which the stock price is considered for redemption of warrants.", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClassOfWarrantOrRightRedemptionPrice", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption price of warrants (in Dollars per share)", "documentation": "The redemption price of class of warrant or rights.", "label": "Class Of Warrant Or Right Redemption Price" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame." } } }, "auth_ref": [ "r1609" ] }, "vsee_ClearThinkConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ClearThinkConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable2" ], "lang": { "en-us": { "role": { "terseLabel": "ClearThink Convertible Note [Member]", "label": "Clear Think Convertible Note Member" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r168", "r932", "r933", "r943", "r986", "r1082" ] }, "vsee_CommitmentsContingenciesAndConcentrationRiskDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommitmentsContingenciesAndConcentrationRiskDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments Contingencies And Concentration Risk Disclosure Abstract" } } }, "auth_ref": [] }, "vsee_CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRisk" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments, Contingencies, and Concentration Risk", "documentation": "The entire disclosure for commitments and contingencies and concentration of risks.", "label": "Commitments Contingencies And Concentration Risk Disclosure Text Block" } } }, "auth_ref": [] }, "vsee_CommitmentsContingenciesandConcentrationRiskDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommitmentsContingenciesandConcentrationRiskDetailsLineItems", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Commitments, Contingencies, and Concentration Risk (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_CommitmentsContingenciesandConcentrationRiskDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommitmentsContingenciesandConcentrationRiskDetailsTable", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Commitments, Contingencies, and Concentration Risk (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued (in Shares)", "verboseLabel": "Common Stock, Capital Shares Reserved for Future Issuance (in Shares)", "netLabel": "Common stock shares", "label": "Issuance of common stock issuable", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r1609" ] }, "vsee_CommonStockConversionPriceEqualPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockConversionPriceEqualPercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock at a conversion price equal percent", "documentation": "Percentage of common stock conversion price equal.", "label": "Common Stock Conversion Price Equal Percentage" } } }, "auth_ref": [] }, "vsee_CommonStockIssuanceObligationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockIssuanceObligationCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issuance obligation", "verboseLabel": "Common stock issuance obligation (in Dollars)", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of common stock issuance obligation within one year or the operating cycle if longer, net of discount.", "label": "Common Stock Issuance Obligation Current" } } }, "auth_ref": [] }, "vsee_CommonStockIssuanceObligationMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockIssuanceObligationMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock Issuance Obligation [Member]", "verboseLabel": "Common stock issuance obligation [Member]", "documentation": "Represents information pertaining to common stock issuance obligation.", "label": "Common Stock Issuance Obligation Member" } } }, "auth_ref": [] }, "vsee_CommonStockIssuedAsConsiderationForInvestmentInGoMyRXInc": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockIssuedAsConsiderationForInvestmentInGoMyRXInc", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued as consideration for investment in GoMyRX Inc.", "documentation": "Common stock issued as consideration for investment in GoMyRX Inc.", "label": "Common Stock Issued As Consideration For Investment In Go My RXInc" } } }, "auth_ref": [] }, "vsee_CommonStockIssuedOnConversionOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockIssuedOnConversionOfNotesPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued on conversion of notes payable", "documentation": "Common stock issued on conversion of notes payable.", "label": "Common Stock Issued On Conversion Of Notes Payable" } } }, "auth_ref": [] }, "vsee_CommonStockIssuedOnConversionOfQuantumNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockIssuedOnConversionOfQuantumNote", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued on conversion of Quantum note", "documentation": "The amount of common stock issued on conversion of quantum note.", "label": "Common Stock Issued On Conversion Of Quantum Note" } } }, "auth_ref": [] }, "vsee_CommonStockIssuedToSettleAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockIssuedToSettleAccountsPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Common and preferred stock issued to settle accounts payable", "documentation": "Common stock issued to settle accounts payable.", "label": "Common Stock Issued To Settle Accounts Payable" } } }, "auth_ref": [] }, "vsee_CommonStockIssuedToSettleDirectorsCompensationPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockIssuedToSettleDirectorsCompensationPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued to settle directors\u2019 compensation payable", "documentation": "Common stock issued to settle directors compensation payable", "label": "Common Stock Issued To Settle Directors Compensation Payable" } } }, "auth_ref": [] }, "vsee_CommonStockIssuedToSettleEmployeesAndConsultantsCompensationPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockIssuedToSettleEmployeesAndConsultantsCompensationPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued to settle employees and consultants\u2019 compensation payable", "documentation": "Common stock issued to settle employees and consultants compensation payable.", "label": "Common Stock Issued To Settle Employees And Consultants Compensation Payable" } } }, "auth_ref": [] }, "vsee_CommonStockIssuedToSettleExecutivesCompensationPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockIssuedToSettleExecutivesCompensationPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued to settle executives\u2019 compensation payable", "documentation": "Common stock issued to settle executives compensation payable.", "label": "Common Stock Issued To Settle Executives Compensation Payable" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r175", "r513", "r932", "r933", "r946", "r1339", "r1340", "r1341", "r1343", "r1344", "r1345", "r1346", "r1506", "r1507", "r1511", "r1706", "r1811", "r1818" ] }, "vsee_CommonStockNumberOfSharesOwned": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockNumberOfSharesOwned", "presentation": [ "http://vseehealth.com/role/DiscontinuedOperationsDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock number of shares owned", "verboseLabel": "Number of shares of common stock owned by the holder (in Shares)", "documentation": "Number of shares of common stock owned by the holder as of the reporting date.", "label": "Common Stock Number Of Shares Owned" } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in Dollars per share)", "verboseLabel": "Common stock at a price (in Dollars per share)", "netLabel": "Common stock, par value per share", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r1429", "r1613", "r1753", "r1754", "r1761" ] }, "vsee_CommonStockPercentageOfCapitalSharesReservedForFutureIssuance": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockPercentageOfCapitalSharesReservedForFutureIssuance", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of shares reserved for issuance", "documentation": "Percentage of common shares reserved for future issuance.", "label": "Common Stock Percentage Of Capital Shares Reserved For Future Issuance" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in Shares)", "verboseLabel": "Common stock, shares authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r175", "r513", "r932", "r933", "r946", "r1083" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockSharesIssued", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in Shares)", "verboseLabel": "Common stock issued shares (in Shares)", "netLabel": "Common stock issued shares", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r175", "r513", "r932", "r933", "r946" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Common stock outstanding immediately following the closing of the Business Combination", "terseLabel": "Common stock, shares outstanding (in Shares)", "verboseLabel": "Common stock outstanding immediately following the closing of the business combination (in Shares)", "netLabel": "Common stock, shares outstanding", "label": "Warrants exercisable", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r175", "r513", "r932", "r933", "r946", "r1083", "r1102", "r1608", "r1818", "r1819" ] }, "vsee_CommonStockSharesSubscribedAndIssuable": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockSharesSubscribedAndIssuable", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee subscription of shares (in Shares)", "documentation": "Number of common stock shares subscribed and issuable.", "label": "Common Stock Shares Subscribed And Issuable" } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, value", "verboseLabel": "Common stock, shares issued", "netLabel": "Common stock, value issued", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r175", "r478", "r485", "r513", "r932", "r933", "r946", "r989", "r1315" ] }, "vsee_CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonStockWarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock Warrants [Member]", "verboseLabel": "Public [Member]", "label": "Common Stock Warrants Member" } } }, "auth_ref": [] }, "vsee_CommonWarrantForGrossProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "CommonWarrantForGrossProceeds", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds fromcommon warrants (in Dollars)", "documentation": "Common warrants, for gross proceeds.", "label": "Common Warrant For Gross Proceeds" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ComponentsOfDeferredTaxAssetsAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets:", "label": "Components of Deferred Tax Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r261", "r308", "r1037", "r1038", "r1160", "r1519", "r1520", "r1521", "r1522", "r1523" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r261", "r308", "r1037", "r1038", "r1160", "r1519", "r1520", "r1521", "r1522", "r1523" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r261", "r308", "r1037", "r1038", "r1160", "r1519", "r1520", "r1521", "r1522", "r1523" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Risk and Major Customers/Supplier Concentration", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument." } } }, "auth_ref": [ "r800", "r801" ] }, "vsee_ConcentrationRiskNumberOfSuppliers": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConcentrationRiskNumberOfSuppliers", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of suppliers", "documentation": "The total number of suppliers representing the concentration risk for the requisite benchmark.", "label": "Concentration Risk Number Of Suppliers" } } }, "auth_ref": [] }, "vsee_ConcentrationRiskThresholdPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConcentrationRiskThresholdPercentage", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk Threshold Percentage" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r261", "r308", "r1037", "r1038", "r1160", "r1519", "r1520", "r1521", "r1522", "r1523" ] }, "srt_CondensedIncomeStatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "CondensedIncomeStatementTable", "presentation": [ "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "label": "Condensed Income Statement [Table]", "documentation": "Disclosure of information about condensed income statement including, but not limited to, income statements of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r67", "r213", "r225", "r957", "r1371" ] }, "srt_CondensedIncomeStatementsCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "CondensedIncomeStatementsCaptionsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "label": "Condensed Income Statements, Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r67", "r213", "r225", "r957", "r1371" ] }, "vsee_ConnectionWithTheBridgeInvestorsDescription": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConnectionWithTheBridgeInvestorsDescription", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Description of connection with the bridge investor", "documentation": "The entire description represents connection with the bridge investor.", "label": "Connection With The Bridge Investors Description" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r67", "r87", "r213", "r225", "r712", "r713", "r716", "r717", "r718", "r844", "r957", "r1165", "r1394", "r1397", "r1398", "r1593", "r1596", "r1597", "r1616" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r67", "r87", "r213", "r225", "r712", "r713", "r716", "r717", "r718", "r844", "r957", "r1165", "r1394", "r1397", "r1398", "r1593", "r1596", "r1597", "r1616" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ConsolidationItemsAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r67", "r97", "r98", "r99", "r100", "r101", "r102", "r103", "r104", "r105", "r212", "r213", "r221", "r225", "r256", "r272", "r294", "r295", "r296", "r297", "r298", "r300", "r301", "r302", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r517", "r957", "r1212", "r1213", "r1395", "r1396", "r1594", "r1595" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ConsolidationItemsDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r67", "r97", "r98", "r99", "r100", "r101", "r102", "r103", "r104", "r105", "r212", "r213", "r221", "r225", "r256", "r272", "r294", "r295", "r296", "r297", "r298", "r300", "r301", "r302", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r517", "r957", "r1212", "r1213", "r1395", "r1396", "r1594", "r1595" ] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "ContactPersonnelName", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Contact Personnel Name", "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "verboseLabel": "Contract liabilities", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r531", "r532", "r533", "r537", "r1186" ] }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ContractWithCustomerLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, net of current portion", "label": "Contract with Customer, Liability, Noncurrent", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r531", "r532", "r533", "r537" ] }, "vsee_ContractWithCustomerLiabilityPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ContractWithCustomerLiabilityPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Revenue", "documentation": "Disclosure of accounting policy for contract with customer liability.", "label": "Contract With Customer Liability Policy Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_ContributionOfProperty": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ContributionOfProperty", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total committed investment", "label": "Contribution of Property", "documentation": "Value of property contributed in noncash investing and financing activities." } } }, "auth_ref": [ "r1494" ] }, "vsee_ConversionOfStockEquivalentCommonStockSharesUponConversion": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConversionOfStockEquivalentCommonStockSharesUponConversion", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of stock, equivalent common stock shares upon conversion", "documentation": "The number of common stock shares equivalent to the shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion Of Stock Equivalent Common Stock Shares Upon Conversion" } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of stock", "label": "Conversion of Stock, Shares Converted", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r1494" ] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate shares (in Shares)", "verboseLabel": "Conversion of shares issued", "label": "Conversion of Stock, Shares Issued", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r1494" ] }, "vsee_ConversionPriceEqualPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConversionPriceEqualPercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion price is equal percent", "documentation": "Percentage of conversion price equal.", "label": "Conversion Price Equal Percentage" } } }, "auth_ref": [] }, "vsee_ConversionRatePerShares": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConversionRatePerShares", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion rate per share (in Dollars per share)", "documentation": "Conversion rate per shares.", "label": "Conversion Rate Per Shares" } } }, "auth_ref": [] }, "vsee_ConversionRatePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConversionRatePricePerShare", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion rate price per share (in Dollars per share)", "documentation": "Conversion rate price per share.", "label": "Conversion Rate Price Per Share" } } }, "auth_ref": [] }, "vsee_ConversionSecuritiesPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConversionSecuritiesPurchaseAgreementsMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion Securities Purchase Agreements [Member]", "documentation": "Represents information related to conversion securities purchase agreement.", "label": "Conversion Securities Purchase Agreements Member" } } }, "auth_ref": [] }, "vsee_ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Note [Member]", "label": "Convertible Note Member" } } }, "auth_ref": [] }, "vsee_ConvertibleNotePayableDescription": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConvertibleNotePayableDescription", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Note payable Description", "documentation": "Description of convertible note payable.", "label": "Convertible Note Payable Description" } } }, "auth_ref": [] }, "vsee_ConvertibleNotesAtFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConvertibleNotesAtFairValueAbstract", "lang": { "en-us": { "role": { "label": "Convertible Notes At Fair Value Abstract" } } }, "auth_ref": [] }, "vsee_ConvertibleNotesAtFairValueMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConvertibleNotesAtFairValueMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Notes, At Fair Value", "label": "Convertible Notes At Fair Value Member" } } }, "auth_ref": [] }, "vsee_ConvertibleNotesAtFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConvertibleNotesAtFairValueTextBlock", "presentation": [ "http://vseehealth.com/role/Convertiblenotesatfairvalue" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible notes, at fair value", "label": "Convertible Notes At Fair Value Text Block" } } }, "auth_ref": [] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible note payable", "verboseLabel": "Principal amount increased", "label": "Convertible Notes Payable, Current", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r1421" ] }, "vsee_ConvertiblenotesatfairvalueDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConvertiblenotesatfairvalueDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "label": "Convertible notes, at fair value (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_ConvertiblenotesatfairvalueDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ConvertiblenotesatfairvalueDetailsTable", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "label": "Convertible notes, at fair value (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CorporateNonSegmentMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]", "verboseLabel": "Non-operating corporate [Member]", "netLabel": "Non-Operating corporate [Member]", "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r295", "r296", "r297", "r298", "r301", "r1532" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenues", "label": "Cost of Product and Service Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r28", "r29", "r894", "r1195", "r1200", "r1297", "r1483" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenues", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r30", "r212", "r215", "r216", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r517", "r804", "r1212", "r1405", "r1411", "r1550", "r1594" ] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Revenue", "label": "Cost of Goods and Service [Policy Text Block]", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r1385" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "CounterpartyNameAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r106", "r107", "r212", "r222", "r223", "r447", "r496", "r842", "r849", "r872", "r982", "r1191", "r1192", "r1193", "r1432", "r1433", "r1434", "r1435", "r1436", "r1437", "r1438", "r1439", "r1440", "r1701", "r1702", "r1703", "r1704", "r1749", "r1750" ] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CreditFacilityAxis", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r146", "r156", "r431", "r932", "r933", "r937", "r1592" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CreditFacilityDomain", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r146", "r156", "r431", "r932", "r933", "r937", "r1592" ] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total current income tax provision/(benefit)", "label": "Current Federal, State and Local, Tax Expense (Benefit)", "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1383" ] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Current income tax provision/(benefit):", "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Current Federal Tax Expense (Benefit)", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1383", "r1496", "r1502", "r1663" ] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Current State and Local Tax Expense (Benefit)", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1383", "r1496", "r1502", "r1663" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk [Member]", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r308", "r1520" ] }, "us-gaap_CustomerListsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CustomerListsMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Lists [Member]", "label": "Customer Lists [Member]", "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information." } } }, "auth_ref": [ "r1270", "r1560", "r1561", "r1562", "r1563", "r1564", "r1566", "r1570", "r1571" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CustomerRelationshipsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships [Member]", "verboseLabel": "Customer Relationships [Member]", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r1272", "r1560", "r1561", "r1562", "r1563", "r1564", "r1566", "r1570", "r1571" ] }, "vsee_DHACAssumedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DHACAssumedWarrantsMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC Assumed Warrants [Member]", "label": "DHACAssumed Warrants Member" } } }, "auth_ref": [] }, "vsee_DateAxis": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DateAxis", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Date [Axis]", "label": "Date Axis" } } }, "auth_ref": [] }, "vsee_DateDomainDomain": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DateDomainDomain", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "DateDomain [Domain]" } } }, "auth_ref": [] }, "vsee_DavidL.WickershamMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DavidL.WickershamMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "David L. Wickersham [Member]", "documentation": "Represents information pertaining to board of directors of David L. Wickersham.", "label": "David L. Wickersham Member" } } }, "auth_ref": [] }, "us-gaap_DebtConversionByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtConversionByUniqueDescriptionAxis", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion Description [Axis]", "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction." } } }, "auth_ref": [ "r1494" ] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as conversion of debt", "label": "Debt Conversion, Converted Instrument, Amount", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r1494" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued on conversion of debt (in Shares)", "label": "Debt Conversion, Converted Instrument, Shares Issued", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r1494" ] }, "us-gaap_DebtConversionNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtConversionNameDomain", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Name [Domain]", "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r1494" ] }, "us-gaap_DebtConversionOriginalDebtAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtConversionOriginalDebtAmount1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt conversion, amount", "verboseLabel": "Principal amount (in Dollars)", "netLabel": "Original issue discount", "label": "Debt Conversion, Original Debt, Amount", "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r1494" ] }, "vsee_DebtConversionOriginalDebtFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtConversionOriginalDebtFairValueAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt conversion, fair value", "documentation": "Fair value of the original debt that is being converted in a noncash or part noncash transaction on the conversion date.", "label": "Debt Conversion Original Debt Fair Value Amount" } } }, "auth_ref": [] }, "vsee_DebtConversionRates": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtConversionRates", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt conversion rates (in Dollars per share)", "documentation": "Debt conversion rates.", "label": "Debt Conversion Rates" } } }, "auth_ref": [] }, "vsee_DebtConvertibleOriginalDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtConvertibleOriginalDebtAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount", "documentation": "The amount of debt convertible into shares of common stock.", "label": "Debt Convertible Original Debt Amount" } } }, "auth_ref": [] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance premiums financed amount", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r1421" ] }, "vsee_DebtDefaultInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtDefaultInterestExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Default interest expense", "documentation": "Represents the amount of interest due to default of debt repayment.", "label": "Debt Default Interest Expense" } } }, "auth_ref": [] }, "vsee_DebtDefaultPercentageOfMandatoryPenalty": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtDefaultPercentageOfMandatoryPenalty", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mandatory default penalty", "documentation": "Represents the percentage of mandatory penalty for debt default.", "label": "Debt Default Percentage Of Mandatory Penalty" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscount" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit and Notes Payable, net of discount", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r43", "r146", "r147", "r156", "r157", "r160", "r162", "r163", "r165", "r166", "r212", "r214", "r419", "r420", "r421", "r422", "r423", "r430", "r431", "r443", "r449", "r450", "r451", "r452", "r453", "r454", "r459", "r466", "r467", "r469", "r749", "r814", "r932", "r933", "r942" ] }, "vsee_DebtInstrumentAdditionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentAdditionalAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, additional amount", "documentation": "Debt instrument, additional amount.", "label": "Debt Instrument Additional Amount" } } }, "auth_ref": [] }, "vsee_DebtInstrumentAdditionalInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentAdditionalInterestRate", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rate for additional interest", "documentation": "Percentage of increased interest rate.", "label": "Debt Instrument Additional Interest Rate" } } }, "auth_ref": [] }, "vsee_DebtInstrumentAggregatePrincipalValueAgreedToBePurchasedByCounterparty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentAggregatePrincipalValueAgreedToBePurchasedByCounterparty", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal value", "documentation": "The aggregate principal value of debt instrument agreed to be purchased by the counterparty.", "label": "Debt Instrument Aggregate Principal Value Agreed To Be Purchased By Counterparty" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable8", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r146", "r147", "r156", "r160", "r161", "r162", "r163", "r164", "r166", "r444", "r445", "r446", "r447", "r448", "r450", "r455", "r456", "r457", "r458", "r460", "r461", "r462", "r463", "r464", "r465", "r507", "r932", "r933", "r942", "r1225", "r1226", "r1227", "r1228", "r1229", "r1313", "r1496", "r1497", "r1499", "r1504", "r1583", "r1584", "r1585", "r1731", "r1733", "r1763" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on the variable rate", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding principal amount", "verboseLabel": "Principal balance of debt (in Dollars)", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r470", "r1753", "r1754", "r1758" ] }, "vsee_DebtInstrumentCashPaymentFee": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentCashPaymentFee", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payment fee percentage", "documentation": "Percentage of fee chargeable on payments not made via draws on line of credit.", "label": "Debt Instrument Cash Payment Fee" } } }, "auth_ref": [] }, "vsee_DebtInstrumentClosingBidPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentClosingBidPrice", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, closing bid price", "documentation": "Debt instrument, closing bid price.", "label": "Debt Instrument Closing Bid Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentCompliancePeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentCompliancePeriod", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, compliance period", "documentation": "Debt instrument, compliance period.", "label": "Debt Instrument Compliance Period" } } }, "auth_ref": [] }, "vsee_DebtInstrumentCompliancePeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentCompliancePeriodAxis", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument Compliance Period [Axis]", "label": "Debt Instrument Compliance Period Axis" } } }, "auth_ref": [] }, "vsee_DebtInstrumentCompliancePeriodDomainDomain": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentCompliancePeriodDomainDomain", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "DebtInstrumentCompliancePeriodDomain [Domain]" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConversionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConversionPricePercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument conversion price percentage", "documentation": "Debt instrument conversion price percentage.", "label": "Debt Instrument Conversion Price Percentage" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average price for share price trigger to determine reset of conversion price (in Dollars per share)", "documentation": "Represents the average price for share price trigger which would be required to be attained for reset of conversion price.", "label": "Debt Instrument Convertible Average Price For Stock Price Trigger For Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPriceMinimum": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPriceMinimum", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum average price for share price trigger to determine reset of conversion price (in Dollars per share)", "documentation": "Represents the minimum average price for share price trigger which would be required to be attained for reset of conversion price.", "label": "Debt Instrument Convertible Average Price For Stock Price Trigger For Reset Of Conversion Price Minimum" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleConversionFloorPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleConversionFloorPrice", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Floor price (in Dollars per share)", "documentation": "Debt instrument, convertible, conversion floor price.", "label": "Debt Instrument Convertible Conversion Floor Price" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion price (in Dollars per share)", "label": "Debt Instrument, Convertible, Conversion Price", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r44", "r446" ] }, "vsee_DebtInstrumentConvertibleMaximumResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleMaximumResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum reset of conversion price (in Dollars per share)", "documentation": "Represents the maximum share price up to which the conversion price of the convertible debt instrument can be reset.", "label": "Debt Instrument Convertible Maximum Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleMinimumConversionPriceToMakeAmortizationPayment": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleMinimumConversionPriceToMakeAmortizationPayment", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum conversion price to make amortization payment (in Dollars per share)", "documentation": "Represents the minimum conversion price to make amortization payment on convertible debt instruments.", "label": "Debt Instrument Convertible Minimum Conversion Price To Make Amortization Payment" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertiblePercentageDiscountToVWPUsedToDetermineConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertiblePercentageDiscountToVWPUsedToDetermineConversionPrice", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage discount on VWAP", "documentation": "Percentage discount to prior trading day VWAP used to determine conversion price in conversion of debt instrument to equity instrument.", "label": "Debt Instrument Convertible Percentage Discount To VWPUsed To Determine Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleQualifiedFinancingPercentageOfEffectivePricePerShare": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleQualifiedFinancingPercentageOfEffectivePricePerShare", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective price per share", "documentation": "Represents the percentage of effective price per share for conversion by holder of debt instrument in qualified financing.", "label": "Debt Instrument Convertible Qualified Financing Percentage Of Effective Price Per Share" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share price trigger to determine reset of conversion price (in Dollars per share)", "documentation": "Price of the entity's common stock which would be required to be attained for reset of conversion price of the convertible debt instrument.", "label": "Debt Instrument Convertible Stock Price Trigger For Reset Of Conversion Price" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consecutive trading days", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature." } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForAmortizationConversionPriceDetermination": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForAmortizationConversionPriceDetermination", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of average lowest VWAP of common stock considered for determination of amortization conversion price", "verboseLabel": "Common stock issue percent", "documentation": "Threshold minimum percentage of average lowest VWAP of common stock considered to determine the amortization conversion price of convertible debt instruments, if common stock is used to make such amortization payments.", "label": "Debt Instrument Convertible Threshold Percentage Of Average Lowest Volume Weighted Average Price Considered For Amortization Conversion Price Determination" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForResetOfConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold percentage", "documentation": "Threshold minimum percentage of average lowest VWAP of common stock considered to determine reset value of conversion price of convertible debt instruments.", "label": "Debt Instrument Convertible Threshold Percentage Of Average Lowest Volume Weighted Average Price Considered For Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdPercentageOfLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleThresholdPercentageOfLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold percentage of lowest VWAP of common stock to determine conversion price", "documentation": "Threshold percentage of lowest VWAP of common stock considered to determine conversion price of convertible debt instruments.", "label": "Debt Instrument Convertible Threshold Percentage Of Lowest Volume Weighted Average Price Considered For Determination Of Conversion Price" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible note differed by more than percent", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentConvertibleThresholdTradingDays", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days (in tradingdays)", "verboseLabel": "Number of trading days", "label": "Debt Instrument, Convertible, Threshold Trading Days", "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature." } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysForResetOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleThresholdTradingDaysForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days to determine reset of conversion price (in tradingdays)", "documentation": "Threshold number of specified trading days to determine reset of conversion price.", "label": "Debt Instrument Convertible Threshold Trading Days For Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysOverWhichAverageDailyVolumeWeightedAveragePriceOfCommonStockConsideredForResetOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleThresholdTradingDaysOverWhichAverageDailyVolumeWeightedAveragePriceOfCommonStockConsideredForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold trading days over which the average daily VWAP of common stock is considered for reset of conversion price (in tradingdays)", "verboseLabel": "Threshold trading days over which the average daily VWAP of common stock is considered for reset of conversion price (in tradingday)", "documentation": "Threshold number of trading days over which daily average VWAP of common stock is considered to reset the conversion price of convertible debt instruments.", "label": "Debt Instrument Convertible Threshold Trading Days Over Which Average Daily Volume Weighted Average Price Of Common Stock Considered For Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysOverWhichLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentConvertibleThresholdTradingDaysOverWhichLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold trading days over which the lowest VWAP of common stock is considered to determine conversion price (in tradingdays)", "verboseLabel": "Threshold trading days over which the lowest VWAP of common stock is considered to determine conversion price (in tradingday)", "documentation": "Threshold number of trading days over which lowest VWAP of common stock is considered to determine conversion price of convertible debt instruments.", "label": "Debt Instrument Convertible Threshold Trading Days Over Which Lowest Volume Weighted Average Price Considered For Determination Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentDefaultInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentDefaultInterestRate", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Default interest", "verboseLabel": "Default interest rate", "documentation": "Percentage of interest chargeable on making default in payments on promissory note from the default date.", "label": "Debt Instrument Default Interest Rate" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentDescription", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, description", "label": "Debt Instrument, Description", "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total." } } }, "auth_ref": [ "r22", "r814", "r1609" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount", "verboseLabel": "Principal amount", "netLabel": "Principal amount (in Dollars)", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r444", "r814", "r815", "r1226", "r1227", "r1313" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value exchange note amount", "verboseLabel": "Convertible Note\u2019s fair value", "label": "Debt Instrument, Fair Value Disclosure", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r457", "r797", "r798", "r799", "r802", "r1226", "r1227", "r1710", "r1711", "r1712", "r1713", "r1720" ] }, "vsee_DebtInstrumentFairValueGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentFairValueGainLoss", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value gain (loss)", "documentation": "Debt instrument, fair value gain (loss)", "label": "Debt Instrument Fair Value Gain Loss" } } }, "auth_ref": [] }, "vsee_DebtInstrumentForbearanceAgreementPaymentsAgreedToBeMade": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentForbearanceAgreementPaymentsAgreedToBeMade", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments for forbearance", "documentation": "The amount of payments agreed to be made as a consideration for the forbearance of bank on its collection rights.", "label": "Debt Instrument Forbearance Agreement Payments Agreed To Be Made" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentIncreaseAccruedInterest", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "label": "Debt Instrument, Increase, Accrued Interest", "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period." } } }, "auth_ref": [ "r1496", "r1499" ] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest accruing percentage", "verboseLabel": "One time interest charge, percent", "label": "Debt Instrument, Interest Rate During Period", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r462", "r1416", "r1422", "r1731", "r1753", "r1754", "r1758" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Debt Instrument, Interest Rate, Effective Percentage", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r472", "r814", "r815", "r1313", "r1416", "r1422", "r1753", "r1754", "r1758" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual fixed rate percentage", "verboseLabel": "Annual fixed interest rate", "netLabel": "Interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r147", "r160", "r445", "r932", "r933", "r942" ] }, "vsee_DebtInstrumentLateFeeEqualPercent": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentLateFeeEqualPercent", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Late fee equal percent", "documentation": "Debt instrument, late fee equal percent.", "label": "Debt Instrument Late Fee Equal Percent" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentLineItems", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "label": "Line of Credit and Notes Payable, Net of Discount", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r147", "r160", "r161", "r162", "r163", "r164", "r166", "r444", "r445", "r446", "r447", "r448", "r450", "r455", "r456", "r457", "r458", "r460", "r461", "r462", "r463", "r464", "r465", "r468", "r507", "r749", "r932", "r933", "r942", "r957", "r1225", "r1226", "r1227", "r1228", "r1229", "r1313", "r1496", "r1497", "r1499", "r1504", "r1731", "r1733" ] }, "us-gaap_DebtInstrumentMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentMeasurementInput", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable8" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement input", "verboseLabel": "Measurement input of notes payable", "label": "Debt Instrument, Measurement Input", "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt." } } }, "auth_ref": [ "r1711", "r1712", "r1713" ] }, "vsee_DebtInstrumentMinimumBidPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentMinimumBidPrice", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, minimum bid price", "documentation": "Debt instrument, minimum bid price.", "label": "Debt Instrument Minimum Bid Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentModificationMinimumActualChangeInCashFlow": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentModificationMinimumActualChangeInCashFlow", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum percentage change to cash flow", "documentation": "Represents the minimum percentage of change in cash flow achieved by the loan modification.", "label": "Debt Instrument Modification Minimum Actual Change In Cash Flow" } } }, "auth_ref": [] }, "vsee_DebtInstrumentModificationMinimumActualChangeInFairValue": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentModificationMinimumActualChangeInFairValue", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum percentage change to fair value", "documentation": "Represents the minimum percentage of change in fair value achieved by the loan modification.", "label": "Debt Instrument Modification Minimum Actual Change In Fair Value" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r146", "r147", "r156", "r160", "r161", "r162", "r163", "r164", "r166", "r444", "r445", "r446", "r447", "r448", "r450", "r455", "r456", "r457", "r458", "r460", "r461", "r462", "r463", "r464", "r465", "r507", "r932", "r933", "r942", "r1225", "r1226", "r1227", "r1228", "r1229", "r1313", "r1496", "r1497", "r1499", "r1504", "r1583", "r1584", "r1585", "r1731", "r1733", "r1763" ] }, "vsee_DebtInstrumentOutstandingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentOutstandingPercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, outstanding percentage", "documentation": "Debt instrument, outstanding percentage.", "label": "Debt Instrument Outstanding Percentage" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfInterestRateIncreasesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPercentageOfInterestRateIncreasesPercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate increases percentage", "documentation": "Debt instrument percentage of interest rate increases percentage.", "label": "Debt Instrument Percentage Of Interest Rate Increases Percentage" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfOriginalIssueDiscount": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPercentageOfOriginalIssueDiscount", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original issue discount", "documentation": "Represents the percentage of debt original issue discount.", "label": "Debt Instrument Percentage Of Original Issue Discount" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfOverdueAmountIsAssessed": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPercentageOfOverdueAmountIsAssessed", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of overdue amount is assessed", "documentation": "Percentage of overdue amount is assessed.", "label": "Debt Instrument Percentage Of Overdue Amount Is Assessed" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfPrepaymentPenaltyInCaseOfDefault": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPercentageOfPrepaymentPenaltyInCaseOfDefault", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding balance, percentage", "documentation": "Represents the prepayment penalty rate of debt instrument in case of default.", "label": "Debt Instrument Percentage Of Prepayment Penalty In Case Of Default" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfPrincipalBalancePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPercentageOfPrincipalBalancePercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of principal balance", "documentation": "Represents the percentage of debt principal balance.", "label": "Debt Instrument Percentage Of Principal Balance Percentage" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfPrincipalEstimatedRecoveredInEventOfDefault": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPercentageOfPrincipalEstimatedRecoveredInEventOfDefault", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of lender recovery on principal outstanding", "documentation": "Represents the percentage of principal of the debt that is estimated to be recoverable in the event of default.", "label": "Debt Instrument Percentage Of Principal Estimated Recovered In Event Of Default" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPeriodOfGuaranteedInterestPayment": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPeriodOfGuaranteedInterestPayment", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period of guaranteed interest payment", "documentation": "The period during which payment of interest is guaranteed regardless of early payment or redemption of notes.", "label": "Debt Instrument Period Of Guaranteed Interest Payment" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentPeriodicPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentPeriodicPayment", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan payments amount", "verboseLabel": "Debt Instrument, Periodic Payment", "netLabel": "Periodic payment", "label": "Debt Instrument, Periodic Payment", "documentation": "Amount of the required periodic payments including both interest and principal payments." } } }, "auth_ref": [ "r23", "r1416", "r1422" ] }, "vsee_DebtInstrumentPeriodicPaymentNumberOfInstallments": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPeriodicPaymentNumberOfInstallments", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of installments", "verboseLabel": "Number of installments (in Installment)", "documentation": "Represents the number of installments for periodic payment of debt instrument.", "label": "Debt Instrument Periodic Payment Number Of Installments" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentPeriodicPaymentPrincipal", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Periodic principal payment", "label": "Debt Instrument, Periodic Payment, Principal", "documentation": "Amount of the required periodic payments applied to principal." } } }, "auth_ref": [ "r1416", "r1422" ] }, "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "payment to be paid", "verboseLabel": "Periodic payment terms, balloon payment to be paid", "label": "Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid", "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt." } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPrincipalAmountIssuable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount of debt issuable", "documentation": "Represents the principal amount of debt issuable.", "label": "Debt Instrument Principal Amount Issuable" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountNotExchangeable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPrincipalAmountNotExchangeable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount not exchangeable", "documentation": "The principal amount of debt that is non exchangeable.", "label": "Debt Instrument Principal Amount Not Exchangeable" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountPurchasedOnLaterDate": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPrincipalAmountPurchasedOnLaterDate", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes purchased", "documentation": "The principal amount of debt which is purchased on the later date.", "label": "Debt Instrument Principal Amount Purchased On Later Date" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountPurchasedOnSigningDate": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentPrincipalAmountPurchasedOnSigningDate", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes purchased", "documentation": "The principal amount of debt which is purchased on the date of signing of the agreement.", "label": "Debt Instrument Principal Amount Purchased On Signing Date" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentRedemptionPeriodAxis", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period [Axis]", "documentation": "Information by period of debt redemption feature under terms of debt agreement." } } }, "auth_ref": [ "r53" ] }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentRedemptionPeriodDomain", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period [Domain]", "documentation": "Period as defined under terms of the debt agreement for debt redemption features." } } }, "auth_ref": [ "r53" ] }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentRedemptionPeriodOneMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Redemption, Period One [Member]", "label": "Debt Instrument, Redemption, Period One [Member]", "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r53" ] }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentRedemptionPeriodTwoMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Redemption, Period Two [Member]", "label": "Debt Instrument, Redemption, Period Two [Member]", "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r53" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentTable", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r21", "r54", "r55", "r56", "r147", "r160", "r161", "r162", "r163", "r164", "r166", "r444", "r445", "r446", "r447", "r448", "r450", "r455", "r456", "r457", "r458", "r460", "r461", "r462", "r463", "r464", "r465", "r468", "r507", "r749", "r932", "r933", "r942", "r957", "r1225", "r1226", "r1227", "r1228", "r1229", "r1313", "r1496", "r1497", "r1499", "r1504", "r1731", "r1733" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentTerm", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of debt", "label": "Debt Instrument, Term", "documentation": "Period between issuance and maturity of debt instrument, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "vsee_DebtInstrumentTotalInterestExpenseOverLifeOfLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DebtInstrumentTotalInterestExpenseOverLifeOfLoan", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total interest over entire loan maturity", "documentation": "Total amount, over entire maturity, of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Debt Instrument Total Interest Expense Over Life Of Loan" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original issue discount", "verboseLabel": "Unamortized debt discount", "label": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r1599", "r1730", "r1731", "r1733" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net of unamortized debt discount", "label": "Debt Instrument, Unamortized Discount (Premium), Net", "documentation": "Amount, after accumulated amortization, of debt discount (premium)." } } }, "auth_ref": [ "r1599", "r1730", "r1731", "r1733" ] }, "us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentVariableInterestRateTypeExtensibleEnumeration", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, variable interest rate, type [Extensible enumeration]", "label": "Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]", "documentation": "Indicates type of variable interest rate on debt instrument." } } }, "auth_ref": [ "r979" ] }, "us-gaap_DebtPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Original Issue Discount on Debt", "label": "Debt, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt." } } }, "auth_ref": [ "r5" ] }, "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs expensed", "label": "Debt Related Commitment Fees and Debt Issuance Costs", "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses." } } }, "auth_ref": [ "r34" ] }, "vsee_DefaultInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DefaultInterestExpense", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Default interest expense (in Dollars)", "documentation": "The amount of default interest expense.", "label": "Default Interest Expense" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1496", "r1502", "r1662", "r1663" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred income tax provision/(benefit)", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1654" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income tax provision/(benefit):", "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing cost", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1599", "r1730", "r1731", "r1733" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r4", "r64", "r1496", "r1502" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r619" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities, net", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r169", "r604", "r605", "r932", "r933", "r938", "r984" ] }, "us-gaap_DeferredRevenueAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredRevenueAdditions", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredRevenueActivitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Additions", "label": "Deferred Revenue, Additions", "documentation": "Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP." } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueByArrangementDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredRevenueByArrangementDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Revenue Activities", "label": "Deferred Revenue, by Arrangement, Disclosure [Table Text Block]", "documentation": "Tabular disclosure of the type of arrangements and the corresponding amounts that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredRevenueCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredRevenueActivitiesTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of year", "periodEndLabel": "End of year", "label": "Deferred Revenue, Current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r1421" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Deferred Revenue, Noncurrent", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r1425" ] }, "us-gaap_DeferredRevenueRevenueRecognized1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredRevenueRevenueRecognized1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredRevenueActivitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Revenue recognized", "label": "Deferred Revenue, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue." } } }, "auth_ref": [] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1496", "r1502", "r1662", "r1663" ] }, "vsee_DeferredTaxAssetAccruedInterestRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxAssetAccruedInterestRelatedParty", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest, related party", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from accrued interest pertaining to related party.", "label": "Deferred Tax Asset Accrued Interest Related Party" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxAssetInterestCarryforward", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest payable", "label": "Deferred Tax Asset, Interest Carryforward", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward." } } }, "auth_ref": [ "r1660" ] }, "vsee_DeferredTaxAssetsBadDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxAssetsBadDebtExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Bad debt expense", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from bad debt expense.", "label": "Deferred Tax Assets Bad Debt Expense" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxAssetsDeferredIncome", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Deferred Tax Assets, Deferred Income", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income." } } }, "auth_ref": [ "r1660" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r620" ] }, "vsee_DeferredTaxAssetsLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxAssetsLeaseLiabilities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating and finance lease liabilities", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.", "label": "Deferred Tax Assets Lease Liabilities" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r1658" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating loss carryforwards", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r1660" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforwards, not subject to expiration", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates." } } }, "auth_ref": [ "r1660" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r1660" ] }, "vsee_DeferredTaxAssetsPayrollLiabilitiesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxAssetsPayrollLiabilitiesPayable", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued payroll", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from payroll liabilities payable.", "label": "Deferred Tax Assets Payroll Liabilities Payable" } } }, "auth_ref": [] }, "vsee_DeferredTaxAssetsStartUpCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxAssetsStartUpCosts", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Start-up costs", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from start-up costs.", "label": "Deferred Tax Assets Start Up Costs" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs." } } }, "auth_ref": [ "r1660" ] }, "vsee_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from accounts payable and accrued liabilities.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accounts Payable And Accrued Liabilities" } } }, "auth_ref": [] }, "vsee_DeferredTaxAssetsTaxEncompassPurchaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxAssetsTaxEncompassPurchaseLiability", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Encompass Purchase Liability", "documentation": "The amount of encompass purchase liability.", "label": "Deferred Tax Assets Tax Encompass Purchase Liability" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "(Less) valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r621" ] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total deferred tax liabilities", "label": "Deferred Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r1658" ] }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredTaxLiabilitiesAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities:", "label": "Deferred Tax Liabilities, Gross [Abstract]" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxLiabilitiesAccountsReceivable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from accounts receivable.", "label": "Deferred Tax Liabilities Accounts Receivable" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxLiabilitiesAmortization", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from amortization.", "label": "Deferred Tax Liabilities Amortization" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxLiabilitiesDepreciation", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from depreciation.", "label": "Deferred Tax Liabilities Depreciation" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesPrepaidsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredTaxLiabilitiesPrepaidsAndOtherCurrentAssets", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaids and other current assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from prepaids and other current assets.", "label": "Deferred Tax Liabilities Prepaids And Other Current Assets" } } }, "auth_ref": [] }, "vsee_DeferredUnderwritingFee": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DeferredUnderwritingFee", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred underwriting fee", "documentation": "The amount of deferred underwriting fee payable by the company.", "label": "Deferred Underwriting Fee" } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r4", "r197", "r405", "r1194", "r1195", "r1197", "r1199" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r4", "r1567", "r1578" ] }, "us-gaap_DepreciationAndAmortizationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DepreciationAndAmortizationAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and Amortization:", "label": "Depreciation, Depletion and Amortization [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r194", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r868", "r1072", "r1074", "r1088", "r1089", "r1090", "r1092", "r1093", "r1094", "r1095", "r1097", "r1098", "r1099", "r1100", "r1114", "r1115", "r1116", "r1117", "r1120", "r1121", "r1122", "r1123", "r1141", "r1142", "r1143", "r1144", "r1190", "r1191", "r1193", "r1298", "r1299", "r1316", "r1339", "r1341", "r1432", "r1433", "r1434", "r1435", "r1436", "r1437", "r1438", "r1439", "r1440", "r1701", "r1702", "r1703", "r1704", "r1714", "r1715", "r1716", "r1717", "r1718", "r1719", "r1721", "r1722" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r194", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r868", "r1072", "r1074", "r1088", "r1089", "r1090", "r1092", "r1093", "r1094", "r1095", "r1097", "r1098", "r1099", "r1100", "r1114", "r1115", "r1116", "r1117", "r1120", "r1121", "r1122", "r1123", "r1141", "r1142", "r1143", "r1144", "r1190", "r1191", "r1193", "r1298", "r1299", "r1316", "r1339", "r1341", "r1432", "r1433", "r1434", "r1435", "r1436", "r1437", "r1438", "r1439", "r1440", "r1701", "r1702", "r1703", "r1704", "r1714", "r1715", "r1716", "r1717", "r1718", "r1719", "r1721", "r1722" ] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Financial Instruments", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r209", "r212", "r224", "r719", "r744", "r745", "r746", "r747", "r748", "r750", "r754" ] }, "vsee_DescriptionOfSettlementAgreement": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DescriptionOfSettlementAgreement", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Description of settlement agreement", "documentation": "Description of settlement agreement.", "label": "Description Of Settlement Agreement" } } }, "auth_ref": [] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed Technology Rights [Member]", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r1560", "r1561", "r1562", "r1563", "r1564", "r1566", "r1570", "r1571", "r1679" ] }, "vsee_DhacPublicShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DhacPublicShareholdersMember", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC Public Shareholders [Member]", "documentation": "Represents the information pertaining to DHAC public shareholders.", "label": "Dhac Public Shareholders Member" } } }, "auth_ref": [] }, "vsee_DhacShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DhacShareholdersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC Shareholders [Member]", "documentation": "Represents information pertaining to DHAC shareholders.", "label": "Dhac Shareholders Member" } } }, "auth_ref": [] }, "vsee_DigitalHealthAcquisitionCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DigitalHealthAcquisitionCorpMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC", "verboseLabel": "Digital Health Acquisition Corp", "netLabel": "DHAC [Member]", "label": "Digital Health Acquisition Corp [Member]", "documentation": "Represents the information pertaining to Digital Health Acquisition Corp." } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "DirectorMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Director [Member]", "verboseLabel": "Board of Directors [Member]", "label": "Director [Member]", "documentation": "Person serving on board of directors." } } }, "auth_ref": [ "r932", "r933", "r940", "r1399", "r1540", "r1812" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable", "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable0" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r535", "r536", "r1233", "r1234", "r1235", "r1236", "r1237", "r1238", "r1239" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable", "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable0" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r535", "r536", "r1233", "r1234", "r1235", "r1236", "r1237", "r1238", "r1239" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregated Revenue by Timing of Revenue Recognition", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1622" ] }, "vsee_DisclosureOfStandbyEquityPurchaseAgreementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DisclosureOfStandbyEquityPurchaseAgreementAbstract", "lang": { "en-us": { "role": { "label": "Disclosure Of Standby Equity Purchase Agreement Abstract" } } }, "auth_ref": [] }, "vsee_DisclosureOfStandbyEquityPurchaseAgreementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DisclosureOfStandbyEquityPurchaseAgreementTextBlock", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreement" ], "lang": { "en-us": { "role": { "terseLabel": "Standby Equity Purchase Agreement", "documentation": "The entire disclosure for standby equity purchase agreement.", "label": "Disclosure Of Standby Equity Purchase Agreement Text Block" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DiscontinuedOperationsDetails", "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on sale of discontinued operations", "verboseLabel": "Sale of discontinued operations (in Dollars)", "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax", "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation." } } }, "auth_ref": [ "r122", "r1403", "r1404", "r1410" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Income (loss) from discontinued operations before provision for income taxes", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r27", "r122", "r1181", "r1183", "r1402", "r1768" ] }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/IncomeTaxesDetails", "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Provision for income taxes for discontinued operations", "negatedTerseLabel": "Provision for income taxes", "terseLabel": "Income tax expense discontinuing operations", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r123", "r606", "r631", "r633", "r1181", "r1183" ] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowance for credit losses", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r1179", "r1182", "r1401", "r1407", "r1408", "r1575", "r1582" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts payable and accrued liabilities", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities", "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r1401", "r1407", "r1408", "r1575", "r1582" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Current assets from discontinued operations", "verboseLabel": "Non-current assets from discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r121", "r132", "r404", "r415", "r1401", "r1407", "r1408" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r1179", "r1182", "r1401", "r1407", "r1408", "r1575", "r1582" ] }, "vsee_DisposalGroupIncludingDiscontinuedOperationCompensationAndRelatedBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DisposalGroupIncludingDiscontinuedOperationCompensationAndRelatedBenefits", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation and related benefits", "documentation": "Compensation and related benefits.", "label": "Disposal Group Including Discontinued Operation Compensation And Related Benefits" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenues", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r1178", "r1180", "r1181", "r1183" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred revenue", "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue", "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r1401", "r1407", "r1408", "r1575", "r1582" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r1406", "r1409" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Disposal Group, Including Discontinued Operation, Interest Expense", "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r137", "r139", "r1178", "r1180", "r1181", "r1183" ] }, "vsee_DisposalGroupIncludingDiscontinuedOperationLoanPayableAndRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DisposalGroupIncludingDiscontinuedOperationLoanPayableAndRelatedParty", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Loan payable, related party", "documentation": "Loan payable, related party.", "label": "Disposal Group Including Discontinued Operation Loan Payable And Related Party" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncome", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Other income, net", "label": "Disposal Group, Including Discontinued Operation, Other Income", "documentation": "Amount of other income attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r1406", "r1409" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaids and other current assets", "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current", "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1401", "r1407", "r1408", "r1575", "r1582" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed assets, net", "label": "Disposal Group, Including Discontinued Operation, Property, Plant, and Equipment, Noncurrent", "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1401", "r1407", "r1408", "r1575", "r1582" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total revenue from discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Revenue", "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r1178", "r1180", "r1181", "r1183" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DiscontinuedOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r120", "r126", "r127", "r128", "r402" ] }, "vsee_DocumentAndEntityInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DocumentAndEntityInformationAbstract", "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentInformationLineItems", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentInformationTable", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentType", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "vsee_DominionMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DominionMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Dominion", "verboseLabel": "Dominion [Member]", "documentation": "Represents information pertaining to dominion.", "label": "Dominion Member" } } }, "auth_ref": [] }, "vsee_DownPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DownPayment", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Down payment", "documentation": "Down payment.", "label": "Down Payment" } } }, "auth_ref": [] }, "vsee_DuePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "DuePayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due payable", "documentation": "Due payable.", "label": "Due Payable" } } }, "auth_ref": [] }, "vsee_ELOCAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ELOCAgreementMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ELOC Agreement [Member]", "label": "ELOCAgreement Member" } } }, "auth_ref": [] }, "vsee_ELOCMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ELOCMember", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "ELOC [Member]", "label": "ELOCMember" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerShareBasic", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Basic and diluted loss per common share (in Dollars per share)", "verboseLabel": "Net loss per share from continuing operations \u2013 basic (in Dollars per share)", "netLabel": "Net loss per share \u2013 basic (in Dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r113", "r190", "r229", "r231", "r232", "r233", "r234", "r236", "r237", "r238", "r240", "r245", "r247", "r250", "r251", "r252", "r255", "r400", "r475", "r540", "r589", "r641", "r709", "r770", "r771", "r952", "r1002", "r1202" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerShareDiluted", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted loss per common share (in Dollars per share)", "verboseLabel": "Net loss per share from continuing operations \u2013 diluted (in Dollars per share)", "netLabel": "Net loss per share diluted (in Dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r113", "r190", "r229", "r231", "r232", "r233", "r234", "r236", "r237", "r238", "r240", "r247", "r250", "r251", "r252", "r255", "r400", "r475", "r540", "r589", "r641", "r709", "r770", "r771", "r952", "r1002", "r1202" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss per Common Share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r254" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails", "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income tax, Percentage", "verboseLabel": "Effective income tax rate, percentage", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r608", "r1249" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails", "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. federal statutory tax, Percentage", "verboseLabel": "Federal statutory income tax rate, percentage", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r212", "r218", "r608", "r629", "r1249" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Change in valuation allowance, Percentage", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r611", "r1249", "r1496", "r1503", "r1655" ] }, "vsee_EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebtAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Extinguishment of debt, Amount (in Dollars)", "documentation": "The amount of extinguishment of debt.", "label": "Effective Income Tax Rate Reconciliation Extinguishment Of Debt Amount" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebtPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebtPercentage", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Extinguishment of debt, Percentage", "documentation": "Percentage of the extinguishment of debt.", "label": "Effective Income Tax Rate Reconciliation Extinguishment Of Debt Percentage" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationGainlossOnChangeInFairValueOfFinancialInstrumentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationGainlossOnChangeInFairValueOfFinancialInstrumentsAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gain/loss on change in fair value of financial instruments, Amount (in Dollars)", "documentation": "The amount of gain/loss on change in fair value of financial instruments.", "label": "Effective Income Tax Rate Reconciliation Gainloss On Change In Fair Value Of Financial Instruments Amount" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationGainlossOnChangeInFairValueOfFinancialInstrumentsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationGainlossOnChangeInFairValueOfFinancialInstrumentsPercentage", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gain/loss on change in fair value of financial instruments, Percentage", "documentation": "Percentage of the Gain/loss on change in fair value of financial instruments.", "label": "Effective Income Tax Rate Reconciliation Gainloss On Change In Fair Value Of Financial Instruments Percentage" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment, Percentage", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss." } } }, "auth_ref": [ "r1249", "r1496", "r1503", "r1655", "r1656" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Meals and entertainment, Percentage", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense." } } }, "auth_ref": [ "r1496", "r1503", "r1655", "r1656" ] }, "vsee_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePenalties": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpensePenalties", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Penalties, Percentage", "documentation": "The percentage of effective income tax non-deductible expenses for penalty.", "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Penalties" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation, Percentage", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement." } } }, "auth_ref": [ "r1249", "r1496", "r1503", "r1655", "r1656" ] }, "vsee_EffectiveIncomeTaxRateReconciliationPermanentDifferencesNetPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesNetPercentage", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Permanent differences, net, Percentage", "documentation": "Percentage of Permanent differences, net.", "label": "Effective Income Tax Rate Reconciliation Permanent Differences Net Percentage" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationReturnToIncomeTaxProvisionAdjustmentsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationReturnToIncomeTaxProvisionAdjustmentsPercentage", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Return to income tax provision adjustments, Percentage", "documentation": "Percentage of the return to income tax provision adjustments.", "label": "Effective Income Tax Rate Reconciliation Return To Income Tax Provision Adjustments Percentage" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "State taxes, net of federal tax benefit, Percentage", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r610", "r1249", "r1496", "r1503", "r1655" ] }, "vsee_EffectiveIncomeTaxRateReconciliationStatutoryTaxRateDifferenceBetweenForeignAndUnitedStatesAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationStatutoryTaxRateDifferenceBetweenForeignAndUnitedStatesAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory tax rate difference between Foreign and United States, Amount (in Dollars)", "documentation": "Statutory tax rate difference between Foreign and United States, Amount.", "label": "Effective Income Tax Rate Reconciliation Statutory Tax Rate Difference Between Foreign And United States Amount" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationStatutoryTaxRateDifferenceBetweenForeignAndUnitedStatesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationStatutoryTaxRateDifferenceBetweenForeignAndUnitedStatesPercentage", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory tax rate difference between Foreign and United States, Percentage", "documentation": "Percentage of statutory tax rate difference between Foreign and United States.", "label": "Effective Income Tax Rate Reconciliation Statutory Tax Rate Difference Between Foreign And United States Percentage" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsOther", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other, Percentage", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits." } } }, "auth_ref": [ "r1249", "r1496", "r1503", "r1655", "r1656" ] }, "vsee_EffectiveIncomeTaxRateReturnToIncomeTaxProvisionAdjustmentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EffectiveIncomeTaxRateReturnToIncomeTaxProvisionAdjustmentsAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Return to income tax provision adjustments, Amount (in Dollars)", "documentation": "The amount of Return to income tax provision adjustments, Amount.", "label": "Effective Income Tax Rate Return To Income Tax Provision Adjustments Amount" } } }, "auth_ref": [] }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of the embedded derivative at issuance", "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability", "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability." } } }, "auth_ref": [ "r1684", "r1711", "r1712", "r1713" ] }, "us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value on embedded derivative", "label": "Embedded Derivative, Gain (Loss) on Embedded Derivative, Net", "documentation": "Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period." } } }, "auth_ref": [ "r1685", "r1705" ] }, "us-gaap_EmbeddedDerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmbeddedDerivativeLiabilityMeasurementInput", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable6", "http://vseehealth.com/role/ScheduleofKeyInputsTable9" ], "lang": { "en-us": { "role": { "terseLabel": "CCC bond rates", "verboseLabel": "Measurement input", "label": "Embedded Derivative Liability, Measurement Input", "documentation": "Value of input used to measure embedded derivative liability." } } }, "auth_ref": [ "r776", "r777", "r778" ] }, "vsee_EmbeddedDerivativeLiabilityMeasurementInputTerm": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EmbeddedDerivativeLiabilityMeasurementInputTerm", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (years)", "documentation": "Expected term (years).", "label": "Embedded Derivative Liability Measurement Input Term" } } }, "auth_ref": [] }, "vsee_EmergingGrowthCompanyPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EmergingGrowthCompanyPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Implications of Being an Emerging Growth Company", "documentation": "Disclosure of accounting policy for emerging growth company.", "label": "Emerging Growth Company Policy Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation and related benefits", "label": "Employee Benefits and Share-Based Compensation", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [ "r1443" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation and benefits", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r1421" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation cost (in Dollars)", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r1651" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmployeeStockOptionMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Option [Member]", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [ "r1624", "r1625", "r1626", "r1627", "r1628", "r1629", "r1630", "r1631", "r1632", "r1633", "r1634", "r1635", "r1636", "r1637", "r1638", "r1639", "r1640", "r1641", "r1642", "r1643", "r1644", "r1646", "r1647", "r1648", "r1649", "r1650" ] }, "vsee_EmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EmployeesMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employees [Member]", "documentation": "Represents the information pertaining to employees.", "label": "Employees Member" } } }, "auth_ref": [] }, "vsee_EncompassHealthcareBillingLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EncompassHealthcareBillingLlcMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Encompass Healthcare Billing, LLC [Member]", "documentation": "Represents the information pertaining to Encompass Healthcare Billing, LLC.", "label": "Encompass Healthcare Billing Llc Member" } } }, "auth_ref": [] }, "vsee_EncompassSBALoanMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EncompassSBALoanMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "Encompass SBA Loan [Member]", "label": "Encompass SBALoan Member" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressAddressLine1", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressAddressLine2", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressCityOrTown", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityCentralIndexKey", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1350" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1350" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityExTransitionPeriod", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r1365" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityFilerCategory", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1350" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityRegistrantName", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1350" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntitySmallBusiness", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1350" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1350" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EquityComponentDomain", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r112", "r113", "r141", "r174", "r175", "r186", "r187", "r188", "r226", "r227", "r228", "r230", "r238", "r241", "r243", "r257", "r345", "r348", "r399", "r400", "r401", "r474", "r506", "r511", "r512", "r513", "r516", "r518", "r521", "r538", "r539", "r541", "r542", "r589", "r627", "r628", "r638", "r639", "r640", "r642", "r708", "r709", "r751", "r752", "r753", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r769", "r806", "r807", "r808", "r809", "r810", "r811", "r816", "r835", "r888", "r932", "r933", "r945", "r946", "r978", "r1000", "r1024", "r1025", "r1026", "r1055", "r1126", "r1621" ] }, "vsee_EquityDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityDetailsLineItems", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Equity (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_EquityDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityDetailsTable", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Equity (Details) [Table]" } } }, "auth_ref": [] }, "vsee_EquityFinancingMaximumRemainingShareCapacityAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityFinancingMaximumRemainingShareCapacityAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum remaining availability under the ELOC", "documentation": "Maximum amount of share capacity available for issuance under the equity financing.", "label": "Equity Financing Maximum Remaining Share Capacity Amount" } } }, "auth_ref": [] }, "vsee_EquityIncentivePlan2024Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityIncentivePlan2024Member", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Incentive Plan 2024 [Member]", "documentation": "Represents information relating to 2024 Equity Incentive Plan.", "label": "Equity Incentive Plan2024 Member" } } }, "auth_ref": [] }, "vsee_EquityLineOfCreditCommitmentFeeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityLineOfCreditCommitmentFeeNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "ELOC Commitment Fee Note", "verboseLabel": "Equity Line Of Credit", "netLabel": "Equity Line Of Credit, Commitment Fee Note [Member]", "documentation": "Represents information pertaining to equity line of credit commitment fee note.", "label": "Equity Line Of Credit Commitment Fee Note Member" } } }, "auth_ref": [] }, "vsee_EquityLineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityLineOfCreditMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable9", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Line of Credit", "verboseLabel": "Equity line of credit [Member]", "netLabel": "ELOC Purchase Agreement [Member]", "label": "Equity Line Of Credit [Member]", "documentation": "Represents information pertaining to equity line of credit." } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r341", "r342", "r343", "r637", "r804", "r1368", "r1369", "r1370", "r1664", "r1665", "r1666", "r1667" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership interest", "verboseLabel": "Percentage of ownership interest", "label": "Equity Method Investment, Ownership Percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r341", "r804" ] }, "vsee_EquityPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Purchase Agreement [Member]", "documentation": "Represents the information pertaining to equity purchase agreement.", "label": "Equity Purchase Agreement Member" } } }, "auth_ref": [] }, "vsee_EquityPurchaseCommitmentNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityPurchaseCommitmentNoteMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Purchase Commitment Note [Member]", "documentation": "Represents information related to Equity Purchase Commitment Note.", "label": "Equity Purchase Commitment Note Member" } } }, "auth_ref": [] }, "vsee_EquityScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "label": "Equity - Schedule of Key Assumptions Used in Valuing Unvested Options (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_EquityScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EquityScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "label": "Equity - Schedule of Key Assumptions Used in Valuing Unvested Options (Details) [Table]" } } }, "auth_ref": [] }, "vsee_EstimatedFairValueOfAssetsAcquiredAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EstimatedFairValueOfAssetsAcquiredAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fair value of assets acquired:", "label": "Estimated Fair Value Of Assets Acquired Abstract" } } }, "auth_ref": [] }, "vsee_EstimatedFairValueOfLiabilitiesAssumedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EstimatedFairValueOfLiabilitiesAssumedAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fair value of liabilities assumed:", "label": "Estimated Fair Value Of Liabilities Assumed Abstract" } } }, "auth_ref": [] }, "vsee_EstimatedValueOfSharesAndOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "EstimatedValueOfSharesAndOptionsGranted", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares and options granted (in Dollars)", "documentation": "The estimated value of shares and options granted.", "label": "Estimated Value Of Shares And Options Granted" } } }, "auth_ref": [] }, "vsee_ExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ExcessAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Excess amount", "documentation": "Excess amount.", "label": "Excess Amount" } } }, "auth_ref": [] }, "vsee_ExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ExchangeAgreementMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange Agreement [Member]", "documentation": "Represents information related to Exchange Agreement.", "label": "Exchange Agreement Member" } } }, "auth_ref": [] }, "vsee_ExchangeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ExchangeNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange Note", "verboseLabel": "Exchange Note [Member]", "documentation": "Represents information related to Exchange Note.", "label": "Exchange Note Member" } } }, "auth_ref": [] }, "vsee_ExchangeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ExchangeNotesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable8" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange Note", "verboseLabel": "Exchange Note [Member]", "netLabel": "Exchange Notes [Member]", "documentation": "Represents information pertaining to exchange note.", "label": "Exchange Notes Member" } } }, "auth_ref": [] }, "vsee_ExcludedSecurities1Abstract1": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ExcludedSecurities1Abstract1", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Excluded securities:(1)", "label": "Excluded Securities1 Abstract1" } } }, "auth_ref": [] }, "vsee_ExtensionNoteBifurcatedDerivativeMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ExtensionNoteBifurcatedDerivativeMember", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "terseLabel": "Extension Note Bifurcated Derivative [Member]", "documentation": "Represents information pertaining to extension note - bifurcated derivative.", "label": "Extension Note Bifurcated Derivative Member" } } }, "auth_ref": [] }, "vsee_ExtensionNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ExtensionNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Extension Note [Member]", "documentation": "Represents information related to Extension Note.", "label": "Extension Note Member" } } }, "auth_ref": [] }, "vsee_ExtensionWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ExtensionWarrantsMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Extension Warrants [Member]", "verboseLabel": "Extension [Member]", "documentation": "Represents information pertaining to Extension Warrants.", "label": "Extension Warrants Member" } } }, "auth_ref": [] }, "vsee_FactoringPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FactoringPayableAbstract", "lang": { "en-us": { "role": { "label": "Factoring Payable Abstract" } } }, "auth_ref": [] }, "vsee_FactoringPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FactoringPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Factoring payable", "documentation": "Carrying value as of the balance sheet date of factoring payable, classified as current.", "label": "Factoring Payable Current" } } }, "auth_ref": [] }, "vsee_FactoringPayableDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FactoringPayableDetailsLineItems", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "label": "Factoring Payable (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_FactoringPayableDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FactoringPayableDetailsTable", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "label": "Factoring Payable (Details) [Table]" } } }, "auth_ref": [] }, "vsee_FactoringPayableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FactoringPayableTextBlock", "presentation": [ "http://vseehealth.com/role/FactoringPayable" ], "lang": { "en-us": { "role": { "terseLabel": "Factoring Payable", "documentation": "The entire disclosure of Factoring Payable.", "label": "Factoring Payable Text Block" } } }, "auth_ref": [] }, "vsee_FairValueAdjustmentOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueAdjustmentOfFinancialInstruments", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of financial instruments", "terseLabel": "Change in fair value of financial instruments", "verboseLabel": "Fair value", "documentation": "Amount of expense (income) related to adjustment to fair value of financial instruments.", "label": "Fair Value Adjustment Of Financial Instruments" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r772", "r774", "r775", "r789", "r1300" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r772", "r774", "r775", "r789", "r1300" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable8", "http://vseehealth.com/role/ScheduleofKeyInputsTable9" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "terseLabel": "Fair Value Measurements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r776", "r777", "r778", "r1251", "r1258", "r1304", "r1751" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable8", "http://vseehealth.com/role/ScheduleofKeyInputsTable9" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r776", "r777", "r778", "r1251", "r1258", "r1304", "r1751" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Key Inputs", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r776", "r777", "r1304" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r457", "r544", "r545", "r546", "r547", "r548", "r549", "r551", "r552", "r772", "r773", "r775", "r776", "r777", "r778", "r787", "r789", "r791", "r797", "r853", "r854", "r855", "r860", "r1226", "r1227", "r1240", "r1241", "r1242", "r1243", "r1244", "r1300", "r1304", "r1311", "r1312" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r774", "r775", "r776", "r778", "r1300", "r1712", "r1723" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://vseehealth.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r776", "r783", "r785", "r786", "r787", "r791", "r792", "r793", "r794", "r795", "r931", "r1300", "r1305" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 1 [Member]", "verboseLabel": "Level 2 [Member]", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r457", "r544", "r549", "r551", "r775", "r789", "r797", "r853", "r1240", "r1241", "r1242", "r1243", "r1244", "r1300", "r1311", "r1312" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1 [Member]", "verboseLabel": "Level 3 [Member]", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r457", "r544", "r549", "r551", "r553", "r775", "r776", "r789", "r797", "r854", "r1226", "r1227", "r1240", "r1241", "r1242", "r1243", "r1244", "r1300", "r1311", "r1312" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 3 [Member]", "verboseLabel": "Level 3 [Member]", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r457", "r544", "r545", "r546", "r547", "r548", "r549", "r551", "r552", "r775", "r776", "r777", "r778", "r789", "r797", "r855", "r1226", "r1227", "r1240", "r1241", "r1242", "r1243", "r1244", "r1300", "r1304", "r1311", "r1312" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value Information on Recurring Basis", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r1709", "r1710" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r779", "r780", "r781", "r782", "r783", "r784" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input." } } }, "auth_ref": [ "r779", "r780", "r781", "r782", "r783", "r784", "r790" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes in the Fair Value of Financial Liabilities", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r779", "r784", "r790" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [ "r774", "r775", "r776", "r778", "r1300", "r1712", "r1723" ] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionsToPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionsToPrincipal", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Additions to principal", "documentation": "The amount of additions to principal.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Additions To Principal" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversion", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion", "negatedLabel": "Conversion", "documentation": "The amount of conversion.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionIntoEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionIntoEquity", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares issued upon conversions of portion of notes", "documentation": "Amount of conversion into equity of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Into Equity" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossFromExtinguishment": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossFromExtinguishment", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "(Gain) Loss due to extinguishment of debt", "documentation": "Amount of gain (loss) recognized from extinguishment of debt measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss From Extinguishment" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarning": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarning", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) Loss on change in fair value", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earning" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r780", "r790" ] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossOnChangeInFairValueAndExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossOnChangeInFairValueAndExtinguishmentOfDebt", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on change in fair value / extinguishment of debt", "documentation": "Amount of gain (loss) on change in fair value / extinguishment of debt of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss On Change In Fair Value And Extinguishment Of Debt" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInitialFairValueAtIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInitialFairValueAtIssuance", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Initial fair value at issuance", "documentation": "The amount of initial fair value at issuance.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Initial Fair Value At Issuance" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInterestAccrued", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Interest accrued", "documentation": "Amount of interest accrued of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Interest Accrued" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuanceDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuanceDiscount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance discount", "documentation": "Amount of issuance discount of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issuance Discount" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Initial fair value at issuance", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r782", "r788", "r790" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment on Notes", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales", "documentation": "Amount of sales of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r782", "r790" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Settlement of Extension Note", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r782", "r790" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfer liabilities levels", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r1718", "r1722" ] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWriteOff": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWriteOff", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Write-off", "documentation": "Amount of write-off of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Write Off" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "periodStartLabel": "Fair value as of beginning of the year", "periodEndLabel": "Fair value as of end of the year", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r779", "r790" ] }, "vsee_FairValueMeasurementsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementsDetailsLineItems", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueMeasurementsDetailsTable", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r457", "r544", "r545", "r546", "r547", "r548", "r549", "r551", "r552", "r772", "r773", "r775", "r776", "r777", "r778", "r787", "r789", "r791", "r797", "r853", "r854", "r855", "r860", "r1226", "r1227", "r1240", "r1241", "r1242", "r1243", "r1244", "r1300", "r1304", "r1311", "r1312" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring [Member]", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r1300", "r1709", "r1710", "r1711", "r1712", "r1713", "r1723" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r1724" ] }, "vsee_FairValueOfSEPALiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueOfSEPALiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of SEPA liability", "documentation": "Fair value of SEPA liability.", "label": "Fair Value Of SEPALiability" } } }, "auth_ref": [] }, "vsee_FairValueOfSharesOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FairValueOfSharesOfCommonStock", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of shares issued to vendor for service (in Dollars)", "documentation": "Amounts of fair values of common stock", "label": "Fair Value Of Shares Of Common Stock" } } }, "auth_ref": [] }, "vsee_FederalMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FederalMember", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal [Member]", "label": "Federal Member" } } }, "auth_ref": [] }, "vsee_FinanceLeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FinanceLeaseCostTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Expenses Incurred with Respect to Finance Leases", "documentation": "Tabular disclosure of lessee's finance lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease.", "label": "Finance Lease Cost Table Text Block" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable", "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Total finance lease expense", "terseLabel": "Total Finance lease expense", "label": "Finance Lease, Interest Expense", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r820", "r826", "r1314" ] }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseInterestPaymentOnLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease payments", "label": "Finance Lease, Interest Payment on Liability", "documentation": "Amount of interest paid on finance lease liability." } } }, "auth_ref": [ "r822", "r828" ] }, "vsee_FinanceLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FinanceLeaseLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease liabilities", "documentation": "Finance lease liabilities.", "label": "Finance Lease Liabilities" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment lease", "verboseLabel": "Present value of payments", "label": "Finance Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r819", "r831" ] }, "us-gaap_FinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Financing lease liabilities", "negatedLabel": "Less: current portion", "label": "Finance Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current." } } }, "auth_ref": [ "r819" ] }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Future Minimum Payments Under Finance Lease", "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1737" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term portion", "label": "Finance Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r819" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total future minimum lease payments", "label": "Finance Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r831", "r1497", "r1504", "r1763" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2026", "label": "Finance Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r831", "r1497", "r1504", "r1763" ] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Imputed interest", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r831" ] }, "vsee_FinanceLeasePayableReclassedFromFinancingActivitiesToAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FinanceLeasePayableReclassedFromFinancingActivitiesToAccountsPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease payable reclassed from financing activities to accounts payable", "documentation": "Finance lease payable reclassed from financing activities to accounts payable.", "label": "Finance Lease Payable Reclassed From Financing Activities To Accounts Payable" } } }, "auth_ref": [] }, "vsee_FinanceLeasePrincipalPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FinanceLeasePrincipalPayment", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on financing lease liability", "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease Principal Payment" } } }, "auth_ref": [] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease payments", "label": "Finance Lease, Principal Payments", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r821", "r828" ] }, "us-gaap_FinanceLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable", "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Leased equipment, net", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r818" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable": { "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": -1.0, "order": 2.0 }, "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable0": { "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable", "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated amortization", "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization", "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease." } } }, "auth_ref": [ "r1374", "r1381" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable0": { "parentTag": "us-gaap_FinanceLeaseInterestExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable", "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "verboseLabel": "Finance lease asset amortization", "label": "Finance Lease, Right-of-Use Asset, Amortization", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r820", "r826", "r1314" ] }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable": { "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable0": { "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable", "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment lease", "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization", "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r1373" ] }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable", "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate*", "verboseLabel": "Weighted average discount rate", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for finance lease calculated at point in time." } } }, "auth_ref": [ "r830", "r1314" ] }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable", "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term (years)*", "label": "Finance Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r829", "r1314" ] }, "vsee_FinancedAgreementTotaled": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FinancedAgreementTotaled", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financed agreement totaled", "documentation": "Financed agreement totaled", "label": "Financed Agreement Totaled" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinancialInstrumentAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable6", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable9" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r350", "r351", "r352", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r468", "r505", "r749", "r796", "r803", "r805", "r850", "r851", "r852", "r853", "r854", "r855", "r857", "r858", "r859", "r860", "r862", "r863", "r864", "r865", "r866", "r867", "r869", "r870", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r958", "r959", "r960", "r961", "r962", "r963", "r964", "r965", "r966", "r967", "r968", "r969", "r970", "r971", "r972", "r973", "r974", "r975", "r981", "r1001", "r1219", "r1300", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1386", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1546", "r1547", "r1548", "r1549", "r1708", "r1711", "r1712", "r1713", "r1720", "r1723", "r1725", "r1726" ] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "verboseLabel": "Fair value amount", "netLabel": "Number of shares issued for business combination (in Dollars)", "label": "Financial Liabilities Fair Value Disclosure", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [ "r1709", "r1710", "r1720", "r1725", "r1726", "r1727", "r1728" ] }, "us-gaap_FinancingInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinancingInterestExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable0": { "parentTag": "us-gaap_FinanceLeaseInterestExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable", "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Financing Interest Expense", "documentation": "This element represents interest incurred for borrowed money which was used to produce goods or render services." } } }, "auth_ref": [ "r30" ] }, "vsee_FinancingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FinancingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 }, "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued financing lease", "verboseLabel": "Financing lease liabilities included in accounts payable and accrued liabilities", "documentation": "Amount of financing lease liabilities that are included in accounts payable and accrued liabilities at balance sheet date.", "label": "Financing Lease Liabilities Included In Accounts Payable And Accrued Liabilities" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for expected credit losses", "label": "Financing Receivable, Excluding Accrued Interest, Credit Loss Expense (Reversal)", "documentation": "Amount, excluding accrued interest, of credit loss expense (reversal of expense) on financing receivable. Excludes net investment in lease." } } }, "auth_ref": [ "r195", "r352" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated useful life", "verboseLabel": "Estimated useful lives, intangible assets", "label": "Intangible Asset, Finite-Lived, Useful Life", "documentation": "Useful life of finite-lived intangible asset, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r398" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated amortization", "label": "Intangible Asset, Finite-Lived, Accumulated Amortization", "documentation": "Amount of accumulated amortization of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r153", "r367", "r390", "r1176", "r1572" ] }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "documentation": "Disclosure of information about finite-lived intangible asset acquired in business combination." } } }, "auth_ref": [ "r1562", "r1563", "r1676", "r1678" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Intangible Asset, Finite-Lived, Estimated Amortization Expense, after Year Five", "documentation": "Amount of amortization expense for finite-lived intangible asset expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r1568" ] }, "vsee_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense After Year Four" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2027", "verboseLabel": "Year ending December 31, 2026", "label": "Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One", "documentation": "Amount of amortization expense for finite-lived intangible asset expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r392", "r1176" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2026 (remaining six months)", "label": "Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year", "documentation": "Amount of amortization expense for finite-lived intangible asset expected to be recognized in remainder of current fiscal year. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r1568" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2030", "label": "Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Five", "documentation": "Amount of amortization expense for finite-lived intangible asset expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r392", "r1176" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 }, "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2030", "verboseLabel": "Year ending December 31, 2029", "label": "Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four", "documentation": "Amount of amortization expense for finite-lived intangible asset expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r392", "r1176" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2029", "verboseLabel": "Year ending December 31, 2028", "label": "Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three", "documentation": "Amount of amortization expense for finite-lived intangible asset expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r392", "r1176" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2028", "verboseLabel": "Year ending December 31, 2027", "label": "Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two", "documentation": "Amount of amortization expense for finite-lived intangible asset expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r392", "r1176" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0" ], "lang": { "en-us": { "role": { "label": "Intangible Asset, Finite-Lived, Class [Axis]", "documentation": "Information by class of finite-lived intangible asset." } } }, "auth_ref": [ "r383", "r385", "r386", "r387", "r389", "r390", "r394", "r395", "r895", "r896", "r1036", "r1173", "r1176", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1280", "r1281", "r1282", "r1283", "r1284", "r1285", "r1286", "r1287", "r1288", "r1289", "r1290", "r1572", "r1821", "r1822", "r1823" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, gross", "label": "Intangible Asset, Finite-Lived, before Accumulated Amortization", "documentation": "Amount, before accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r367", "r390", "r896", "r1176", "r1572" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0" ], "lang": { "en-us": { "role": { "label": "Intangible Asset, Finite-Lived [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r383", "r390", "r394", "r395", "r397", "r895", "r1173", "r1176", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1280", "r1281", "r1282", "r1283", "r1284", "r1285", "r1286", "r1287", "r1288", "r1289", "r1290", "r1572", "r1821", "r1822", "r1823" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0" ], "lang": { "en-us": { "role": { "label": "Intangible Asset, Finite-Lived, Class [Domain]", "documentation": "Class of finite-lived intangible asset." } } }, "auth_ref": [ "r383", "r385", "r386", "r387", "r389", "r390", "r394", "r395", "r1036", "r1173", "r1176", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1280", "r1281", "r1282", "r1283", "r1284", "r1285", "r1286", "r1287", "r1288", "r1289", "r1290", "r1572", "r1821", "r1822", "r1823" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "terseLabel": "Intangible assets, net", "label": "Intangible Asset, Finite-Lived, after Accumulated Amortization", "documentation": "Amount, after accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r895", "r1566" ] }, "vsee_FirstInsuranceFundingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FirstInsuranceFundingAgreementMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "First Insurance Funding Agreement [Member]", "label": "First Insurance Funding Agreement Member" } } }, "auth_ref": [] }, "vsee_FirstInsuranceFundingLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FirstInsuranceFundingLoanMember", "presentation": [ "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "First Insurance Funding Loan [Member]", "label": "First Insurance Funding Loan Member" } } }, "auth_ref": [] }, "vsee_FixedAssetRecognitionThreshold": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FixedAssetRecognitionThreshold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed asset recognition threshold", "documentation": "The monetary threshold for which fixed assets are required to be recorded.", "label": "Fixed Asset Recognition Threshold" } } }, "auth_ref": [] }, "vsee_FixedSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FixedSettlement", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed settlement", "documentation": "The amount represents the fixed settlement.", "label": "Fixed Settlement" } } }, "auth_ref": [] }, "vsee_ForeignTaxEffectsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ForeignTaxEffectsAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign tax effects", "label": "Foreign Tax Effects Abstract" } } }, "auth_ref": [] }, "vsee_FoundersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FoundersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC founders [Member]", "verboseLabel": "Founders [Member]", "documentation": "Represents information pertaining to founders.", "label": "Founders Member" } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture [Member]", "verboseLabel": "Furniture [Member", "netLabel": "Furniture and Fixtures [Member]", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [ "r1224", "r1579", "r1580" ] }, "vsee_FutureReceiptsSaleAgreement1Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreement1Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 1 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 1.", "label": "Future Receipts Sale Agreement1 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement2Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreement2Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 2 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 2.", "label": "Future Receipts Sale Agreement2 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement3Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreement3Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 3 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 3.", "label": "Future Receipts Sale Agreement3 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement4Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreement4Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 4 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 4.", "label": "Future Receipts Sale Agreement4 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement5Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreement5Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 5 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 5.", "label": "Future Receipts Sale Agreement5 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement6Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreement6Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 6 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 6.", "label": "Future Receipts Sale Agreement6 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement7Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreement7Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 7 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 7.", "label": "Future Receipts Sale Agreement7 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserDaily": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserDaily", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount to be collected by purchaser daily", "documentation": "Represents the amount to be collected by purchaser daily under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Amount To Be Collected By Purchaser Daily" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserWeekly": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserWeekly", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount to be collected by purchaser weekly", "documentation": "Represents the amount to be collected by purchaser weekly under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Amount To Be Collected By Purchaser Weekly" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementAxis": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreementAxis", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement [Axis]", "documentation": "Schedule of information pertaining to Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Axis" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementBalloonCollectionByPurchaser": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreementBalloonCollectionByPurchaser", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balloon collection", "documentation": "Represents the amount to be collected by purchaser as a final payment under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Balloon Collection By Purchaser" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementDomainDomain": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreementDomainDomain", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "label": "FutureReceiptsSaleAgreementDomain [Domain]" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementFutureReceiptsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreementFutureReceiptsSold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future receipts sold", "documentation": "Represents the amount of Future receipts sold under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Future Receipts Sold" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreementInterestRate", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "documentation": "Represents the interest rate associated with the transactions under Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Interest Rate" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementNetSalePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreementNetSalePrice", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net purchase price", "documentation": "Represents the amount of Net sales under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Net Sale Price" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementPeriodOverWhichAmountIsToBeCollectedByPurchaserWeekly": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "FutureReceiptsSaleAgreementPeriodOverWhichAmountIsToBeCollectedByPurchaserWeekly", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period over which amount is to be collected by purchaser weekly", "documentation": "Represents the period over which the amount is to be collected by purchaser weekly under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Period Over Which Amount Is To Be Collected By Purchaser Weekly" } } }, "auth_ref": [] }, "vsee_GainLossOnDebtConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainLossOnDebtConversion", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on debt conversion", "documentation": "The amount of gain loss recorded during the period on conversion of debt.", "label": "Gain Loss On Debt Conversion" } } }, "auth_ref": [] }, "vsee_GainLossOnExtinguishmentOfELOC": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainLossOnExtinguishmentOfELOC", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on extinguishment of ELOC", "documentation": "Gain (loss) on extinguishment of ELOC.", "label": "Gain Loss On Extinguishment Of ELOC" } } }, "auth_ref": [] }, "vsee_GainLossOnIssuanceOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainLossOnIssuanceOfFinancialInstruments", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 5.0 }, "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on issuance of financial instruments", "negatedLabel": "Loss on issuance of financial instruments", "documentation": "Amount of increase (decrease) in the fair value of financial instruments at issuance recognized in the income statement.", "label": "Gain Loss On Issuance Of Financial Instruments" } } }, "auth_ref": [] }, "vsee_GainLossOnIssuanceOfStandbyEquityPurchaseAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainLossOnIssuanceOfStandbyEquityPurchaseAgreement", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on issuance of SEPA", "documentation": "The amount of gain (loss) on issuance of standby equity purchase agreement.", "label": "Gain Loss On Issuance Of Standby Equity Purchase Agreement" } } }, "auth_ref": [] }, "us-gaap_GainLossOnTerminationOfLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "GainLossOnTerminationOfLease", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 22.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on termination of lease", "label": "Gain (Loss) on Termination of Lease", "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term." } } }, "auth_ref": [ "r817" ] }, "vsee_GainOnExtinguishmentOfELOC": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainOnExtinguishmentOfELOC", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 21.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on extinguishment of ELOC", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain On Extinguishment Of ELOC" } } }, "auth_ref": [] }, "vsee_GainOnExtinguishmentOfEquityLineOfCreditELOC": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainOnExtinguishmentOfEquityLineOfCreditELOC", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on extinguishment of Equity Line of Credit (\u201cELOC\u201d)", "documentation": "Gain on extinguishment of equity line of credit (\u201cELOC\u201d).", "label": "Gain On Extinguishment Of Equity Line Of Credit ELOC" } } }, "auth_ref": [] }, "vsee_GainOnExtinguishmentOfFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainOnExtinguishmentOfFinancialLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on extinguishment of financial liabilities", "negatedLabel": "Gain on extinguishment of financial liabilities", "documentation": "The amount of gain on extinguishment of financial liabilities.", "label": "Gain On Extinguishment Of Financial Liabilities" } } }, "auth_ref": [] }, "vsee_GainlossOnChangeInFairValueConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainlossOnChangeInFairValueConversion", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on change in fair value conversion", "documentation": "Gain (loss) on change in fair value conversion.", "label": "Gainloss On Change In Fair Value Conversion" } } }, "auth_ref": [] }, "vsee_GainlossOnIssuanceOfSEPA": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainlossOnIssuanceOfSEPA", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on issuance of SEPA", "documentation": "Gain (loss) on issuance of SEPA.", "label": "Gainloss On Issuance Of SEPA" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 7.0 }, "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of debt", "negatedLabel": "Loss on extinguishment of loan", "verboseLabel": "Gain on extinguishment", "netLabel": "Loss on extinguishment", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r4", "r13", "r14" ] }, "vsee_GainsLossesOnExtinguishmentOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GainsLossesOnExtinguishmentOfFinancialInstruments", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of financial instruments", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gains Losses On Extinguishment Of Financial Instruments" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "verboseLabel": "General and administrative expenses", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r32", "r1106" ] }, "vsee_GianLossOnIssuanceOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GianLossOnIssuanceOfFinancialInstruments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on issuance of financial instruments", "documentation": "Amount of increase (decrease) in the fair value of financial instruments at issuance recognized in the income statement.", "label": "Gian Loss On Issuance Of Financial Instruments" } } }, "auth_ref": [] }, "vsee_GoMyRxIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GoMyRxIncMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "GoMyRx Inc [Member}", "label": "Go My Rx Inc Member" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "verboseLabel": "Total goodwill", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r145", "r152", "r369", "r932", "r933", "r934", "r1213", "r1220", "r1251", "r1255", "r1256", "r1294", "r1302", "r1315", "r1556", "r1557", "r1682" ] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r368", "r380", "r1220" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment charges", "verboseLabel": "Goodwill impairment", "label": "Goodwill, Impairment Loss", "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r4", "r370", "r376", "r380", "r382", "r706", "r1220", "r1302" ] }, "vsee_GrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GrantDateFairValue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grant date fair value (in Dollars)", "documentation": "The amount of grant date fair value.", "label": "Grant Date Fair Value" } } }, "auth_ref": [] }, "vsee_GrossProceedsFromIssuanceOfCommonStockAndWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "GrossProceedsFromIssuanceOfCommonStockAndWarrants", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common warrants, for gross proceeds (in Dollars)", "documentation": "Gross proceeds from issuance of common stock and warrants.", "label": "Gross Proceeds From Issuance Of Common Stock And Warrants" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Gross margin", "terseLabel": "Segment gross margin", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r24", "r30", "r212", "r215", "r216", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r517", "r804", "r1206", "r1212", "r1405", "r1411", "r1518", "r1526", "r1533", "r1537", "r1538", "r1550", "r1594" ] }, "us-gaap_HealthCarePatientServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "HealthCarePatientServiceMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Patient fees", "verboseLabel": "Health Care, Patient Service", "label": "Health Care, Patient Service [Member]", "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility." } } }, "auth_ref": [ "r1622", "r1623" ] }, "us-gaap_HomeEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "HomeEquityMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Line of Credit", "verboseLabel": "Home Equity Line of Credit [Member]", "label": "Home Equity Line of Credit [Member]", "documentation": "Revolving, open-end loan extended under a line of credit and secured by the borrower's residential property." } } }, "auth_ref": [ "r1544" ] }, "vsee_IdocNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IdocNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IDoc Note [Member]", "documentation": "Represents information related to iDoc Note.", "label": "Idoc Note Member" } } }, "auth_ref": [] }, "vsee_IdocStockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IdocStockholdersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IDoc Stockholders [Member]", "documentation": "Represents information pertaining to iDoc stockholders.", "label": "Idoc Stockholders Member" } } }, "auth_ref": [] }, "vsee_IdocVirtualTelehealthSolutionsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IdocVirtualTelehealthSolutionsIncMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IDoc Virtual Telehealth Solutions, Inc", "verboseLabel": "iDoc", "netLabel": "IDoc Virtual Telehealth Solutions, Inc [Member]", "label": "iDoc [Member]", "documentation": "Represents the information pertaining to iDoc Virtual Telehealth Solutions, INC." } } }, "auth_ref": [] }, "vsee_IfStockPriceDropsBelow2DollarsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IfStockPriceDropsBelow2DollarsMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "If stock Price Drops Below 2 Dollars [Member]", "documentation": "Represents scenario information pertaining to stock price drops below $2.", "label": "If Stock Price Drops Below2 Dollars Member" } } }, "auth_ref": [] }, "vsee_ImoAisikuMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ImoAisikuMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Imo Aisiku [Member]", "documentation": "Represents information pertaining to Co-CEO Imo Aisiku.", "label": "Imo Aisiku Member" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of intangible assets other than goodwill", "label": "Intangible Asset, Excluding Goodwill, Impairment Loss", "documentation": "Amount of impairment loss for finite- and indefinite-lived intangible assets and capitalized cost for software to be sold, leased, or marketed. Excludes goodwill." } } }, "auth_ref": [ "r4", "r192", "r384", "r396" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of long-lived", "label": "Long-Lived Asset, Held and Used, Impairment Loss", "documentation": "Amount of impairment loss for long-lived asset held and used. Includes, but is not limited to, impairment loss for long-lived asset to be disposed of other than by sale." } } }, "auth_ref": [ "r4", "r193", "r410", "r1195", "r1301", "r1576" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of Long-Lived and Intangible Assets Other than Goodwill", "label": "Long-Lived Asset, Including Intangible Asset and Goodwill, Impairment and Disposal [Policy Text Block]", "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from continuing operations, net of tax", "terseLabel": "Net loss Continuing operations", "verboseLabel": "Net loss from continuing operations", "netLabel": "Net loss from continuing operations - basic and diluted, net of tax (in Dollars)", "label": "Income (loss) from continuing operations, net of tax", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r19", "r26", "r42", "r113", "r233", "r234", "r236", "r237", "r238", "r249", "r252", "r709" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeLossIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations." } } }, "auth_ref": [ "r212", "r217", "r607" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from continuing operations before provision for income taxes", "terseLabel": "Income tax expense", "verboseLabel": "Loss before (provision) benefit for income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r25", "r50", "r953", "r955", "r996", "r1177", "r1196", "r1198", "r1200", "r1206", "r1212", "r1518", "r1526", "r1533", "r1537", "r1538" ] }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r48", "r113", "r125", "r212", "r215", "r216", "r229", "r238", "r400", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r475", "r517", "r540", "r589", "r641", "r709", "r771", "r804", "r996", "r1177", "r1206", "r1405", "r1411", "r1518", "r1526", "r1533", "r1537", "r1538", "r1550", "r1594" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Basic loss per common share- continuing operations (in Dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r26", "r51", "r113", "r190", "r229", "r231", "r232", "r233", "r234", "r236", "r237", "r238", "r247", "r250", "r251", "r400", "r475", "r540", "r641", "r709", "r771", "r952", "r1769" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted loss per common share- continuing operations (in Dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r26", "r113", "r190", "r229", "r231", "r232", "r233", "r234", "r236", "r237", "r238", "r247", "r250", "r251", "r252", "r400", "r540", "r709", "r771", "r952", "r1769" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Income (loss) from discontinued operations, net of tax", "terseLabel": "Net income (loss) Discontinued operations", "verboseLabel": "Net income (loss) from discontinued operations", "netLabel": "Net income (loss) from discontinued operations - basic (in Dollars)", "label": "Net income/(loss) from discontinued operations", "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r122", "r123", "r125", "r134", "r634", "r997", "r1183" ] }, "vsee_IncomeLossFromDiscontinuedOperationsNetOfTaxDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxDiluted", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net income (loss) from discontinued operations - diluted (in Dollars)", "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income Loss From Discontinued Operations Net Of Tax Diluted" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Basic income (loss) per common share- discontinued operations (in Dollars per share)", "verboseLabel": "Net income (loss) per share from discontinued operations \u2013 basic (in Dollars per share)", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share", "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r27", "r190", "r248", "r250", "r251", "r1762", "r1769" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted income (loss) per common share- discontinued operations (in Dollars per share)", "verboseLabel": "Net income (loss) per share from discontinued operations \u2013 diluted (in Dollars per share)", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r49", "r248", "r250", "r251" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Axis]", "documentation": "Information by income tax jurisdiction." } } }, "auth_ref": [ "r207", "r608", "r612", "r616", "r624", "r1249", "r1659" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Domain]", "documentation": "Income tax jurisdiction." } } }, "auth_ref": [ "r207", "r608", "r612", "r616", "r624", "r1249", "r1659" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r212", "r218", "r601", "r608", "r613", "r614", "r615", "r617", "r623", "r630", "r632", "r635", "r636", "r980", "r1035", "r1049", "r1249" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0, "order": 2.0 }, "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/IncomeTaxesDetails", "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable", "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total income tax provision for (benefit from) continuing operations", "negatedLabel": "Benefit from (provision for) income taxes for continuing operations", "terseLabel": "Provision for income tax, Amount (in Dollars)", "verboseLabel": "Income tax expense", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r57", "r65", "r212", "r242", "r243", "r256", "r278", "r300", "r606", "r608", "r631", "r1003", "r1177", "r1196", "r1198", "r1200", "r1249" ] }, "vsee_IncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Continuing operations", "documentation": "Amount of income tax expense (benefit), continuing operations.", "label": "Income Tax Expense Benefit Continuing Operations" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations", "documentation": "Amount of current tax expense (benefit) and deferred tax expense (benefit) pertaining to income (loss) from continuing operations and income (loss) from discontinued operations." } } }, "auth_ref": [ "r1250" ] }, "vsee_IncomeTaxExpenseBenefitDiscontinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IncomeTaxExpenseBenefitDiscontinuingOperations", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxExpenseBenefitTable" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations", "documentation": "Income tax expense (benefit), discontinuing operations.", "label": "Income Tax Expense Benefit Discontinuing Operations" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r185", "r602", "r603", "r617", "r618", "r622", "r626", "r1043" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Change in valuation allowance, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r611", "r1249", "r1655" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. federal statutory tax, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r608", "r1249" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Meals and entertainment, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense." } } }, "auth_ref": [ "r1655", "r1656" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxReconciliationNondeductibleExpenseOther", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses." } } }, "auth_ref": [ "r1249", "r1655", "r1656" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r1249", "r1655", "r1656" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "State taxes, net of federal tax benefit, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r610", "r1249", "r1655" ] }, "vsee_IncomeTaxReconciliationTaxPenalties": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IncomeTaxReconciliationTaxPenalties", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Penalties, Amount (in Dollars)", "documentation": "The amount of tax penalties during the year.", "label": "Income Tax Reconciliation Tax Penalties" } } }, "auth_ref": [] }, "vsee_IncomeTaxesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IncomeTaxesDetailsTable", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Taxes (Details) [Table]" } } }, "auth_ref": [] }, "vsee_IncomeTaxesScheduleofIncomeLossIncomeTaxesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IncomeTaxesScheduleofIncomeLossIncomeTaxesDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeLossIncomeTaxesTable" ], "lang": { "en-us": { "role": { "label": "Income Taxes - Schedule of Income/ (Loss) Income Taxes (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_IncomeTaxesScheduleofIncomeLossIncomeTaxesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IncomeTaxesScheduleofIncomeLossIncomeTaxesDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeLossIncomeTaxesTable" ], "lang": { "en-us": { "role": { "label": "Income Taxes - Schedule of Income/ (Loss) Income Taxes (Details) [Table]" } } }, "auth_ref": [] }, "vsee_IncreaseDecreaseChangeInFairValueOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IncreaseDecreaseChangeInFairValueOfFinancialInstruments", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of financial instruments", "documentation": "The amount of change in fair value of financial instruments.", "label": "Increase Decrease Change In Fair Value Of Financial Instruments" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "verboseLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r890", "r1491" ] }, "us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInDueFromRelatedPartiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Due from related party", "label": "Increase (Decrease) in Due from Related Parties, Current", "documentation": "The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInDueToRelatedParties", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Due to related parties", "label": "Increase (Decrease) in Due to Related Parties", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r3" ] }, "vsee_IncreaseDecreaseInEncompassPurchaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IncreaseDecreaseInEncompassPurchaseLiability", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 23.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Encompass Purchase liability", "documentation": "The amount represents the encompass purchase liability.", "label": "Increase Decrease In Encompass Purchase Liability" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r1382", "r1491" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaids and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Asset, Indefinite-Lived, Class [Axis]", "documentation": "Information by class of indefinite-lived intangible asset." } } }, "auth_ref": [ "r383", "r388", "r393", "r1176", "r1264", "r1265", "r1266", "r1275", "r1276", "r1290" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Asset, Indefinite-Lived, Class [Domain]", "documentation": "Class of indefinite-lived intangible asset." } } }, "auth_ref": [ "r383", "r388", "r393", "r1176", "r1264", "r1265", "r1266", "r1275", "r1276", "r1290" ] }, "vsee_InitialFixedConversionPriceMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "InitialFixedConversionPriceMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial Fixed Conversion Price [Member]", "label": "Initial Fixed Conversion Price Member" } } }, "auth_ref": [] }, "vsee_InitialMBLANoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "InitialMBLANoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial MBLA Note [Member]", "label": "Initial MBLANote Member" } } }, "auth_ref": [] }, "vsee_InstitutionalFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "InstitutionalFeesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Institutional fees", "verboseLabel": "Institutional Fees", "netLabel": "Institutional Fees [Member]", "label": "Institutional fees [Member]", "documentation": "Represents fess relating to institutional activities." } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r891", "r892", "r893", "r895", "r1201", "r1559" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Asset, Excluding Goodwill, after Accumulated Amortization", "documentation": "Amount, after accumulated amortization, of finite- and indefinite-lived intangible assets and capitalized cost for software to be sold, leased, or marketed. Excludes goodwill." } } }, "auth_ref": [ "r383", "r932", "r933", "r935", "r1566", "r1569" ] }, "vsee_InterestAccruedPerMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "InterestAccruedPerMonth", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest accrued per month", "documentation": "The amount of interest accrued per month.", "label": "Interest Accrued Per Month" } } }, "auth_ref": [] }, "vsee_InterestAccruesOfImmediatelyGuaranteedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "InterestAccruesOfImmediatelyGuaranteedPeriod", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrues immediately and is guaranteed period", "verboseLabel": "Interest Accrues Of Immediately Guaranteed Period", "documentation": "Accrues immediately and is guaranteed.", "label": "Interest Accrues Of Immediately Guaranteed Period" } } }, "auth_ref": [] }, "vsee_InterestChargePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "InterestChargePercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest charge percent", "documentation": "Percentage of interest charge.", "label": "Interest Charge Percentage" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "verboseLabel": "Interest amount", "label": "Interest Expense, Operating and Nonoperating", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r256", "r270", "r274", "r280", "r300", "r813", "r1212", "r1213", "r1815" ] }, "us-gaap_InterestExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestExpenseAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Expense:", "label": "Interest Expense, Operating and Nonoperating [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest amount", "verboseLabel": "Total interest expense", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r34", "r463", "r473", "r1228", "r1229", "r1815" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "terseLabel": "Interest expense", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r274", "r1196", "r1200", "r1444" ] }, "us-gaap_InterestExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestExpenseOther", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, other", "verboseLabel": "Default interest expense", "label": "Interest Expense, Other", "documentation": "Amount of interest expense classified as other." } } }, "auth_ref": [] }, "us-gaap_InterestPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestPaid", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Paid amount", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities." } } }, "auth_ref": [ "r1493" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for interest expense", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activity", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r200", "r202", "r206" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "verboseLabel": "Accrued interest payable", "netLabel": "Accrued interest expense", "label": "Accrued interest expense (in Dollars)", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r1189" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "label": "Interest Payable", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r1424", "r1753", "r1754", "r1757", "r1764" ] }, "us-gaap_InterestRateFloorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestRateFloorMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Floor [Member]", "label": "Interest Rate Floor [Member]", "documentation": "Contracts in which the floor writer, in return for a premium, agrees to limit the risk associated with a decline in interest rates based on a notional amount. If rates fall below an agreed rate, the floor holder will receive cash payments from the floor writer equal to the difference between the market rate and an agreed rate multiplied by the notional principal amount." } } }, "auth_ref": [ "r1684", "r1686", "r1687", "r1688", "r1689", "r1690", "r1691", "r1692", "r1693", "r1694", "r1695", "r1696", "r1697", "r1698", "r1699", "r1700" ] }, "us-gaap_InvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InvestorMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investor [Member]", "label": "Investor [Member]", "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value." } } }, "auth_ref": [ "r1741", "r1742" ] }, "vsee_IssuanceOfCommonStockShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IssuanceOfCommonStockShares", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock shares (in Shares)", "documentation": "Issuance of common stock shares.", "label": "Issuance Of Common Stock Shares" } } }, "auth_ref": [] }, "vsee_IssuanceOfCompanySharesWithAnAggregateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IssuanceOfCompanySharesWithAnAggregateFairValue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of company shares with an aggregate fair value", "documentation": "Issuance of company shares with an aggregate fair value.", "label": "Issuance Of Company Shares With An Aggregate Fair Value" } } }, "auth_ref": [] }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as part of stock grants to vendors", "label": "Issuance of Stock and Warrants for Services or Claims", "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims." } } }, "auth_ref": [ "r4" ] }, "vsee_IssuedDebtOnAugust32023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "IssuedDebtOnAugust32023Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued Debt on August 3, 2023 [Member]", "label": "Issued Debt On August32023 Member" } } }, "auth_ref": [] }, "vsee_LabrysConvertiblePromissoryNoteFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LabrysConvertiblePromissoryNoteFinancingMember", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Labrys Convertible Promissory Note Financing [Member]", "label": "Labrys Convertible Promissory Note Financing Member" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Expenses Incurred for Operating Leases", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1736" ] }, "vsee_LeaseDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LeaseDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "documentation": "The entire disclosure of information about leases.", "label": "Lease Disclosure Text Block" } } }, "auth_ref": [] }, "vsee_LeasedEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LeasedEquipmentMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Leased Equipment [Member]", "verboseLabel": "Leased equipment [Member", "documentation": "Tangible personal property leased, used to produce goods and services.", "label": "Leased Equipment Member" } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold Improvements [Member]", "verboseLabel": "Leasehold improvements [Member", "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r832", "r1579", "r1580" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "LegalEntityAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LegalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LegalFees", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal fees (in Dollars)", "label": "Legal Fees", "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings." } } }, "auth_ref": [ "r1384", "r1816", "r1817" ] }, "vsee_LendersUnderARLoanConversionSpasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LendersUnderARLoanConversionSpasMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Lenders under A&R Loan Conversion SPAs [Member]", "verboseLabel": "Lenders Under A&R Loan Conversion SPAs [Member]", "documentation": "Represents information pertaining to lenders under A&R Loan Conversion SPAs.", "label": "Lenders Under ARLoan Conversion Spas Member" } } }, "auth_ref": [] }, "vsee_LendersUnderLoanConversionSpasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LendersUnderLoanConversionSpasMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lenders Under Loan Conversion SPAs [Member]", "documentation": "Represents information pertaining to lenders under Loan Conversion SPAs.", "label": "Lenders Under Loan Conversion Spas Member" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LesseeFinanceLeaseLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finance Lease Liabilities", "documentation": "Tabular disclosure of information relating to components of the lessee's finance lease liabilities.", "label": "Lessee Finance Lease Liabilities Table Text Block" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseRightOfUseAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LesseeFinanceLeaseRightOfUseAssetsTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finance Leased Equipment", "documentation": "Tabular disclosure of information relating to components of the lessee's finance lease right-of-use assets.", "label": "Lessee Finance Lease Right Of Use Assets Table Text Block" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseSupplementalInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LesseeFinanceLeaseSupplementalInformationTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted Average Remaining Lease Term and Discount Rate on Finance Leases", "documentation": "Tabular disclosure of the information pertaining to other supplemental information relating to the lessee's finance leases.", "label": "Lessee Finance Lease Supplemental Information Table Text Block" } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Leases", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r825", "r833", "r1735" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r825", "r833", "r1735" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r824" ] }, "vsee_LesseeOperatingLeaseLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LesseeOperatingLeaseLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Operating Lease Liabilities", "documentation": "Tabular disclosure of information relating to components of the lessee's operating lease liabilities.", "label": "Lessee Operating Lease Liabilities Table Text Block" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Future Minimum Rent Payments Under the Operating Lease", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1737" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable", "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Total future minimum lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r831", "r1497", "r1504", "r1763" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable0": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable", "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2027", "verboseLabel": "Year ending December 31, 2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r831", "r1497", "r1504", "r1763" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable0": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r831", "r1497", "r1504", "r1763" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2026 (remaining 6 months)", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r1737" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable", "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r831" ] }, "vsee_LesseeOperatingLeaseRightOfUseAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Operating Lease Right-of-Use Assets", "documentation": "Tabular disclosure of information relating to components of the lessee's operating lease right-of-use assets.", "label": "Lessee Operating Lease Right Of Use Assets Table Text Block" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r129", "r135", "r212", "r215", "r216", "r344", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r517", "r713", "r717", "r718", "r804", "r1081", "r1205", "r1230", "r1349", "r1431", "r1594", "r1746", "r1747" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r180", "r932", "r933", "r948", "r991", "r1315", "r1336", "r1337", "r1496", "r1501", "r1550", "r1729" ] }, "us-gaap_LiabilitiesAssumed1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesAssumed1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net liabilities acquired in reverse merger", "label": "Liabilities Assumed", "documentation": "The fair value of liabilities assumed in noncash investing or financing activities." } } }, "auth_ref": [ "r1494" ] }, "vsee_LiabilitiesAssumedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LiabilitiesAssumedAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities assumed", "label": "Liabilities Assumed Abstract" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r129", "r135", "r140", "r159", "r212", "r215", "r216", "r344", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r517", "r713", "r717", "r718", "r804", "r1315", "r1594", "r1746", "r1747" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current liabilities", "label": "Liabilities, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total liabilities from discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r121", "r132", "r404", "r415", "r1182", "r1401", "r1407", "r1408" ] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities from discontinued operations", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r121", "r132", "r404", "r415", "r1401", "r1407", "r1408" ] }, "vsee_LiabilitiesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LiabilitiesPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount payable", "documentation": "Liabilities payable.", "label": "Liabilities Payable" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesSubjectToCompromiseEarlyContractTerminationFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesSubjectToCompromiseEarlyContractTerminationFees", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Early termination fee", "label": "Liabilities Subject to Compromise, Early Contract Termination Fees", "documentation": "The amount of early contract termination fees included in liabilities subject to compromise." } } }, "auth_ref": [ "r1745" ] }, "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original discount", "label": "Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance", "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected net premium component of liability for future policy benefit, discounted at original rate." } } }, "auth_ref": [ "r1329", "r1780", "r1797" ] }, "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LineOfCreditFacilityCommitmentFeeAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit.", "label": "Line of Credit Facility, Commitment Fee Amount", "documentation": "Amount of the fee for available but unused credit capacity under the credit facility." } } }, "auth_ref": [ "r146", "r156", "r431", "r932", "r933", "r937" ] }, "vsee_LineOfCreditIssuedNovember292021Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LineOfCreditIssuedNovember292021Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line Of Credit Issued November 29, 2021 [Member]", "documentation": "Represents information related to Line of credit issued November 29, 2021", "label": "Line Of Credit Issued November292021 Member" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LineOfCreditMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit [Member]", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "us-gaap_LinesOfCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LinesOfCreditCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit", "label": "Line of Credit, Current", "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r1421" ] }, "vsee_LiquidatedDamages": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LiquidatedDamages", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liquidated damages", "documentation": "Liquidated damages.", "label": "Liquidated Damages" } } }, "auth_ref": [] }, "us-gaap_LoansPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LoansPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan payable, related party, net of discount", "verboseLabel": "Loan payable, related party", "label": "Loans Payable, Current", "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r1421" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "LocalPhoneNumber", "presentation": [ "http://vseehealth.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0", "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable", "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Total notes payable and line of credit", "totalLabel": "Total", "verboseLabel": "Outstanding balance", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r213", "r225", "r456", "r471", "r932", "r933", "r942", "r957", "r1226", "r1227", "r1313", "r1416", "r1423", "r1765" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Current portion", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r1188", "r1189" ] }, "vsee_LongTermDebtFairValueAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LongTermDebtFairValueAdjustments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Fair value adjustment for debt", "documentation": "The amount of increase (decrease) in long term debt from fair value adjustments.", "label": "Long Term Debt Fair Value Adjustments" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 6.0 }, "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable", "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Long-Term Debt, Maturity, after Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r1497", "r1504", "r1600", "r1763" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable", "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year Ending December 31, 2027", "verboseLabel": "Year Ending December 31, 2026", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r213", "r225", "r461", "r957" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2030", "label": "Long-Term Debt, Maturity, Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r213", "r225", "r461", "r957" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 4.0 }, "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable", "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2030", "verboseLabel": "Year ending December 31, 2029", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r213", "r225", "r461", "r957" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable", "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2029", "verboseLabel": "Year Ending December 31, 2028", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r213", "r225", "r461", "r957" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable", "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Year Ending December 31, 2028", "verboseLabel": "Year Ending December 31, 2027", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r5", "r213", "r225", "r461", "r957" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year Ending December 31, 2026 (Remaining 6 months)", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r1497", "r1504" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable, less current portion, net of discount", "verboseLabel": "Total notes payable, net of current portion", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r1416", "r1423" ] }, "us-gaap_LongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermInvestments", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term investments", "label": "Long-Term Investments", "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)." } } }, "auth_ref": [ "r143", "r149" ] }, "vsee_LongTermInvestmentsCash": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LongTermInvestmentsCash", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "documentation": "The amount of cash.", "label": "Long Term Investments Cash" } } }, "auth_ref": [] }, "vsee_LongTermInvestmentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LongTermInvestmentsPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Long Term Investments", "documentation": "Disclosure of accounting policy for long term investments.", "label": "Long Term Investments Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermPurchaseCommitmentAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total purchase commitment", "label": "Long-Term Purchase Commitment, Amount", "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Category of Item Purchased [Axis]", "documentation": "Information by category of items purchased under a long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Purchase Commitment, Category of Item Purchased [Domain]", "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment." } } }, "auth_ref": [] }, "vsee_LongTermPurchaseCommitmentNumberOfRobotsForWhichLifetimeUsePaymentToBeMade": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LongTermPurchaseCommitmentNumberOfRobotsForWhichLifetimeUsePaymentToBeMade", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of robots for which lifetime use payments is to be made (in robot)", "documentation": "The total number of robots for which lifetime use payment is required as per the agreement with the vendor.", "label": "Long Term Purchase Commitment Number Of Robots For Which Lifetime Use Payment To Be Made" } } }, "auth_ref": [] }, "vsee_LongTermPurchaseCommitmentNumberOfRobotsToBePurchased": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LongTermPurchaseCommitmentNumberOfRobotsToBePurchased", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of robots purchased (in robot)", "documentation": "The total number of robots to be purchased as per the agreement with the vendor.", "label": "Long Term Purchase Commitment Number Of Robots To Be Purchased" } } }, "auth_ref": [] }, "vsee_LongTermPurchaseCommitmentUnpaidAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LongTermPurchaseCommitmentUnpaidAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unpaid commitment amount", "documentation": "The unpaid amount of the total amount that the the entity agreed to spend under the long-term purchase commitment.", "label": "Long Term Purchase Commitment Unpaid Amount" } } }, "auth_ref": [] }, "vsee_LossContingencyAndReservePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LossContingencyAndReservePolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies and Litigation", "documentation": "Disclosure of accounting policy for estimating the loss if an asset has been impaired or liability had been incurred as of the balance sheet date.", "label": "Loss Contingency And Reserve Policy Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_LossContingencyDamagesSoughtValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LossContingencyDamagesSoughtValue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Company owes services", "label": "Loss Contingency, Damages Sought, Value", "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter." } } }, "auth_ref": [ "r1587", "r1588", "r1589" ] }, "vsee_LossOnConversionOfAccountsPayableToEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LossOnConversionOfAccountsPayableToEquity", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of accounts payable (in Dollars)", "documentation": "The amount of loss recognized on the conversion of accounts payable to equity.", "label": "Loss On Conversion Of Accounts Payable To Equity" } } }, "auth_ref": [] }, "vsee_LossOnIssuanceOfSEPA": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "LossOnIssuanceOfSEPA", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on issuance of SEPA", "documentation": "The amount of loss on issuance of SEPA.", "label": "Loss On Issuance Of SEPA" } } }, "auth_ref": [] }, "vsee_M2BMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "M2BMember", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "M2B [Member]", "label": "M2 BMember" } } }, "auth_ref": [] }, "stpr_MA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2026", "localname": "MA", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "MASSACHUSETTS", "label": "MASSACHUSETTS" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "MajorCustomersAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r308", "r1231", "r1235", "r1328", "r1334", "r1770", "r1771", "r1772", "r1774", "r1775", "r1776", "r1777", "r1778", "r1779", "r1780", "r1781", "r1782", "r1783", "r1784", "r1785", "r1786", "r1787", "r1788", "r1789", "r1790", "r1791", "r1792", "r1793", "r1794", "r1795", "r1796", "r1809", "r1810" ] }, "srt_ManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ManagementMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Key Managerial Personnel [Member]", "label": "Management [Member]", "documentation": "Person or persons designated as part of management." } } }, "auth_ref": [ "r1540", "r1743" ] }, "vsee_MandatorilyPrepayableUponChangeOfControlOutstandingBalance": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MandatorilyPrepayableUponChangeOfControlOutstandingBalance", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mandatorily prepayable upon change of control outstanding balance, percentage", "documentation": "Mandatorily prepayable upon change of control outstanding balance.", "label": "Mandatorily Prepayable Upon Change Of Control Outstanding Balance" } } }, "auth_ref": [] }, "vsee_March2025ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "March2025ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "terseLabel": "March 2025 convertible Note", "verboseLabel": "March 2025 Convertible Note [Member]", "netLabel": "May 2025 convertible Note [Member]", "label": "March2025 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_MasterBusinessLoanAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MasterBusinessLoanAgreementMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Master Business Loan Agreement [Member]", "label": "Master Business Loan Agreement Member" } } }, "auth_ref": [] }, "vsee_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity of related party promissory note", "documentation": "Amount of maximum borrowing capacity of related party promissory note.", "label": "Maximum Borrowing Capacity Of Related Party Promissory Note" } } }, "auth_ref": [] }, "vsee_MaximumCalendarYearDaysForSuspensionForUseOfResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MaximumCalendarYearDaysForSuspensionForUseOfResaleRegistrationStatement", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum calendar year days for suspension for use of resale registration statement", "documentation": "Represents the maximum calendar year days for suspension for use of resale registration statement.", "label": "Maximum Calendar Year Days For Suspension For Use Of Resale Registration Statement" } } }, "auth_ref": [] }, "vsee_MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum consecutive days for suspension for use of resale registration statement", "documentation": "Represents the maximum consecutive days for suspension for use of resale registration statement.", "label": "Maximum Consecutive Days For Suspension For Use Of Resale Registration Statement" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "MaximumMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum [Member]", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r68", "r70", "r72", "r73", "r75", "r93", "r95", "r96", "r110", "r111", "r136", "r138", "r265", "r426", "r427", "r428", "r429", "r555", "r583", "r584", "r585", "r600", "r778", "r856", "r857", "r858", "r859", "r861", "r862", "r863", "r864", "r889", "r1022", "r1023", "r1034", "r1073", "r1074", "r1134", "r1136", "r1138", "r1139", "r1145", "r1155", "r1156", "r1158", "r1159", "r1171", "r1172", "r1218", "r1247", "r1251", "r1258", "r1261", "r1304", "r1305", "r1309", "r1310", "r1330", "r1598", "r1607" ] }, "vsee_MaximumTermForCarriedForwardOfAdjustmentsFromDateOfFirstEventForWarrants": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MaximumTermForCarriedForwardOfAdjustmentsFromDateOfFirstEventForWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum term for carried forward of adjustments from the date of first event for warrants", "documentation": "Represents the maximum term for carried forward of adjustments from the date of first event for warrants.", "label": "Maximum Term For Carried Forward Of Adjustments From Date Of First Event For Warrants" } } }, "auth_ref": [] }, "vsee_MaximumValueOfSharesAgreedToBeIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MaximumValueOfSharesAgreedToBeIssued", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum amount of shares issuable", "documentation": "The maximum value of shares agreed to be issued.", "label": "Maximum Value Of Shares Agreed To Be Issued" } } }, "auth_ref": [] }, "vsee_May2025ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "May2025ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable12" ], "lang": { "en-us": { "role": { "terseLabel": "May 2025 Convertible Note [Member]", "label": "May2025 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_May2025ConvertiblePromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "May2025ConvertiblePromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "May 2025 Convertible Promissory Note [Member]", "label": "May2025 Convertible Promissory Note Member" } } }, "auth_ref": [] }, "vsee_May2025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "May2025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "May 2025 Promissory Note [Member]", "label": "May2025 Promissory Note Member" } } }, "auth_ref": [] }, "vsee_May2026QuantumConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "May2026QuantumConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "May 2026 Quantum Convertible Note [Member]", "label": "May2026 Quantum Convertible Note Member" } } }, "auth_ref": [] }, "vsee_MeasurementInputCccBondRateMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MeasurementInputCccBondRateMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input CCC Bond Rate [Member]", "documentation": "Represents information pertaining to ccc bond rates.", "label": "Measurement Input Ccc Bond Rate Member" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable8" ], "lang": { "en-us": { "role": { "terseLabel": "Debt discount rate [Member]", "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r1251", "r1258", "r1261", "r1318", "r1711", "r1712", "r1713" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable8", "http://vseehealth.com/role/ScheduleofKeyInputsTable9" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Expected Term [Member]", "verboseLabel": "Expected term (years) [Member]", "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r582", "r1711", "r1712", "r1713" ] }, "us-gaap_MeasurementInputInceptionDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MeasurementInputInceptionDiscountRateMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable10" ], "lang": { "en-us": { "role": { "terseLabel": "Market discount rate [Member]", "label": "Measurement Input, Inception Discount Rate [Member]", "documentation": "Measurement input using interest rate at inception of contract to determine present value of future cash flows." } } }, "auth_ref": [ "r1711", "r1712", "r1713" ] }, "us-gaap_MeasurementInputOptionVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MeasurementInputOptionVolatilityMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable5" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility [Member]", "label": "Measurement Input, Option Volatility [Member]", "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns." } } }, "auth_ref": [ "r1711", "r1712", "r1713" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable8", "http://vseehealth.com/role/ScheduleofKeyInputsTable9" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Price Volatility [Member]", "verboseLabel": "Volatility [Member]", "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r583", "r1304", "r1711", "r1712", "r1713" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable8", "http://vseehealth.com/role/ScheduleofKeyInputsTable9" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Risk Free Interest Rate [Member]", "verboseLabel": "Risk-free interest rate [Member]", "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r585", "r1711", "r1712", "r1713" ] }, "us-gaap_MeasurementInputSharePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MeasurementInputSharePriceMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable8", "http://vseehealth.com/role/ScheduleofKeyInputsTable9" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Share Price [Member]", "verboseLabel": "Stock price [Member]", "label": "Measurement Input, Share Price [Member]", "documentation": "Measurement input using share price of saleable stock." } } }, "auth_ref": [ "r1711", "r1712", "r1713" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofKeyInputsTable11", "http://vseehealth.com/role/ScheduleofKeyInputsTable12", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6", "http://vseehealth.com/role/ScheduleofKeyInputsTable7", "http://vseehealth.com/role/ScheduleofKeyInputsTable8", "http://vseehealth.com/role/ScheduleofKeyInputsTable9" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r581", "r582", "r583", "r584", "r585", "r586", "r776", "r777", "r778", "r1251", "r1258", "r1261", "r1304", "r1751" ] }, "vsee_MedicalEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MedicalEquipmentMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Equipment [Member]", "verboseLabel": "Medical equipment [Member", "documentation": "Tangible personal properties used in the field of medicine that are held by the entity.", "label": "Medical Equipment Member" } } }, "auth_ref": [] }, "vsee_MiltonChenMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MiltonChenMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Milton Chen [Member]", "documentation": "Represents information pertaining to Co-CEO Milton Chen.", "label": "Milton Chen Member" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "MinimumMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r68", "r70", "r72", "r73", "r75", "r93", "r95", "r96", "r110", "r111", "r136", "r138", "r265", "r426", "r427", "r428", "r429", "r555", "r583", "r584", "r585", "r600", "r778", "r856", "r857", "r858", "r859", "r861", "r862", "r863", "r864", "r889", "r1022", "r1023", "r1034", "r1073", "r1074", "r1134", "r1136", "r1138", "r1139", "r1145", "r1155", "r1156", "r1158", "r1159", "r1171", "r1172", "r1218", "r1247", "r1251", "r1258", "r1261", "r1304", "r1305", "r1309", "r1330", "r1598", "r1607" ] }, "vsee_MinimumNoticePeriodForRedemptionOfNotes": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MinimumNoticePeriodForRedemptionOfNotes", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum notice period for redemption of notes", "verboseLabel": "Minimum Notice Period For Redemption Of Notes", "documentation": "Represents the minimum notice period for redemption of notes.", "label": "Minimum Notice Period For Redemption Of Notes" } } }, "auth_ref": [] }, "vsee_MinimumNoticePeriodForRedemptionOfWarrants": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MinimumNoticePeriodForRedemptionOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum notice period for redemption of Warrants", "documentation": "Represents the Minimum notice period for redemption of Warrants.", "label": "Minimum Notice Period For Redemption Of Warrants" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment to Michelle Griffith", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r1614", "r1617" ] }, "vsee_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersPaymentToShareholder": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersPaymentToShareholder", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Payment to shareholder", "documentation": "The amount of payment to shareholder.", "label": "Minority Interest Decrease From Distributions To Noncontrolling Interest Holders Payment To Shareholder" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership percentage", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "vsee_MonthlyRequiredOperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MonthlyRequiredOperatingLeasePayments", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Monthly required lease payments", "documentation": "Amount of monthly required payments from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Monthly Required Operating Lease Payments" } } }, "auth_ref": [] }, "vsee_MunroTrustMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "MunroTrustMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Munro Trust [Member]", "documentation": "Represents information related to Munro Trust.", "label": "Munro Trust Member" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r308", "r1231", "r1235", "r1328", "r1334", "r1770", "r1771", "r1772", "r1774", "r1775", "r1776", "r1777", "r1778", "r1779", "r1780", "r1781", "r1782", "r1783", "r1784", "r1785", "r1786", "r1787", "r1788", "r1789", "r1790", "r1791", "r1792", "r1793", "r1794", "r1795", "r1796", "r1809", "r1810" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in) provided by financing activities", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r201" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in) provided by financing activities - continuing operations", "label": "Cash Provided by (Used in) Financing Activity, Continuing Operation", "documentation": "Amount of cash inflow (outflow) from financing activity attributable to continuing operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r1490" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r201" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities- continuing operations", "label": "Cash Provided by (Used in) Investing Activity, Continuing Operation", "documentation": "Amount of cash inflow (outflow) from investing activity attributable to continuing operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r1490" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r40", "r41", "r42" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities - continuing operations", "label": "Cash Provided by (Used in) Operating Activity, Continuing Operation", "documentation": "Amount of cash inflow (outflow) from operating activity attributable to continuing operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r40", "r41", "r42" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss (in Dollars)", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r31", "r42", "r52", "r113", "r129", "r135", "r183", "r184", "r188", "r212", "r215", "r216", "r221", "r229", "r233", "r234", "r236", "r237", "r238", "r242", "r243", "r249", "r344", "r400", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r475", "r479", "r482", "r487", "r517", "r540", "r589", "r641", "r709", "r771", "r804", "r999", "r1103", "r1124", "r1125", "r1196", "r1198", "r1200", "r1347", "r1594" ] }, "vsee_NetIncomelossFromDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NetIncomelossFromDiscontinuedOperations", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Income (loss) from discontinued operations, net of tax", "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Net Incomeloss From Discontinued Operations" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [ "r244" ] }, "vsee_NonCurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NonCurrentAssetsAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current assets:", "label": "Non Current Assets Abstract" } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash investing and financing activities:", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NoncontrollingInterestMember", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Non- Controlling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r17", "r516", "r518", "r1506", "r1507", "r1508", "r1511", "r1818" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense), net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r33", "r1405", "r1411", "r1550" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense)", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "vsee_NontaxableOrNondeductibleItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NontaxableOrNondeductibleItemsAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Nontaxable or nondeductible items", "label": "Nontaxable Or Nondeductible Items Abstract" } } }, "auth_ref": [] }, "vsee_NoteFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NoteFairValueAdjustment", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value", "documentation": "Amount of expense (income) related to adjustment to fair value of equity contract.", "label": "Note Fair Value Adjustment" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedAugust182023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NotePayableIssuedAugust182023Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued August 18, 2023 [Member]", "documentation": "Represents information related to Note Payable issued August 18, 2023", "label": "Note Payable Issued August182023 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedAugust32023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NotePayableIssuedAugust32023Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued August 3, 2023 [Member]", "documentation": "Represents information related to Note Payable issued August 3, 2023", "label": "Note Payable Issued August32023 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedDecember12021Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NotePayableIssuedDecember12021Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued December 1, 2021 [Member]", "documentation": "Represents information related to Note payable issued December 1, 2021", "label": "Note Payable Issued December12021 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedJanuary142024Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NotePayableIssuedJanuary142024Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued January 14, 2024 [Member]", "documentation": "Represents information related to Note payable issued January 14, 2024", "label": "Note Payable Issued January142024 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember132023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NotePayableIssuedNovember132023Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued November 13, 2023 [Member]", "documentation": "Represents information related to Note Payable issued November 13, 2023", "label": "Note Payable Issued November132023 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember292021Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NotePayableIssuedNovember292021Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued November 29, 2021 [Member]", "documentation": "Represents information related to Note payable issued November 29, 2021", "label": "Note Payable Issued November292021 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember292023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NotePayableIssuedNovember292023Member", "presentation": [ "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued November 29, 2023 [Member]", "documentation": "Represents information related to Note payable issued November 29, 2023", "label": "Note Payable Issued November292023 Member" } } }, "auth_ref": [] }, "us-gaap_NotesAndLoansReceivableGrossNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NotesAndLoansReceivableGrossNoncurrent", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note receivable with principal balance", "label": "Financing Receivable, before Allowance for Credit Loss, Noncurrent", "documentation": "Amortized cost, before allowance for credit loss, of financing receivable classified as noncurrent. Excludes net investment in lease." } } }, "auth_ref": [ "r1154", "r1541", "r1553" ] }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NotesAndLoansReceivableNetNoncurrent", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note receivable, related party", "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent", "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent." } } }, "auth_ref": [ "r1541", "r1553", "r1555" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable, current portion", "label": "Notes Payable, Current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r1421" ] }, "vsee_NotesPayableCurrentNetOfDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NotesPayableCurrentNetOfDiscount", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable, net of discount", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer, net of discount.", "label": "Notes Payable Current Net Of Discount" } } }, "auth_ref": [] }, "vsee_NotesReceivableAllowanceForCreditLossWriteoff": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NotesReceivableAllowanceForCreditLossWriteoff", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note receivable write-off", "documentation": "Amount of direct write-downs of notes receivable charged against the allowance.", "label": "Notes Receivable Allowance For Credit Loss Writeoff" } } }, "auth_ref": [] }, "us-gaap_NotesReduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NotesReduction", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as principal payment of notes", "label": "Notes Reduction", "documentation": "The value of notes retired (or transferred to another entity) in noncash investing or financing transactions." } } }, "auth_ref": [ "r1494" ] }, "vsee_NumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of deployed telepresence robots rights considered for calculating percentage of monthly revenue generation", "verboseLabel": "Telepresence robots deployed (in robot)", "documentation": "Number of deployed telepresence robots rights considered for calculating percentage of monthly revenue generation.", "label": "Number Of Deployed Telepresence Robots Rights Considered For Calculating Percentage Of Monthly Revenue Generation" } } }, "auth_ref": [] }, "vsee_NumberOfDeployedTelepresenceRobotsRightsHeld": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NumberOfDeployedTelepresenceRobotsRightsHeld", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of deployed telepresence robots rights held", "verboseLabel": "Number of deployed telepresence robots rights held (in robot)", "documentation": "Number of deployed telepresence robots for which rights are held by the related party.", "label": "Number Of Deployed Telepresence Robots Rights Held" } } }, "auth_ref": [] }, "vsee_NumberOfFractionalSharesThatWillBeIssuedUponExerciseOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NumberOfFractionalSharesThatWillBeIssuedUponExerciseOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of fractional shares that will be issued upon exercise of warrants", "documentation": "Number of fractional shares that will be issued upon exercise of warrants", "label": "Number Of Fractional Shares That Will Be Issued Upon Exercise Of Warrants" } } }, "auth_ref": [] }, "vsee_NumberOfInvestors": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NumberOfInvestors", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of investors (in investor)", "documentation": "Number Of Investors..", "label": "Number Of Investors" } } }, "auth_ref": [] }, "vsee_NumberOfLegacyOperatingEntities": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NumberOfLegacyOperatingEntities", "presentation": [ "http://vseehealth.com/role/ReportablesegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of legacy operating entities", "documentation": "Number of legacy operating entities.", "label": "Number Of Legacy Operating Entities" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NumberOfOperatingSegments", "presentation": [ "http://vseehealth.com/role/ReportablesegmentDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments (in segment)", "verboseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r1213", "r1525" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NumberOfReportableSegments", "presentation": [ "http://vseehealth.com/role/ReportablesegmentDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments (in segment)", "verboseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r1207", "r1217", "r1525" ] }, "us-gaap_NumberOfReportingUnits": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NumberOfReportingUnits", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reporting units", "label": "Goodwill, Reporting Unit, Number", "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment." } } }, "auth_ref": [ "r1558" ] }, "vsee_NumberOfSharesCommonStockOutstandingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NumberOfSharesCommonStockOutstandingPercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of the common stock outstanding percent", "documentation": "Number of shares of the common stock outstanding percent.", "label": "Number Of Shares Common Stock Outstanding Percentage" } } }, "auth_ref": [] }, "vsee_NumberOfTopCustomers": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NumberOfTopCustomers", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of top customers", "documentation": "Number of top customers of the company.", "label": "Number Of Top Customers" } } }, "auth_ref": [] }, "vsee_NumberOfTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NumberOfTradingDays", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days (in tradingday)", "documentation": "Number of trading days .", "label": "Number Of Trading Days" } } }, "auth_ref": [] }, "vsee_NumberOfVotesPerShare": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "NumberOfVotesPerShare", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of vote per share", "documentation": "Number of votes that each share entitles the holder.", "label": "Number Of Votes Per Share" } } }, "auth_ref": [] }, "vsee_October2025ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "October2025ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October 2025 Convertible Note [Member]", "label": "October2025 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_October2025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "October2025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October 2025 Promissory Note [Member]", "label": "October2025 Promissory Note Member" } } }, "auth_ref": [] }, "vsee_October2025QuantumConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "October2025QuantumConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October 2025 Quantum Convertible Note [Member]", "label": "October2025 Quantum Convertible Note Member" } } }, "auth_ref": [] }, "vsee_October212025ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "October212025ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October 21, 2025 Convertible Note [Member]", "label": "October212025 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_OctoberPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OctoberPromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October Promissory Note [Member]", "label": "October Promissory Note Member" } } }, "auth_ref": [] }, "vsee_OctoberPromissoryNoteTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OctoberPromissoryNoteTwoMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October Promissory Note - 2 [Member]", "verboseLabel": "October Promissory Note Two[Member]", "label": "October Promissory Note Two Member" } } }, "auth_ref": [] }, "vsee_OfficeAndMedicalEquipmentFurnitureMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OfficeAndMedicalEquipmentFurnitureMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office and Medical Equipment, Furniture [Member]", "documentation": "Tangible personal property used in an office or medical setting as well as furniture.", "label": "Office And Medical Equipment Furniture Member" } } }, "auth_ref": [] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OfficeEquipmentMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Office Equipment [Member]", "verboseLabel": "Office equipment [Member]", "label": "Office Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [ "r1579", "r1580" ] }, "vsee_OfficeSpaceInHoustonMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OfficeSpaceInHoustonMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office Space In Houston [Member]", "documentation": "Represents information relating to the office space leased in Houston.", "label": "Office Space In Houston Member" } } }, "auth_ref": [] }, "vsee_OfficeSpaceInTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OfficeSpaceInTexasMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office Space In Texas [Member]", "documentation": "Represents information relating to the office space leased in Texas.", "label": "Office Space In Texas Member" } } }, "auth_ref": [] }, "vsee_OnNovember112025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OnNovember112025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "On November 11, 2025 Promissory Note [Member]", "label": "On November112025 Promissory Note Member" } } }, "auth_ref": [] }, "vsee_OneCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OneCustomerMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One Customer [Member]", "label": "One Customer Member" } } }, "auth_ref": [] }, "vsee_OneOfLendersUnderArLoanConversionSpasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OneOfLendersUnderArLoanConversionSpasMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "One of the lenders under A&R Loan Conversion SPAs [Member]", "verboseLabel": "One of The Lenders Under AR Loan Conversion Spas [Member]", "documentation": "Represents information pertaining to one of the lenders under A&R Loan Conversion SPAs.", "label": "One Of Lenders Under Ar Loan Conversion Spas Member" } } }, "auth_ref": [] }, "vsee_OneVendorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OneVendorMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One Vendor [Member]", "verboseLabel": "Two Vendor [Member]", "documentation": "Represents information relating to one vendor.", "label": "One Vendor Member" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [ "r1200", "r1405", "r1411", "r1550" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingExpensesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Net operating loss", "terseLabel": "Segment operating loss", "verboseLabel": "Segment operating income (loss)", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r1196", "r1200", "r1206", "r1405", "r1411", "r1518", "r1526", "r1533", "r1537", "r1538", "r1550" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofExpensesIncurredforOperatingLeasesTable", "http://vseehealth.com/role/ScheduleofExpensesIncurredforOperatingLeasesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r827", "r1314" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofExpensesIncurredforOperatingLeasesTable", "http://vseehealth.com/role/ScheduleofExpensesIncurredforOperatingLeasesTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating lease expense", "label": "Operating Lease, Expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r1734" ] }, "vsee_OperatingLeaseFirstRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OperatingLeaseFirstRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, First Rental Period [Member]", "documentation": "Information pertaining to the first specified rental period under the operating lease.", "label": "Operating Lease First Rental Period Member" } } }, "auth_ref": [] }, "vsee_OperatingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OperatingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities included in accounts payable and accrued liabilities", "documentation": "Amount of operating lease liabilities that are included in accounts payable and accrued liabilities at balance sheet date.", "label": "Operating Lease Liabilities Included In Accounts Payable And Accrued Liabilities" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable", "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable0", "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable", "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Office lease", "terseLabel": "Present value of payments", "verboseLabel": "Related lease liability", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r819" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable0": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable", "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "negatedLabel": "Less: current portion", "negatedTerseLabel": "Less: Current portion", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r819", "r1187" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable0": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable", "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities, less current portion", "verboseLabel": "Long term portion", "netLabel": "Long-term portion", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r819" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office space lease payments", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r823", "r828" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable", "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Right-of-use assets, net", "terseLabel": "Right-of-use assets, net", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r818" ] }, "vsee_OperatingLeaseRightOfUseAssetAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable": { "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable", "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable0" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated amortization", "documentation": "Amount of accumulated amortization of right-of-use asset from operating lease.", "label": "Operating Lease Right Of Use Asset Accumulated Amortization" } } }, "auth_ref": [] }, "vsee_OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable": { "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable", "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Office lease", "documentation": "Amount, before accumulated amortization, of right-of-use asset from operating lease.", "label": "Operating Lease Right Of Use Asset Before Accumulated Amortization" } } }, "auth_ref": [] }, "vsee_OperatingLeaseRightOfUseAssetReductionFromContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OperatingLeaseRightOfUseAssetReductionFromContractTermination", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of use asset relieved due to termination of lease", "documentation": "Amount of reduction of operating lease right of use asset due to termination of lease.", "label": "Operating Lease Right Of Use Asset Reduction From Contract Termination" } } }, "auth_ref": [] }, "vsee_OperatingLeaseRightOfUseLiabilityReductionFromContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OperatingLeaseRightOfUseLiabilityReductionFromContractTermination", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of use liability relieved due to termination of lease", "documentation": "Amount of reduction of operating lease right of use liability due to termination of lease.", "label": "Operating Lease Right Of Use Liability Reduction From Contract Termination" } } }, "auth_ref": [] }, "vsee_OperatingLeaseSecondRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OperatingLeaseSecondRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Second Rental Period [Member]", "documentation": "Information pertaining to the second specified rental period under the operating lease.", "label": "Operating Lease Second Rental Period Member" } } }, "auth_ref": [] }, "vsee_OperatingLeaseThirdRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OperatingLeaseThirdRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Third Rental Period [Member]", "documentation": "Information pertaining to the third specified rental period under the operating lease.", "label": "Operating Lease Third Rental Period Member" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable", "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r830", "r1314" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable", "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term (years)", "verboseLabel": "Weighted average remaining lease term", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r829", "r1314" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforwards", "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r625" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingSegmentsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments [Member]", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r294", "r295", "r296", "r297", "r298", "r301", "r1212", "r1213" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusiness" ], "lang": { "en-us": { "role": { "terseLabel": "Organization and Description of Business", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r47", "r114", "r116", "r118", "r1039", "r1040" ] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Consolidation", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r47", "r1495", "r1505" ] }, "vsee_OriginalLoanTermsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OriginalLoanTermsAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original loan terms amount", "documentation": "Original loan terms amount.", "label": "Original Loan Terms Amount" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 }, "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued liabilities", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1421" ] }, "us-gaap_OtherAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherAssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash goodwill impairment charges", "label": "Other Asset Impairment Charges", "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value." } } }, "auth_ref": [ "r1492", "r1581" ] }, "vsee_OtherCurrentDhacShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OtherCurrentDhacShareholdersMember", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current DHAC Shareholders [Member]", "documentation": "Represents the information pertaining to other current DHAC shareholders.", "label": "Other Current Dhac Shareholders Member" } } }, "auth_ref": [] }, "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherIncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Income Tax Expense (Benefit), Continuing Operations", "label": "Other Income Tax Expense (Benefit), Continuing Operations", "documentation": "Amount of other current and other deferred income tax expense (benefit) attributable to continuing operations." } } }, "auth_ref": [ "r1654" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due to related party", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r146", "r155", "r158", "r1315" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Other income, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r35", "r1297" ] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other segment items, net", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due from related party", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [ "r1185" ] }, "vsee_OutstandingPrincipalBalanceAnnualRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OutstandingPrincipalBalanceAnnualRatePercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Principal balance annual rate percentage", "verboseLabel": "Outstanding principal balance increased to an annual rate", "documentation": "Percentage of outstanding principal balance shall increase to an annual rate.", "label": "Outstanding Principal Balance Annual Rate Percentage" } } }, "auth_ref": [] }, "vsee_OutstandingPrincipalBalancePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "OutstandingPrincipalBalancePercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding principal percent", "documentation": "Percentage of outstanding principal balance.", "label": "Outstanding Principal Balance Percentage" } } }, "auth_ref": [] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "OwnershipAxis", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [ "r516", "r518" ] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "OwnershipDomain", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [ "r516", "r518" ] }, "vsee_PatientFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PatientFeesMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Patient fees [Member]", "label": "Patient Fees Member" } } }, "auth_ref": [] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "vsee_PaymentOfCash": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PaymentOfCash", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment Of Cash (in Dollars)", "documentation": "The amount of payment of cash.", "label": "Payment Of Cash" } } }, "auth_ref": [] }, "vsee_PaymentsDueOnAcquisitionPurchase": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PaymentsDueOnAcquisitionPurchase", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments due on acquisition purchase", "documentation": "The amount of payments due on acquisition purchase.", "label": "Payments Due On Acquisition Purchase" } } }, "auth_ref": [] }, "us-gaap_PaymentsForFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsForFees", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due diligence fee", "label": "Payments for Other Fees", "documentation": "Amount of cash outflow for fees classified as other." } } }, "auth_ref": [ "r2" ] }, "us-gaap_PaymentsForLegalSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsForLegalSettlements", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payment", "label": "Payments for Legal Settlements", "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period." } } }, "auth_ref": [ "r2" ] }, "vsee_PaymentsForOptionalPrepaymentAsPercentageOfOutstandingObligationIncludingGuaranteedMinimumInterest": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PaymentsForOptionalPrepaymentAsPercentageOfOutstandingObligationIncludingGuaranteedMinimumInterest", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments for optional prepayment as percentage of outstanding obligation including guaranteed minimum interest", "documentation": "Represents the payments for optional prepayment as percentage of outstanding obligation including guaranteed minimum interest.", "label": "Payments For Optional Prepayment As Percentage Of Outstanding Obligation Including Guaranteed Minimum Interest" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on Encompass acquisition liability", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r38" ] }, "vsee_PaymentsForSettlementOfFrostBankObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PaymentsForSettlementOfFrostBankObligations", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments for settlement of bank obligations", "verboseLabel": "Payments for settlement of frost bank obligations", "documentation": "Payments for settlement of frost bank obligations.", "label": "Payments For Settlement Of Frost Bank Obligations" } } }, "auth_ref": [] }, "vsee_PaymentsOnExchangeNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PaymentsOnExchangeNotes", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on Exchange note", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Payments On Exchange Notes" } } }, "auth_ref": [] }, "vsee_PaymentsOnSeptember2024ConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PaymentsOnSeptember2024ConvertibleNote", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on September 2024 Convertible Note", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Payments On September2024 Convertible Note" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Encompass for a cash payment", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r10", "r691", "r1251", "r1256", "r1292" ] }, "us-gaap_PaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsToAcquireInvestments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment acquisition, purchase consideration", "label": "Payments to Acquire Investments", "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period." } } }, "auth_ref": [ "r36" ] }, "us-gaap_PaymentsToAcquireLongtermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsToAcquireLongtermInvestments", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of long-term investments", "label": "Payments to Acquire Long-Term Investments", "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term." } } }, "auth_ref": [ "r1488" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of fixed assets", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r37" ] }, "us-gaap_PaymentsToMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsToMinorityShareholders", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment to shareholder", "label": "Payments to Noncontrolling Interests", "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest." } } }, "auth_ref": [ "r12" ] }, "vsee_PaymentsToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PaymentsToRelatedParties", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments to related parties", "documentation": "Amount of cash outflow to related parties during the period.", "label": "Payments To Related Parties" } } }, "auth_ref": [] }, "vsee_PercentageOfAllowableDeductionOfTaxableIncome": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfAllowableDeductionOfTaxableIncome", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of allowable deduction of taxable income", "documentation": "The percentage of allowable deduction of taxable income.", "label": "Percentage Of Allowable Deduction Of Taxable Income" } } }, "auth_ref": [] }, "vsee_PercentageOfBeneficialOwnershipCap": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfBeneficialOwnershipCap", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of beneficial ownership cap", "documentation": "Percentage of beneficial ownership cap.", "label": "Percentage Of Beneficial Ownership Cap" } } }, "auth_ref": [] }, "vsee_PercentageOfEquityInterest": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfEquityInterest", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of equity interest", "documentation": "Percentage of equity interest.", "label": "Percentage Of Equity Interest" } } }, "auth_ref": [] }, "vsee_PercentageOfInitialAdvance": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfInitialAdvance", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of initial advance", "documentation": "Percentage of initial advance.", "label": "Percentage Of Initial Advance" } } }, "auth_ref": [] }, "vsee_PercentageOfInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfInterestRate", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of interest rate", "documentation": "Percentage of interest rate.", "label": "Percentage Of Interest Rate" } } }, "auth_ref": [] }, "vsee_PercentageOfLowestDailyVolumeWeightedAveragePrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfLowestDailyVolumeWeightedAveragePrice", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of lowest daily volume weighted average price", "documentation": "Percentage of lowest daily volume weighted average price.", "label": "Percentage Of Lowest Daily Volume Weighted Average Price" } } }, "auth_ref": [] }, "vsee_PercentageOfMinimumIncreaseOrDecreaseInAggregateNumberOfCommonSharesPurchasableUponExerciseOfAllWarrantsConsideredForAdjustmentToSharesReceivableUponExerciseOfEachWarrant": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfMinimumIncreaseOrDecreaseInAggregateNumberOfCommonSharesPurchasableUponExerciseOfAllWarrantsConsideredForAdjustmentToSharesReceivableUponExerciseOfEachWarrant", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of increase or decrease in aggregate number of common shares purchasable upon exercise of all warrants considered for adjustment to shares receivable upon exercise of each warrant", "documentation": "Represents the percentage of minimum increase or decrease in aggregate number of common shares purchasable upon exercise of all warrants considered for adjustment to shares receivable upon exercise of each warrant.", "label": "Percentage Of Minimum Increase Or Decrease In Aggregate Number Of Common Shares Purchasable Upon Exercise Of All Warrants Considered For Adjustment To Shares Receivable Upon Exercise Of Each Warrant" } } }, "auth_ref": [] }, "vsee_PercentageOfMonthlyRevenueGeneratedFromTelepresenceRobotsConsideredForPaymentsOnPromissoryNote": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfMonthlyRevenueGeneratedFromTelepresenceRobotsConsideredForPaymentsOnPromissoryNote", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of monthly revenue generated from telepresence robots, considered for payment", "documentation": "Percentage of monthly revenue generated on eight telepresence robots, based on which company is required to make payments to the related party on promissory note.", "label": "Percentage Of Monthly Revenue Generated From Telepresence Robots Considered For Payments On Promissory Note" } } }, "auth_ref": [] }, "vsee_PercentageOfOutstandingBalance": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfOutstandingBalance", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of outstanding balance", "documentation": "Percentage of outstanding balance.", "label": "Percentage Of Outstanding Balance" } } }, "auth_ref": [] }, "vsee_PercentageOfOwnershipInterest": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PercentageOfOwnershipInterest", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of ownership interest", "documentation": "Percentage of ownership interest.", "label": "Percentage Of Ownership Interest" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PerformanceSharesMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Shares [Member]", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [ "r1624", "r1625", "r1626", "r1627", "r1628", "r1629", "r1630", "r1631", "r1632", "r1633", "r1634", "r1635", "r1636", "r1637", "r1638", "r1639", "r1640", "r1641", "r1642", "r1643", "r1644", "r1646", "r1647", "r1648", "r1649", "r1650" ] }, "vsee_PeriodAgreedToFileResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PeriodAgreedToFileResaleRegistrationStatement", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period agreed to file a resale registration statement", "documentation": "Represents the period agreed to file a resale registration statement.", "label": "Period Agreed To File Resale Registration Statement" } } }, "auth_ref": [] }, "vsee_PeriodWithinWhichRegistrationStatementShallBeDeclaredEffective": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PeriodWithinWhichRegistrationStatementShallBeDeclaredEffective", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period within which registration statement shall be declared effective", "documentation": "Represents the period within which registration statement shall be declared effective.", "label": "Period Within Which Registration Statement Shall Be Declared Effective" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PlanNameAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1624", "r1625", "r1626", "r1627", "r1628", "r1629", "r1630", "r1631", "r1632", "r1633", "r1634", "r1635", "r1636", "r1637", "r1638", "r1639", "r1640", "r1641", "r1642", "r1643", "r1644", "r1646", "r1647", "r1648", "r1649", "r1650" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PlanNameDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1624", "r1625", "r1626", "r1627", "r1628", "r1629", "r1630", "r1631", "r1632", "r1633", "r1634", "r1635", "r1636", "r1637", "r1638", "r1639", "r1640", "r1641", "r1642", "r1643", "r1644", "r1646", "r1647", "r1648", "r1649", "r1650" ] }, "vsee_PlanProvidesInitialSharesEqual": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PlanProvidesInitialSharesEqual", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan provides initial shares equal (in Shares)", "documentation": "The amount Plan provides initial shares equal", "label": "Plan Provides Initial Shares Equal" } } }, "auth_ref": [] }, "vsee_PreFundedWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreFundedWarrantMember", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre Funded Warrants [Member]", "label": "Pre Funded Warrant Member" } } }, "auth_ref": [] }, "vsee_PreFundedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreFundedWarrantsMember", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-Funded Warrants [Member]", "label": "Pre Funded Warrants Member" } } }, "auth_ref": [] }, "us-gaap_PreferredClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PreferredClassAMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Class A [Member]", "label": "Preferred Class A [Member]", "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer." } } }, "auth_ref": [ "r1413", "r1428", "r1609", "r1610", "r1611", "r1612" ] }, "vsee_PreferredSharesIssuedAsConversionOfVSeeDebtAsContemplatedByTheBusinessCombinati": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredSharesIssuedAsConversionOfVSeeDebtAsContemplatedByTheBusinessCombinati", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued as conversion of VSee debt as contemplated by the business combination transaction", "documentation": "Preferred shares issued as conversion of VSee debt as contemplated by the business combination.", "label": "Preferred Shares Issued As Conversion Of VSee Debt As Contemplated By The Business Combinati" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleAlternateConversionMeasuringPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockConvertibleAlternateConversionMeasuringPeriod", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alternate conversion measuring period", "documentation": "Represents the alternate conversion measuring period for conversion of preferred stock.", "label": "Preferred Stock Convertible Alternate Conversion Measuring Period" } } }, "auth_ref": [] }, "us-gaap_PreferredStockConvertibleConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PreferredStockConvertibleConversionPrice", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, conversion rate (in Dollars per share)", "label": "Preferred Stock, Convertible, Conversion Price", "documentation": "Per share conversion price of preferred stock." } } }, "auth_ref": [ "r494" ] }, "vsee_PreferredStockConvertibleConversionPricePercentageUsedForCalculation": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockConvertibleConversionPricePercentageUsedForCalculation", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage used for calculation of conversion price", "documentation": "Represents the percentage used for calculation of conversion price of convertible preferred stock.", "label": "Preferred Stock Convertible Conversion Price Percentage Used For Calculation" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockConvertibleTerm", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, convertible term", "documentation": "Period between issuance and conversion of preferred stock, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Preferred Stock Convertible Term" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleThresholdConsecutiveTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockConvertibleThresholdConsecutiveTradingDays", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold period of specified consecutive trading days", "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of preferred stock must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Preferred Stock Convertible Threshold Consecutive Trading Days" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockConvertibleThresholdTradingDays", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold number of specified trading days", "documentation": "Threshold number of specified trading days that common stock price to conversion price of preferred stock must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Preferred Stock Convertible Threshold Trading Days" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued to settle debt as part of the consideration in the acquisition (in Shares)", "verboseLabel": "Preferred shares issued to settle debt as part of the consideration in the acquisition", "documentation": "Number of shares of preferred stock issued as a settlement of debt during the period pursuant to acquisitions.", "label": "Preferred Stock Issued During Period Shares Settlement Of Debt As Part Of Consideration In Acquisitions" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodSharesSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockIssuedDuringPeriodSharesSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisitions", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction (in Shares)", "documentation": "Number of shares of preferred stock issued as a settlement of underwriting fee during the period pursuant to acquisitions.", "label": "Preferred Stock Issued During Period Shares Settlement Of Underwriting Fee As Part Of Consideration In Acquisitions" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued to settle debt as part of the consideration in the acquisition", "documentation": "Value of preferred stock issued to settle debt pursuant to consideration in acquisitions during the period.", "label": "Preferred Stock Issued During Period Value Settlement Of Debt As Part Of Consideration In Acquisition" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodValueSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockIssuedDuringPeriodValueSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction", "documentation": "Value of preferred stock issued to settle underwriting fee pursuant to consideration in acquisitions during the period.", "label": "Preferred Stock Issued During Period Value Settlement Of Underwriting Fee As Part Of Consideration In Acquisition" } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PreferredStockMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock", "verboseLabel": "Preferred Shares", "netLabel": "Preferred Stock [Member]", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r141", "r174", "r511", "r512", "r521", "r932", "r933", "r945", "r1339", "r1340", "r1343", "r1344", "r1345", "r1346", "r1811", "r1818" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in Dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r492", "r1413", "r1428", "r1612", "r1753", "r1754", "r1760" ] }, "us-gaap_PreferredStockRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PreferredStockRedemptionPricePerShare", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption price per share (in Dollars per share)", "label": "Preferred Stock, Redemption Price Per Share", "documentation": "The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer." } } }, "auth_ref": [ "r509", "r1609" ] }, "vsee_PreferredStockRedemptionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PreferredStockRedemptionPricePercentage", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of redemption price", "documentation": "Percentage price of stated value of shares at which preferred stock can be redeemed.", "label": "Preferred Stock Redemption Price Percentage" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in Shares)", "verboseLabel": "Preferred stock, shares authorized", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r141", "r174", "r512", "r932", "r933", "r945", "r1083" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PreferredStockSharesIssued", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in Shares)", "verboseLabel": "Preferred stock, shares issued", "label": "Preferred Stock, Shares Issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r141", "r174", "r492", "r512", "r932", "r933", "r945" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in Shares)", "verboseLabel": "Preferred stock, shares outstanding", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r141", "r174", "r512", "r932", "r933", "r945", "r1083", "r1102", "r1608", "r1818", "r1819" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, value", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r141", "r174", "r478", "r484", "r512", "r932", "r933", "r945", "r988", "r1315" ] }, "vsee_PrefundedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PrefundedWarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-funded Warrants [Member]", "label": "Prefunded Warrants Member" } } }, "auth_ref": [] }, "vsee_PrepaidAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PrepaidAssetsPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid Assets and Other Current Assets", "documentation": "Disclosure of accounting policy for prepaid assets.", "label": "Prepaid Assets Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaids and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1430" ] }, "vsee_PrepaymentPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PrepaymentPercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayment percentage", "documentation": "Percentage of prepayment.", "label": "Prepayment Percentage" } } }, "auth_ref": [] }, "vsee_PriorSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PriorSettlement", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior settlement", "documentation": "The amount represents the prior settlement related to judgment.", "label": "Prior Settlement" } } }, "auth_ref": [] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PrivatePlacementMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Placement [Member]", "verboseLabel": "Private Placement Shares [Member]", "label": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "vsee_PrivatePlacementSaleConversionRightsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PrivatePlacementSaleConversionRightsAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private placement sale (in Dollars)", "documentation": "The amount of private placement from the sale.", "label": "Private Placement Sale Conversion Rights Amount" } } }, "auth_ref": [] }, "vsee_PrivatePlacementWarrantsExpiryTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PrivatePlacementWarrantsExpiryTerm", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private placement warrants expiry term", "documentation": "Private placement warrants expiry term.", "label": "Private Placement Warrants Expiry Term" } } }, "auth_ref": [] }, "vsee_PrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PrivatePlacementWarrantsMember", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Placement Warrants [Member]", "documentation": "Represents the information pertaining to private placement warrants.", "label": "Private Placement Warrants Member" } } }, "auth_ref": [] }, "vsee_PrivatePlacementWithArmisticeMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PrivatePlacementWithArmisticeMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Placement with Armistice [Member]", "label": "Private Placement With Armistice Member" } } }, "auth_ref": [] }, "vsee_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PrivateWarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Private Warrants [Member]", "verboseLabel": "Private [Member]", "documentation": "Represents the information pertaining to Private warrants.", "label": "Private Warrants Member" } } }, "auth_ref": [] }, "vsee_ProceedsFromCashAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProceedsFromCashAdvance", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate advance amount", "documentation": "The cash inflow from cash advance.", "label": "Proceeds From Cash Advance" } } }, "auth_ref": [] }, "vsee_ProceedsFromCommonStockWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProceedsFromCommonStockWarrants", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds from common stock warrants (in Dollars)", "documentation": "Net proceeds from common stock warrants.", "label": "Proceeds From Common Stock Warrants" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from convertible debt", "verboseLabel": "Proceeds from convertible note (in Dollars)", "label": "Proceeds from Convertible Debt", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r11" ] }, "vsee_ProceedsFromConvertibleNotesIssuedDuringThePeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProceedsFromConvertibleNotesIssuedDuringThePeriod", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from convertible notes issued during the period", "documentation": "The amount of proceeds from convertible notes issued during the period.", "label": "Proceeds From Convertible Notes Issued During The Period" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromDebtNetOfIssuanceCosts", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds", "label": "Proceeds from Debt, Net of Issuance Costs", "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination." } } }, "auth_ref": [ "r199" ] }, "vsee_ProceedsFromInitialCashAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProceedsFromInitialCashAdvance", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial advance amount", "documentation": "The cash inflow from initial cash advance.", "label": "Proceeds From Initial Cash Advance" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of common stock", "verboseLabel": "Net proceeds from issuance of common stock (in Dollars)", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProceedsFromIssuanceOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromIssuanceOfDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash proceeds received", "label": "Proceeds from Issuance of Debt", "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt." } } }, "auth_ref": [ "r1489" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds of before deducting the placement agent\u2019s fees and other estimated offering expenses", "label": "Proceeds from Issuance of Private Placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r1" ] }, "vsee_ProceedsFromNotesIssuedDuringThePeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProceedsFromNotesIssuedDuringThePeriod", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from notes issued during the period", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds From Notes Issued During The Period" } } }, "auth_ref": [] }, "vsee_ProceedsFromPreFundedWarrantsNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProceedsFromPreFundedWarrantsNetOfIssuanceCosts", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from pre-funded warrants, net of issuance costs", "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds From Pre Funded Warrants Net Of Issuance Costs" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from loan payable, related party", "label": "Proceeds from Related Party Debt", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r11" ] }, "vsee_ProceedsFromReverseRecapitalization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProceedsFromReverseRecapitalization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from reverse recapitalization with DHAC", "documentation": "The cash inflow from a reverse recapitalization.", "label": "Proceeds From Reverse Recapitalization" } } }, "auth_ref": [] }, "vsee_ProceedsFromSaleOfDebtSecuritiesNetOfIssuanceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProceedsFromSaleOfDebtSecuritiesNetOfIssuanceCost", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of debt securities, net of issuance cost (in Dollars)", "documentation": "Proceeds from sale of debt securities, net of issuance cost.", "label": "Proceeds From Sale Of Debt Securities Net Of Issuance Cost" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange of recognized proceeds (in Dollars)", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r1", "r8" ] }, "us-gaap_ProceedsFromSubordinatedShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromSubordinatedShortTermDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Received on issuance", "label": "Proceeds from Subordinated Short-Term Debt", "documentation": "The cash inflow from an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r11" ] }, "vsee_ProceedsFromSubscriptionsOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProceedsFromSubscriptionsOfCommonStock", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee subscription of shares in cash", "documentation": "The amount of cash inflow received for common stock subscriptions during the period.", "label": "Proceeds From Subscriptions Of Common Stock" } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ProductOrServiceAxis", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r77", "r78", "r79", "r80", "r81", "r82", "r108", "r304", "r894", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1174", "r1195", "r1198", "r1200", "r1231", "r1233", "r1327", "r1330", "r1331", "r1335", "r1338", "r1400", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1463", "r1464", "r1465", "r1466", "r1467", "r1468", "r1469", "r1470", "r1471", "r1472", "r1473", "r1474", "r1475", "r1476", "r1477", "r1478", "r1479", "r1480", "r1481", "r1482", "r1484", "r1485", "r1486", "r1487", "r1590", "r1591", "r1770", "r1771", "r1772", "r1773", "r1774", "r1775", "r1776", "r1777", "r1778", "r1779", "r1780", "r1781", "r1782", "r1783", "r1784", "r1785", "r1786", "r1787", "r1788", "r1789", "r1790", "r1791", "r1792", "r1793", "r1794", "r1795", "r1796", "r1798", "r1799", "r1800", "r1801", "r1802", "r1803", "r1804", "r1805", "r1806", "r1807", "r1808", "r1809", "r1810" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ProductsAndServicesDomain", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r77", "r78", "r79", "r80", "r81", "r82", "r108", "r304", "r894", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1174", "r1195", "r1198", "r1200", "r1231", "r1233", "r1327", "r1330", "r1331", "r1335", "r1338", "r1400", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1463", "r1464", "r1465", "r1466", "r1467", "r1468", "r1469", "r1470", "r1471", "r1472", "r1473", "r1474", "r1475", "r1476", "r1477", "r1478", "r1479", "r1480", "r1481", "r1482", "r1484", "r1485", "r1486", "r1487", "r1590", "r1591", "r1770", "r1771", "r1772", "r1773", "r1774", "r1775", "r1776", "r1777", "r1778", "r1779", "r1780", "r1781", "r1782", "r1783", "r1784", "r1785", "r1786", "r1787", "r1788", "r1789", "r1790", "r1791", "r1792", "r1793", "r1794", "r1795", "r1796", "r1798", "r1799", "r1800", "r1801", "r1802", "r1803", "r1804", "r1805", "r1806", "r1807", "r1808", "r1809", "r1810" ] }, "us-gaap_ProfessionalAndContractServicesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProfessionalAndContractServicesExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consulting expense recognized (in Dollars)", "label": "Professional and Contracted Services Expense", "documentation": "Amount of expense for professional and contracted services." } } }, "auth_ref": [ "r1442" ] }, "vsee_ProfessionalServicesAndOtherFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ProfessionalServicesAndOtherFeesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Professional Services And Other Fees", "verboseLabel": "Professional services and other fees [Member]", "netLabel": "Professional Services And Other Fees [Member]", "documentation": "Represents fees relating to professional and other services.", "label": "Professional Services And Other Fees Member" } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProfitLoss", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r113", "r129", "r135", "r183", "r184", "r203", "r212", "r215", "r216", "r221", "r229", "r238", "r242", "r243", "r344", "r400", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r475", "r517", "r540", "r589", "r641", "r709", "r711", "r714", "r715", "r771", "r804", "r953", "r955", "r998", "r1054", "r1103", "r1124", "r1125", "r1177", "r1295", "r1296", "r1348", "r1441", "r1594" ] }, "vsee_PromissoryNoteAndLineOfCreditRelatingToForbearanceAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PromissoryNoteAndLineOfCreditRelatingToForbearanceAgreementMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory Note and Line of Credit Relating to Forbearance Agreement [Member]", "documentation": "Represents information pertaining to promissory note and line of credit relating to forbearance agreement.", "label": "Promissory Note And Line Of Credit Relating To Forbearance Agreement Member" } } }, "auth_ref": [] }, "vsee_PromissoryNoteCommonSharesValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PromissoryNoteCommonSharesValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory note common shares value", "documentation": "Promissory note common shares value.", "label": "Promissory Note Common Shares Value" } } }, "auth_ref": [] }, "vsee_PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory Note [Member]", "documentation": "Promissory Note [Member]", "label": "Promissory Note Member" } } }, "auth_ref": [] }, "vsee_PromissoryNoteWithRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PromissoryNoteWithRelatedPartyMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory Note With Related Party [Member]", "documentation": "This member stands for promissory note with related party.", "label": "Promissory Note With Related Party Member" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant, and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Asset, Class [Axis]", "documentation": "Information by class of long-lived asset. Includes, but is not limited to, property, plant, and equipment; right-of-use asset from finance lease; long-lived asset of lessor subject to operating lease; proved oil and gas property accounted for under successful efforts method; and long-term prepaid asset." } } }, "auth_ref": [ "r406", "r407", "r832", "r1221", "r1222", "r1223", "r1224", "r1572", "r1573", "r1752" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/FixedAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed Assets", "label": "Property, Plant, and Equipment [Text Block]", "documentation": "The entire disclosure for property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r61", "r62", "r63", "r402", "r403", "r409", "r413", "r414", "r418" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed Assets, gross", "label": "Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization", "documentation": "Amount, before accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r144", "r150", "r406", "r995", "r1572" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "label": "Fixed Assets", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r406", "r407", "r832", "r1221", "r1222", "r1223", "r1224", "r1572", "r1573", "r1752" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed assets, net", "label": "Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization", "documentation": "Amount, after accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r832", "r932", "r933", "r951", "r976", "r977", "r995", "r1315", "r1579" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed Assets", "label": "Property, Plant, and Equipment [Policy Text Block]", "documentation": "Disclosure of accounting policy for property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r61", "r62", "r408", "r411", "r993", "r1572" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://vseehealth.com/role/FixedAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Fixed Assets", "label": "Property, Plant, and Equipment [Table Text Block]", "documentation": "Tabular disclosure of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r1577" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Asset, Class [Domain]", "documentation": "Class of long-lived asset. Includes, but is not limited to, property, plant, and equipment; right-of-use asset from finance lease; long-lived asset of lessor subject to operating lease; proved oil and gas property accounted for under successful efforts method; and long-term prepaid asset." } } }, "auth_ref": [ "r406", "r407", "r832", "r1221", "r1222", "r1223", "r1224", "r1572", "r1573", "r1752" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated useful lives of fixed assets", "verboseLabel": "Useful life", "label": "Property, Plant, and Equipment, Useful Life", "documentation": "Useful life of property, plant, and equipment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r1574" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable", "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable0", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Add: Credit loss expense", "verboseLabel": "Add: Provision for credit losses", "netLabel": "Provision for credit losses", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r191", "r195", "r352" ] }, "vsee_PublicAndPrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PublicAndPrivateWarrantsMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public And Private Warrants [Member]", "documentation": "Represents the information pertaining to public and private warrants.", "label": "Public And Private Warrants Member" } } }, "auth_ref": [] }, "vsee_PublicStockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PublicStockholdersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public Stockholders [Member]", "documentation": "Represents information pertaining to public stockholders.", "label": "Public Stockholders Member" } } }, "auth_ref": [] }, "vsee_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PublicWarrantsMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public Warrants [Member]", "verboseLabel": "Public [Member]", "documentation": "Represents the information pertaining to public warrants.", "label": "Public Warrants Member" } } }, "auth_ref": [] }, "vsee_PurchaseAgreementForTelepresenceRobotsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PurchaseAgreementForTelepresenceRobotsMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase Agreement for Telepresence Robots [Member]", "documentation": "Represents information relating to purchase of Telepresence Robots.", "label": "Purchase Agreement For Telepresence Robots Member" } } }, "auth_ref": [] }, "vsee_PurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase Agreement [Member]", "label": "Purchase Agreement Member" } } }, "auth_ref": [] }, "vsee_PurchaseAgreementPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PurchaseAgreementPeriod", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase agreement period", "verboseLabel": "Purchase Agreement Period", "documentation": "Purchase agreement period.", "label": "Purchase Agreement Period" } } }, "auth_ref": [] }, "vsee_PurchaseCommitmentAdjustmentsAndPaymentsMade": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PurchaseCommitmentAdjustmentsAndPaymentsMade", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase commitment amount, payments made", "documentation": "The amount of adjustments and payments made to the purchase commitment.", "label": "Purchase Commitment Adjustments And Payments Made" } } }, "auth_ref": [] }, "vsee_PurchasePricePerPrivatePlacementWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "PurchasePricePerPrivatePlacementWarrants", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price per private placement warrants", "documentation": "Purchase price per private placement warrants.", "label": "Purchase Price Per Private Placement Warrants" } } }, "auth_ref": [] }, "vsee_QuantumConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Convertible Note", "verboseLabel": "Quantum Convertible Note [Member]", "label": "Quantum Convertible Note Member" } } }, "auth_ref": [] }, "vsee_QuantumConvertibleNoteRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumConvertibleNoteRelatedPartyMember", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Convertible Note, Related Party [Member]", "verboseLabel": "Quantum Convertible Note, related party [Member]", "label": "Quantum Convertible Note Related Party Member" } } }, "auth_ref": [] }, "vsee_QuantumFinancingPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumFinancingPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Financing Purchase Agreement [Member]", "label": "Quantum Financing Purchase Agreement Member" } } }, "auth_ref": [] }, "vsee_QuantumInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumInvestorMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Investor [Member]", "documentation": "Represents information related to Quantum Investor.", "label": "Quantum Investor Member" } } }, "auth_ref": [] }, "vsee_QuantumNoteConversionMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumNoteConversionMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Note Conversion", "label": "Quantum Note Conversion Member" } } }, "auth_ref": [] }, "vsee_QuantumNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Note [Member]", "verboseLabel": "Quantum Convertible Note [Member]", "documentation": "Represents information related to Quantum Note.", "label": "Quantum Note Member" } } }, "auth_ref": [] }, "vsee_QuantumNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumNotesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Convertible Note", "verboseLabel": "Quantum Convertible Note [Member]", "documentation": "Represents information pertaining to quantum note.", "label": "Quantum Notes Member" } } }, "auth_ref": [] }, "vsee_QuantumPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumPromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Promissory Note [Member]", "label": "Quantum Promissory Note Member" } } }, "auth_ref": [] }, "vsee_QuantumPromissoryPrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumPromissoryPrincipalAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount (in Dollars)", "documentation": "The amount of quantum Promissory note consisting principal amount.", "label": "Quantum Promissory Principal Amount" } } }, "auth_ref": [] }, "vsee_QuantumPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "QuantumPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Purchase Agreement [Member]", "documentation": "Represents the information pertaining to quantum purchase agreement.", "label": "Quantum Purchase Agreement Member" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "RangeAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r68", "r70", "r72", "r73", "r75", "r93", "r95", "r96", "r110", "r111", "r136", "r138", "r265", "r426", "r427", "r428", "r429", "r543", "r555", "r583", "r584", "r585", "r588", "r600", "r778", "r856", "r857", "r858", "r859", "r861", "r862", "r863", "r864", "r871", "r889", "r1022", "r1023", "r1034", "r1073", "r1074", "r1134", "r1136", "r1138", "r1139", "r1145", "r1155", "r1156", "r1158", "r1159", "r1171", "r1172", "r1218", "r1247", "r1251", "r1258", "r1261", "r1304", "r1305", "r1309", "r1310", "r1330", "r1341", "r1586", "r1598", "r1607", "r1712" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "RangeMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r68", "r70", "r72", "r73", "r75", "r93", "r95", "r96", "r110", "r111", "r136", "r138", "r265", "r426", "r427", "r428", "r429", "r543", "r555", "r583", "r584", "r585", "r588", "r600", "r778", "r856", "r857", "r858", "r859", "r861", "r862", "r863", "r864", "r871", "r889", "r1022", "r1023", "r1034", "r1073", "r1074", "r1134", "r1136", "r1138", "r1139", "r1145", "r1155", "r1156", "r1158", "r1159", "r1171", "r1172", "r1218", "r1247", "r1251", "r1258", "r1261", "r1304", "r1305", "r1309", "r1310", "r1330", "r1341", "r1586", "r1598", "r1607", "r1712" ] }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "presentation": [ "http://vseehealth.com/role/ReportablesegmentTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Total Assets by Segment", "label": "Segment Reporting, Reconciliation of Asset by Segment to Consolidated [Table Text Block]", "documentation": "Tabular disclosure of reconciliation of asset by reportable segment to consolidated asset." } } }, "auth_ref": [ "r1534", "r1535" ] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://vseehealth.com/role/ReportablesegmentTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Consolidated Segment", "label": "Segment Reporting, Reconciliation of Profit (Loss) by Segment to Consolidated [Table Text Block]", "documentation": "Tabular disclosure of reconciliation of profit (loss) by reportable segment to consolidated profit (loss). Includes, but is not limited to, reconciliation of income (loss) before income tax expense (benefit) and after income tax if income tax is allocated to reportable segment." } } }, "auth_ref": [ "r1533", "r1535", "r1538" ] }, "vsee_RedemptionPriceEqualPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RedemptionPriceEqualPercentage", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption price equal percentage", "documentation": "Percentage of redemption price equal.", "label": "Redemption Price Equal Percentage" } } }, "auth_ref": [] }, "vsee_RelatedPartyAgreementExtensionTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RelatedPartyAgreementExtensionTerm", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Extension term", "documentation": "Term of the extension of the agreement with related party.", "label": "Related Party Agreement Extension Term" } } }, "auth_ref": [] }, "vsee_RelatedPartyAgreementTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RelatedPartyAgreementTerm", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreement term", "documentation": "Term of the agreement with related party.", "label": "Related Party Agreement Term" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Domain]", "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r146", "r147", "r155", "r165", "r167", "r212", "r220", "r221", "r309", "r550", "r554", "r839", "r840", "r932", "r933", "r939", "r940", "r942", "r949", "r985", "r992", "r1076", "r1077", "r1078", "r1079", "r1080", "r1101", "r1133", "r1185", "r1814", "r1820" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "verboseLabel": "Related Party [Member]", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r146", "r147", "r155", "r165", "r167", "r212", "r220", "r221", "r839", "r840", "r841", "r842", "r932", "r933", "r942", "r985", "r992", "r1076", "r1077", "r1078", "r1079", "r1080", "r1101", "r1133" ] }, "vsee_RelatedPartyPromissoryNoteOneMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RelatedPartyPromissoryNoteOneMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Promissory Note One [Member]", "documentation": "Represents information pertaining to Related party promissory note one.", "label": "Related Party Promissory Note One Member" } } }, "auth_ref": [] }, "vsee_RelatedPartyPromissoryNoteThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RelatedPartyPromissoryNoteThreeMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Promissory Note Three [Member]", "documentation": "Represents information pertaining to Related party promissory note three.", "label": "Related Party Promissory Note Three Member" } } }, "auth_ref": [] }, "vsee_RelatedPartyPromissoryNoteTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RelatedPartyPromissoryNoteTwoMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Promissory Note Two [Member]", "documentation": "Represents information pertaining to Related party promissory note two.", "label": "Related Party Promissory Note Two Member" } } }, "auth_ref": [] }, "vsee_RelatedPartyTransactionAmountsOfTransactionPerMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RelatedPartyTransactionAmountsOfTransactionPerMonth", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expense per month", "documentation": "Amount of transactions with related party per month during the financial reporting period.", "label": "Related Party Transaction Amounts Of Transaction Per Month" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r212", "r220", "r221", "r839", "r840", "r1744" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [ "r212", "r220", "r221", "r1744" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r212", "r220", "r221", "r309", "r839", "r840", "r842", "r932", "r933", "r939", "r940", "r942", "r949", "r1107", "r1108", "r1111", "r1820" ] }, "us-gaap_RelatedPartyTransactionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionRate", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Related Party Transaction, Rate", "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties." } } }, "auth_ref": [ "r1740" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r146", "r147", "r155", "r165", "r167", "r212", "r220", "r221", "r309", "r550", "r554", "r839", "r840", "r932", "r933", "r939", "r940", "r942", "r949", "r985", "r992", "r1076", "r1077", "r1078", "r1079", "r1080", "r1101", "r1133", "r1185", "r1744", "r1814", "r1820" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/RelatedParty" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r836", "r837", "r838", "r840", "r843", "r932", "r933", "r950", "r1050", "r1051", "r1052", "r1109", "r1110", "r1111", "r1130", "r1132" ] }, "vsee_RepaymentOnAdditionalBridgeFinancing": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RepaymentOnAdditionalBridgeFinancing", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment on Additional Bridge Financing", "documentation": "Repayment on additional bridge financing.", "label": "Repayment On Additional Bridge Financing" } } }, "auth_ref": [] }, "vsee_RepaymentOnExtensionNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RepaymentOnExtensionNote", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment on Extension Note", "documentation": "The represent value of repayment on extension note.", "label": "Repayment On Extension Note" } } }, "auth_ref": [] }, "vsee_RepaymentOnFactoringPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RepaymentOnFactoringPayable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Proceeds from factoring payable", "documentation": "The amount of cash outflow to settle factoring payable during the year.", "label": "Repayment On Factoring Payable" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on line of credit", "label": "Repayments of Lines of Credit", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r39", "r1496", "r1499" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of notes payable", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r39" ] }, "vsee_RepaymentsOfNotesPayablePrincipalPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RepaymentsOfNotesPayablePrincipalPortion", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of notes payable, principal portion", "documentation": "The cash outflow for the principal portion of a borrowing supported by a written promise to pay an obligation.", "label": "Repayments Of Notes Payable Principal Portion" } } }, "auth_ref": [] }, "vsee_RepaymentsOfNotesPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RepaymentsOfNotesPayables", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of notes payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments Of Notes Payables" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment on advances of related party", "terseLabel": "Advances repaid", "label": "Repayments of Related Party Debt", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r39" ] }, "us-gaap_RepaymentsOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RepaymentsOfSecuredDebt", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate purchase price", "label": "Repayments of Secured Debt", "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt." } } }, "auth_ref": [ "r39" ] }, "vsee_ReportablesegmentScheduleofReconciliationofConsolidatedSegmentDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ReportablesegmentScheduleofReconciliationofConsolidatedSegmentDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "label": "Reportable segment - Schedule of Reconciliation of Consolidated Segment (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_ReportablesegmentScheduleofReconciliationofConsolidatedSegmentDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ReportablesegmentScheduleofReconciliationofConsolidatedSegmentDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "label": "Reportable segment - Schedule of Reconciliation of Consolidated Segment (Details) [Table]" } } }, "auth_ref": [] }, "vsee_ReportablesegmentsScheduleofReconciliationofConsolidatedSegmentDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ReportablesegmentsScheduleofReconciliationofConsolidatedSegmentDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "label": "Reportable segments - Schedule of Reconciliation of Consolidated Segment (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_ReportablesegmentsScheduleofReconciliationofConsolidatedSegmentDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ReportablesegmentsScheduleofReconciliationofConsolidatedSegmentDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "label": "Reportable segments - Schedule of Reconciliation of Consolidated Segment (Details) [Table]" } } }, "auth_ref": [] }, "vsee_ReportablesegmentsScheduleofTotalAssetsbySegmentDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ReportablesegmentsScheduleofTotalAssetsbySegmentDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Reportable segments - Schedule of Total Assets by Segment (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_ReportablesegmentsScheduleofTotalAssetsbySegmentDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ReportablesegmentsScheduleofTotalAssetsbySegmentDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Reportable segments - Schedule of Total Assets by Segment (Details) [Table]" } } }, "auth_ref": [] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r106", "r107", "r212", "r222", "r223", "r447", "r496", "r842", "r849", "r872", "r982", "r1191", "r1192", "r1193", "r1432", "r1433", "r1434", "r1435", "r1436", "r1437", "r1438", "r1439", "r1440", "r1701", "r1702", "r1703", "r1704", "r1749", "r1750" ] }, "vsee_RepurchaseOfCommonStockInConnectionWithSaleOfVSeeLab": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RepurchaseOfCommonStockInConnectionWithSaleOfVSeeLab", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Repurchase of common stock in connection with sale of VSee Labs (in Shares)", "documentation": "Repurchase of common stock in connection with sale of VSee Labs .", "label": "Repurchase Of Common Stock In Connection With Sale Of VSee Lab" } } }, "auth_ref": [] }, "vsee_RepurchaseOfCommonStockInConnectionWithSaleOfVSeeLabs": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RepurchaseOfCommonStockInConnectionWithSaleOfVSeeLabs", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Repurchase of common stock in connection with sale of VSee Labs", "documentation": "Repurchase of common stock in connection with sale of VSee Labs.", "label": "Repurchase Of Common Stock In Connection With Sale Of VSee Labs" } } }, "auth_ref": [] }, "srt_RestatementAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "RestatementAdjustmentMember", "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period, Adjustment [Member]", "label": "Revision of Prior Period, Adjustment [Member]", "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r226", "r227", "r228", "r240", "r241", "r255", "r516", "r518", "r769", "r770", "r1375", "r1376", "r1377", "r1378", "r1510", "r1514", "r1515", "r1539" ] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "RestatementAxis", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r109", "r112", "r113", "r115", "r125", "r196", "r226", "r227", "r228", "r229", "r230", "r233", "r234", "r235", "r236", "r239", "r240", "r241", "r242", "r243", "r244", "r255", "r346", "r347", "r400", "r474", "r475", "r516", "r518", "r539", "r540", "r589", "r639", "r640", "r641", "r642", "r708", "r709", "r765", "r768", "r769", "r770", "r771", "r834", "r835", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1041", "r1539" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "RestatementDomain", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r109", "r112", "r113", "r115", "r125", "r196", "r226", "r227", "r228", "r229", "r230", "r233", "r234", "r235", "r236", "r239", "r240", "r241", "r242", "r243", "r244", "r255", "r346", "r347", "r400", "r474", "r475", "r516", "r518", "r539", "r540", "r589", "r639", "r640", "r641", "r642", "r708", "r709", "r765", "r768", "r769", "r770", "r771", "r834", "r835", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1041", "r1539" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r177", "r178", "r514", "r932", "r933", "r947", "r990", "r1028", "r1033", "r1048", "r1084", "r1315" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RetainedEarningsMember", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r112", "r113", "r226", "r227", "r228", "r230", "r238", "r241", "r243", "r345", "r348", "r399", "r400", "r401", "r474", "r511", "r521", "r538", "r539", "r541", "r542", "r589", "r627", "r628", "r638", "r639", "r640", "r642", "r708", "r709", "r751", "r752", "r753", "r755", "r757", "r758", "r760", "r769", "r816", "r888", "r978", "r1024", "r1026", "r1055", "r1614", "r1617", "r1818" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenues", "terseLabel": "Total revenues", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r256", "r271", "r272", "r294", "r300", "r304", "r306", "r308", "r534", "r535", "r536", "r894", "r1196", "r1200" ] }, "vsee_RevenueRecognitionNoticePeriodForCancelationOfContract": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RevenueRecognitionNoticePeriodForCancelationOfContract", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notice period for cancelation of contract", "documentation": "Period within which notice is required for cancellation of contract with customers for generation of revenue.", "label": "Revenue Recognition Notice Period For Cancelation Of Contract" } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r1105" ] }, "vsee_RevenueRecognitionTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RevenueRecognitionTermOfContract", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of contract", "documentation": "Term of the contract for revenues generated by the company.", "label": "Revenue Recognition Term Of Contract" } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable", "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r189", "r212", "r215", "r216", "r256", "r271", "r272", "r294", "r300", "r304", "r306", "r308", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r517", "r804", "r953", "r955", "r1212", "r1297", "r1336", "r1337", "r1405", "r1411", "r1550", "r1594" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenuesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "vsee_RevenuesAbstract1": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RevenuesAbstract1", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues:", "label": "Revenues Abstract1" } } }, "auth_ref": [] }, "vsee_RevenuesAbstract2": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "RevenuesAbstract2", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues:", "label": "Revenues Abstract2" } } }, "auth_ref": [] }, "srt_RevisionOfPriorPeriodReclassificationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "RevisionOfPriorPeriodReclassificationAdjustmentMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification Adjustment", "verboseLabel": "Revision of Prior Period, Reclassification, Adjustment [Member]", "label": "Revision of Prior Period, Reclassification, Adjustment [Member]", "documentation": "Cumulative increase (decrease) to previously issued financial statements for reclassification. Excludes adjustment for reclassification from amendment to accounting standards." } } }, "auth_ref": [ "r115", "r125", "r196", "r765", "r1539" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "vsee_SEPALiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SEPALiability", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEPA liability", "documentation": "SEPA liability.", "label": "SEPALiability" } } }, "auth_ref": [] }, "vsee_SEPALiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SEPALiabilityMember", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable4" ], "lang": { "en-us": { "role": { "terseLabel": "SEPA liability [Member]", "label": "SEPALiability Member" } } }, "auth_ref": [] }, "vsee_SaleOfStockCommitmentPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SaleOfStockCommitmentPeriod", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of stock, commitment period", "documentation": "Sale of stock, commitment period.", "label": "Sale Of Stock Commitment Period" } } }, "auth_ref": [] }, "vsee_SaleOfStockMaximumCommitmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SaleOfStockMaximumCommitmentAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of stock, maximum commitment amount", "documentation": "Maximum amount of shares committed to be issued under the stock transaction.", "label": "Sale Of Stock Maximum Commitment Amount" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of shares of common", "verboseLabel": "Aggregate shares of common stock", "label": "Sale of Stock, Number of Shares Issued in Transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Par value per share (in Dollars per share)", "verboseLabel": "Pre-funded warrants exercisable for per share", "label": "Sale of Stock, Price Per Share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SalesAndExciseTaxPayableCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Excise tax payable", "label": "Sales and Excise Tax Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r1415", "r1418" ] }, "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued sales and use tax", "label": "Sales and Excise Tax Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax." } } }, "auth_ref": [ "r1424" ] }, "srt_ScenarioPreviouslyReportedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ScenarioPreviouslyReportedMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Previously Reported", "verboseLabel": "Previously Reported [Member]", "label": "Previously Reported [Member]", "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r112", "r113", "r226", "r228", "r229", "r230", "r233", "r234", "r243", "r255", "r400", "r474", "r475", "r516", "r518", "r539", "r540", "r589", "r639", "r641", "r642", "r708", "r709", "r768", "r769", "r770", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1041", "r1509", "r1510", "r1512", "r1513", "r1514", "r1539", "r1551", "r1552", "r1707", "r1738", "r1739" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r109", "r117", "r119", "r244", "r556", "r1367" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/AccountsPayableandAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "vsee_ScheduleOfAllocationOfTotalPurchaseConsiderationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfAllocationOfTotalPurchaseConsiderationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Allocation Of Total Purchase Consideration Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfAllowanceForCreditLossesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfAllowanceForCreditLossesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Allowance For Credit Losses Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfBalanceSheetDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfBalanceSheetDiscontinuedOperationsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Balance Sheet Discontinued Operations Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfBasicAndDilutedEarningsPerShareAttributableToContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfBasicAndDilutedEarningsPerShareAttributableToContinuingOperationsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Basic And Diluted Earnings Per Share Attributable To Continuing Operations Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Purchase Consideration", "label": "Business Combination, Consideration Transferred, Equity Interest [Table Text Block]", "documentation": "Tabular disclosure of equity interest issued or issuable by acquirer as part of consideration transferred in business combination." } } }, "auth_ref": [ "r1680", "r1681" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability." } } }, "auth_ref": [ "r381", "r646", "r647", "r648", "r649", "r655", "r656", "r657", "r658", "r664", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r682", "r683", "r684", "r685", "r686", "r689", "r690", "r691", "r692", "r693", "r694", "r700", "r701", "r702", "r706", "r1251", "r1261", "r1670", "r1675", "r1677" ] }, "vsee_ScheduleOfChangesInTheFairValueOfFinancialLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfChangesInTheFairValueOfFinancialLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Changes In The Fair Value Of Financial Liabilities Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfCommonStockBusinessCombinationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfCommonStockBusinessCombinationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Common Stock Business Combination Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://vseehealth.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Income/ (Loss) Income Taxes", "verboseLabel": "Schedule of Income Tax Provision", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r1661" ] }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "presentation": [ "http://vseehealth.com/role/DiscontinuedOperationsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Balance sheet - Discontinued operations", "label": "Condensed Balance Sheet [Table Text Block]", "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r1393", "r1497", "r1504", "r1763" ] }, "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock", "presentation": [ "http://vseehealth.com/role/DiscontinuedOperationsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Statement of Operations - Discontinued Operations", "label": "Condensed Income Statement [Table Text Block]", "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r1393", "r1497", "r1504", "r1763" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Line of Credit and Notes Payable, Net of Discount", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "vsee_ScheduleOfDeferredRevenueActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfDeferredRevenueActivitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Deferred Revenue Activities Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Tax Assets and Liabilities", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r1658" ] }, "vsee_ScheduleOfDisaggregatedRevenueByTimingOfRevenueRecognitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfDisaggregatedRevenueByTimingOfRevenueRecognitionAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Disaggregated Revenue By Timing Of Revenue Recognition Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Basic and Diluted Earnings Per Share Attributable to Continuing Operations", "verboseLabel": "Schedule of Net Loss Per Common Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1517" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://vseehealth.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Federal Income Tax Rate to Company's Effective Tax Rate", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r609", "r1249", "r1655" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r341", "r342", "r343", "r637", "r804", "r1368", "r1369", "r1370", "r1664", "r1665", "r1666", "r1667" ] }, "vsee_ScheduleOfExpensesIncurredForOperatingLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfExpensesIncurredForOperatingLeasesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Expenses Incurred For Operating Leases Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfExpensesIncurredWithRespectToFinanceLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfExpensesIncurredWithRespectToFinanceLeasesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Expenses Incurred With Respect To Finance Leases Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfFinanceLeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfFinanceLeaseLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Finance Lease Liabilities Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0" ], "lang": { "en-us": { "role": { "label": "Intangible Asset, Finite-Lived [Table]", "documentation": "Disclosure of information about finite-lived intangible asset. Excludes goodwill." } } }, "auth_ref": [ "r383", "r390", "r394", "r395", "r397", "r895", "r1173", "r1176", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269", "r1270", "r1271", "r1272", "r1273", "r1274", "r1275", "r1276", "r1277", "r1278", "r1279", "r1280", "r1281", "r1282", "r1283", "r1284", "r1285", "r1286", "r1287", "r1288", "r1289", "r1290", "r1572", "r1821", "r1822", "r1823" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Identifiable Intangible Assets Subject to Amortization", "label": "Intangible Asset, Finite-Lived [Table Text Block]", "documentation": "Tabular disclosure of finite-lived intangible asset. Excludes goodwill." } } }, "auth_ref": [ "r1176", "r1565" ] }, "vsee_ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssets": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssets", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets", "documentation": "Tabular disclosure of fixed assets are depreciated using the straight-line method over the estimated useful lives of the assets.", "label": "Schedule Of Fixed Assets Are Depreciated Using The Straight Line Method Over The Estimated Useful Lives Of The Assets" } } }, "auth_ref": [] }, "vsee_ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Fixed Assets Are Depreciated Using The Straight Line Method Over The Estimated Useful Lives Of The Assets Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfFutureMinimumPaymentsUnderFinanceLeaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfFutureMinimumPaymentsUnderFinanceLeaseAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Future Minimum Payments Under Finance Lease Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfFutureMinimumRentPaymentsUnderTheOperatingLeaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfFutureMinimumRentPaymentsUnderTheOperatingLeaseAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Future Minimum Rent Payments Under The Operating Lease Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfIdentifiableIntangibleAssetsSubjectToAmortizationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfIdentifiableIntangibleAssetsSubjectToAmortizationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Identifiable Intangible Assets Subject To Amortization Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfIncomeLossIncomeTaxesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfIncomeLossIncomeTaxesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Income Loss Income Taxes Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfIncomeTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfIncomeTaxExpenseBenefitAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Income Tax Expense Benefit Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://vseehealth.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Income Tax Expense (Benefit)", "label": "Schedule Of Income Tax Expense Benefit Table Text Block" } } }, "auth_ref": [] }, "vsee_ScheduleOfKeyAssumptionsUsedInValuingUnvestedOptionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfKeyAssumptionsUsedInValuingUnvestedOptionsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Key Assumptions Used In Valuing Unvested Options Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfKeyInputsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfKeyInputsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Key Inputs Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Required Principal Payments", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r5" ] }, "vsee_ScheduleOfNetLossPerCommonShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfNetLossPerCommonShareAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Net Loss Per Common Share Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Common Stock Business Combination", "documentation": "Tabular disclosure of common stock outstanding following the consummation of business combination.", "label": "Schedule Of Number Of Common Stock Outstanding After Business Combination Table Text Block" } } }, "auth_ref": [] }, "vsee_ScheduleOfProFormaFinancialInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfProFormaFinancialInformationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Pro Forma Financial Information Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r406", "r407", "r832", "r1221", "r1222", "r1223", "r1224", "r1572", "r1573", "r1752" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Allocation of Total Purchase Consideration", "label": "Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block]", "documentation": "Tabular disclosure of asset acquired and liability assumed in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1676", "r1678" ] }, "vsee_ScheduleOfReconciliationOfConsolidatedSegmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfReconciliationOfConsolidatedSegmentAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reconciliation Of Consolidated Segment Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfReconciliationOfFederalIncomeTaxRateToCompanysEffectiveTaxRateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfReconciliationOfFederalIncomeTaxRateToCompanysEffectiveTaxRateAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reconciliation Of Federal Income Tax Rate To Companys Effective Tax Rate Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r212", "r220", "r221", "r839", "r840", "r842", "r932", "r933", "r939", "r940", "r942", "r949", "r1107", "r1108", "r1111", "r1820" ] }, "vsee_ScheduleOfReportableSegmentDepreciationAndAmortizationAndCapitalExpendituresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfReportableSegmentDepreciationAndAmortizationAndCapitalExpendituresAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reportable Segment Depreciation And Amortization And Capital Expenditures Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "label": "Segment Reporting [Table]", "documentation": "Disclosure of information about segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total." } } }, "auth_ref": [ "r267", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r282", "r284", "r285", "r286", "r294", "r295", "r296", "r297", "r298", "r300", "r301", "r302" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://vseehealth.com/role/ReportablesegmentTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reportable Segment Depreciation and Amortization and Capital Expenditures", "label": "Segment Reporting [Table Text Block]", "documentation": "Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total." } } }, "auth_ref": [ "r1524", "r1526", "r1527", "r1528", "r1529", "r1530", "r1531", "r1535", "r1536", "r1539" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://vseehealth.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock Options", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r6", "r7", "r45" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://vseehealth.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Key Assumptions Used in Valuing Unvested Options", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r46" ] }, "vsee_ScheduleOfStatementOfOperationsDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfStatementOfOperationsDiscontinuedOperationsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Statement Of Operations Discontinued Operations Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfStockOptionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfStockOptionsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Stock Options Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://vseehealth.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Warrants Issued and Outstanding", "verboseLabel": "Schedule of Warrants Issued and outstanding", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r1609" ] }, "vsee_ScheduleOfTheRecapitalizationAndNetEquityImpactOnBusinessCombinationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfTheRecapitalizationAndNetEquityImpactOnBusinessCombinationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of The Recapitalization And Net Equity Impact On Business Combination Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfTotalAssetsBySegmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfTotalAssetsBySegmentAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Total Assets By Segment Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfWarrantsIssuedAndOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfWarrantsIssuedAndOutstandingAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Issued And Outstanding Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateOnFinanceLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateOnFinanceLeasesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Weighted Average Remaining Lease Term And Discount Rate On Finance Leases Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Expected Amortization Expense", "label": "Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of estimated amortization expense for finite-lived intangible asset and capitalized cost for software to be sold, leased, or marketed, expected to be recognized for each of five succeeding fiscal years. Excludes goodwill." } } }, "auth_ref": [ "r1176", "r1568" ] }, "vsee_ScsCapitalPartnersLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ScsCapitalPartnersLlcMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SCS Capital Partners LLC [Member]", "documentation": "Represents the information pertaining to SCS Capital Partners LLC .", "label": "Scs Capital Partners Llc Member" } } }, "auth_ref": [] }, "vsee_SecuredPromissoryNoteIssuedOnMarch202025Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SecuredPromissoryNoteIssuedOnMarch202025Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "March 2025 Promissory Note [Member]", "documentation": "Represents information related to secured promissory note issued March 20, 2025.", "label": "Secured Promissory Note Issued On March202025 Member" } } }, "auth_ref": [] }, "vsee_SecuritiesSoldCombinedPurchasePrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SecuritiesSoldCombinedPurchasePrice", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Securities sold combined purchase price (in Dollars per share)", "documentation": "Securities sold combined purchase price.", "label": "Securities Sold Combined Purchase Price" } } }, "auth_ref": [] }, "us-gaap_SegmentContinuingOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentContinuingOperationsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing Operations [Member]", "label": "Continuing Operations [Member]", "documentation": "Component of an entity expected to operate in the foreseeable future." } } }, "auth_ref": [] }, "us-gaap_SegmentDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentDiscontinuedOperationsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations [Member]", "label": "Discontinued Operations [Member]", "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, classified as held-for-sale or disposed of by sale or by means other than sale, and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale." } } }, "auth_ref": [ "r130", "r133", "r137", "r139" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r124", "r256", "r267", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r282", "r284", "r285", "r286", "r294", "r295", "r296", "r297", "r298", "r300", "r301", "r302", "r308", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r397", "r412", "r416", "r424", "r425", "r699", "r702", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1209", "r1212", "r1213", "r1220", "r1333", "r1770", "r1771", "r1772", "r1773", "r1774", "r1775", "r1776", "r1777", "r1778", "r1779", "r1780", "r1781", "r1782", "r1783", "r1784", "r1785", "r1786", "r1787", "r1788", "r1789", "r1790", "r1791", "r1792", "r1793", "r1794", "r1795", "r1796", "r1809", "r1810" ] }, "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentExpenditureAdditionToLongLivedAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Capital expenditures", "label": "Segment Reporting, Long-Lived Asset, Expenditure for Addition", "documentation": "Amount of expenditure for addition to long-lived asset included in determination of segment asset by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Long-lived asset excludes financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax asset." } } }, "auth_ref": [ "r256", "r282", "r300", "r1212", "r1213" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "SegmentGeographicalDomain", "presentation": [ "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofIncomeLossIncomeTaxesTable" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r69", "r71", "r74", "r76", "r83", "r84", "r85", "r86", "r88", "r89", "r90", "r91", "r92", "r94", "r95", "r96", "r262", "r306", "r307", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r953", "r954", "r955", "r956", "r1069", "r1070", "r1071", "r1135", "r1137", "r1140", "r1146", "r1155", "r1157", "r1158", "r1159", "r1161", "r1162", "r1163", "r1164", "r1166", "r1167", "r1168", "r1169", "r1170", "r1175", "r1203", "r1231", "r1234", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325", "r1326", "r1332", "r1341", "r1770", "r1771", "r1772", "r1774", "r1775", "r1776", "r1777", "r1778", "r1779", "r1780", "r1781", "r1782", "r1783", "r1784", "r1785", "r1786", "r1787", "r1788", "r1789", "r1790", "r1791", "r1792", "r1793", "r1794", "r1795", "r1796", "r1809", "r1810" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/Reportablesegment" ], "lang": { "en-us": { "role": { "terseLabel": "Reportable segment", "label": "Segment Reporting [Text Block]", "documentation": "The entire disclosure for segment reporting." } } }, "auth_ref": [ "r256", "r266", "r267", "r268", "r269", "r270", "r283", "r285", "r286", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r308", "r1207", "r1210", "r1211", "r1212", "r1214", "r1216", "r1217" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "label": "Segment Reporting [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r267", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r282", "r284", "r285", "r286", "r294", "r295", "r296", "r297", "r298", "r300", "r301", "r302" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Segments", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r303", "r306", "r1208", "r1209", "r1215" ] }, "us-gaap_SeniorNotesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SeniorNotesCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ELOC commitment fee note", "label": "Senior Notes, Current", "documentation": "Carrying value as of the balance sheet date of the portion of long-term notes having the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment." } } }, "auth_ref": [ "r1315", "r1421" ] }, "vsee_September2024ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "September2024ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable10", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "September 2024 Convertible Note", "verboseLabel": "September 2024 Convertible Note [Member]", "documentation": "Information pertaining to September 2024 Convertible Note.", "label": "September2024 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_September2024NoteWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "September2024NoteWarrantsMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "September 2024 Note Warrants [Member]", "verboseLabel": "September 2024 Warrants [Member]", "documentation": "Information pertaining to September 2024 Note Warrants.", "label": "September2024 Note Warrants Member" } } }, "auth_ref": [] }, "vsee_September2024SecurityPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "September2024SecurityPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "September 2024 Security Purchase Agreement [Member]", "label": "September2024 Security Purchase Agreement Member" } } }, "auth_ref": [] }, "vsee_September2024WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "September2024WarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "September 2024 Warrants [Member]", "verboseLabel": "Septemberb 2024 Warrants [Member]", "documentation": "Represents information pertaining to September 2024 Warrants.", "label": "September2024 Warrants Member" } } }, "auth_ref": [] }, "vsee_September2025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "September2025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable0" ], "lang": { "en-us": { "role": { "terseLabel": "May 2025 convertible Note [Member]", "verboseLabel": "September 2025 Promissory Note [Member]", "label": "September2025 Promissory Note Member" } } }, "auth_ref": [] }, "vsee_September302024CompanyAndTheBridgeInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "September302024CompanyAndTheBridgeInvestorMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "September 30, 2024 Company and the Bridge Investor [Member]", "label": "September302024 Company And The Bridge Investor Member" } } }, "auth_ref": [] }, "vsee_SeptemberConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SeptemberConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "September Convertible Note [Member]", "label": "September Convertible Note Member" } } }, "auth_ref": [] }, "vsee_SeptemberNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SeptemberNotesMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "September Notes [Member]", "label": "September Notes Member" } } }, "auth_ref": [] }, "vsee_SeriesA1PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SeriesA1PreferredStockMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series A-1 Preferred Stock [Member]", "documentation": "Represents information pertaining to Series A-1 preferred stock.", "label": "Series A1 Preferred Stock Member" } } }, "auth_ref": [] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Series A Preferred Stock", "verboseLabel": "Series A", "netLabel": "Series A Preferred Stock [Member]", "label": "Series A Preferred Stock [Member]", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r1413", "r1414", "r1426", "r1427", "r1428", "r1603", "r1608", "r1609", "r1610", "r1611", "r1612", "r1753", "r1754", "r1759", "r1760" ] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Series B Preferred Stock", "verboseLabel": "Series B", "netLabel": "Series B Preferred Stock [Member]", "label": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r1413", "r1414", "r1426", "r1427", "r1428", "r1603", "r1608", "r1609", "r1610", "r1611", "r1612", "r1753", "r1754", "r1759", "r1760" ] }, "vsee_ServiceContractsWithHospitalsOrHospitalSystemsPhysicianPracticeGroupsAndOtherUsersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ServiceContractsWithHospitalsOrHospitalSystemsPhysicianPracticeGroupsAndOtherUsersMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service Contracts With Hospitals Or Hospital Systems, Physician Practice Groups, And Other Users [Member]", "documentation": "Represents information pertaining to service contracts with hospitals or hospital systems, physician practice groups, and other users.", "label": "Service Contracts With Hospitals Or Hospital Systems Physician Practice Groups And Other Users Member" } } }, "auth_ref": [] }, "vsee_SettlementAgreementDescription": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SettlementAgreementDescription", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement agreement description", "documentation": "Settlement agreement description.", "label": "Settlement Agreement Description" } } }, "auth_ref": [] }, "vsee_SettlementOfEncompassPurchaseLiabilityAggregateAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SettlementOfEncompassPurchaseLiabilityAggregateAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement of encompass purchase liability aggregate amount", "documentation": "Settlement of encompass purchase liability aggregate amount.", "label": "Settlement Of Encompass Purchase Liability Aggregate Amount" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, noncash expense (in Dollars)", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award requisite service period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "documentation": "Estimated period when employee is required to provide service in exchange for share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1248" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r1248" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award." } } }, "auth_ref": [ "r1645" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r583" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free rate of return", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r585" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Options, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r564" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r564" ] }, "vsee_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Granted", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options granted.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value" } } }, "auth_ref": [] }, "vsee_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Average Remaining Life In Years, Granted", "documentation": "Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Options, Granted", "verboseLabel": "Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r566", "r1413", "r1428", "r1429", "r1612", "r1613" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value (in Dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r576" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Options, Outstanding, Balance", "periodEndLabel": "Number of Options, Outstanding, Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r562", "r563" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Outstanding, Balance", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r562", "r563" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment award, shares issued in period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "documentation": "Number of shares issued under share-based payment arrangement." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r558", "r559", "r560", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r582", "r583", "r584", "r585", "r586" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Granted", "verboseLabel": "Granted (in Dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r566" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Tranche One [Member]", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [ "r1624", "r1625", "r1626", "r1627", "r1628", "r1629", "r1630", "r1631", "r1632", "r1633", "r1634", "r1635", "r1636", "r1637", "r1638", "r1639", "r1640", "r1641", "r1642", "r1643", "r1644", "r1646", "r1647", "r1648", "r1649", "r1650" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r557", "r561", "r580", "r581", "r582", "r583", "r586", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598" ] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier [Axis]", "documentation": "Information by supplier." } } }, "auth_ref": [] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier [Domain]", "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received." } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharePrice", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock price", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment award, award vesting rights, percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r1624" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r582" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r15" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Average Remaining Life In Years, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term", "documentation": "Weighted-average contractual term remaining for vested portion of option outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r15" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [ "r1652" ] }, "vsee_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Average Remaining Life In Years, Outstanding, Balance", "periodEndLabel": "Average Remaining Life In Years, Outstanding, Balance", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recapitalization value (in Dollars)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock." } } }, "auth_ref": [ "r577" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "documentation": "Number of options vested." } } }, "auth_ref": [ "r1652" ] }, "vsee_SharesAgreedToBeIssuedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesAgreedToBeIssuedPeriod", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term for shares to be issued", "documentation": "Duration over which shares agreed to be issued.", "label": "Shares Agreed To Be Issued Period" } } }, "auth_ref": [] }, "vsee_SharesAgreedToBePurchasedMaximumValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesAgreedToBePurchasedMaximumValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum value of shares agreed to be purchased", "documentation": "The maximum value of shares agreed to be purchased.", "label": "Shares Agreed To Be Purchased Maximum Value" } } }, "auth_ref": [] }, "vsee_SharesAgreedToBePurchasedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesAgreedToBePurchasedPeriod", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period to purchase the shares agreed", "documentation": "Period over which shares agreed to be purchased.", "label": "Shares Agreed To Be Purchased Period" } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharesIssued", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in Shares)", "periodEndLabel": "Ending balance (in Shares)", "terseLabel": "Shares issued (in Shares)", "label": "Shares, Issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [] }, "vsee_SharesIssuedAsPartOfStockGrantsToVendors": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesIssuedAsPartOfStockGrantsToVendors", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as part of stock grants to vendors", "documentation": "The amount of Noncash Financial of Shares Issued as Part of Stock Grants to Vendors.", "label": "Shares Issued As Part Of Stock Grants To Vendors" } } }, "auth_ref": [] }, "vsee_SharesIssuedAsPaymentForMarch2025PromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesIssuedAsPaymentForMarch2025PromissoryNote", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as payment for March 2025 promissory Note", "documentation": "Shares issued as payment for March 2025 promissory Note.", "label": "Shares Issued As Payment For March2025 Promissory Note" } } }, "auth_ref": [] }, "vsee_SharesIssuedDuringThePeriodinShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesIssuedDuringThePeriodinShares", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance during the period (in Shares)", "documentation": "Shares issued during the period (in Shares).", "label": "Shares Issued During The Periodin Shares" } } }, "auth_ref": [] }, "vsee_SharesIssuedForPriorServicesOfPlacementAgentShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesIssuedForPriorServicesOfPlacementAgentShares", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued to placement agent", "documentation": "Number of shares issued in lieu of cash for prior services of placement agent", "label": "Shares Issued For Prior Services Of Placement Agent Shares" } } }, "auth_ref": [] }, "vsee_SharesIssuedOnConversionOfTheExchangeNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesIssuedOnConversionOfTheExchangeNote", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued on conversion of the Exchange Note", "documentation": "The shares issued on conversion of the exchange note.", "label": "Shares Issued On Conversion Of The Exchange Note" } } }, "auth_ref": [] }, "vsee_SharesIssuedUponConversionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesIssuedUponConversionAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon conversion", "documentation": "Shares issued upon conversion.", "label": "Shares Issued Upon Conversion Amount" } } }, "auth_ref": [] }, "vsee_SharesOfCommonStockConversion": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesOfCommonStockConversion", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares of common stock conversion (in Shares)", "documentation": "Shares of common stock conversion.", "label": "Shares Of Common Stock Conversion" } } }, "auth_ref": [] }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due on share purchase", "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current", "documentation": "The amount that is required to be paid, determined under the conditions specified in the contract, if as of the reporting date, the holder of the share has exercised the right to or the shares are mandatorily redeemable within one year of the reporting date or operating cycle, if longer." } } }, "auth_ref": [ "r476", "r1601" ] }, "vsee_SharesToBeIssuedAtInceptionAndLaterForConsultingServicesPerAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SharesToBeIssuedAtInceptionAndLaterForConsultingServicesPerAgreement", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of shares issued and to be issued under the agreement (in Dollars)", "documentation": "Fair value of shares to be issued, at inception and at later date, as share-based compensation for consulting services.", "label": "Shares To Be Issued At Inception And Later For Consulting Services Per Agreement" } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r1415", "r1419", "r1583", "r1584", "r1585" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r1415", "r1419", "r1583", "r1584", "r1585" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r210", "r211" ] }, "vsee_SmallerReportingCompanyStatusDescription": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SmallerReportingCompanyStatusDescription", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Smaller reporting company disclosure", "documentation": "Disclosure of the registrant's status as a smaller reporting company, including the applicable qualification criteria and availability of scaled disclosures.", "label": "Smaller Reporting Company Status Description" } } }, "auth_ref": [] }, "vsee_SponsorAffiliateMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SponsorAffiliateMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sponsor Affiliate [Member]", "documentation": "Represents information related to Sponsor Affiliate.", "label": "Sponsor Affiliate Member" } } }, "auth_ref": [] }, "vsee_SponsorAffiliatesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SponsorAffiliatesMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sponsor Affiliates [Member]", "documentation": "Represent information pertains to Sponsor affiliates.", "label": "Sponsor Affiliates Member" } } }, "auth_ref": [] }, "vsee_SponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SponsorMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sponsor [Member]", "documentation": "Represents information pertaining to sponsor.", "label": "Sponsor Member" } } }, "auth_ref": [] }, "vsee_StandbyEquityPUrchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StandbyEquityPUrchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Standby Equity P urchase Agreement [Member]", "label": "Standby Equity PUrchase Agreement Member" } } }, "auth_ref": [] }, "vsee_StandbyEquityPurchaseAgreementDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StandbyEquityPurchaseAgreementDetailsLineItems", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Standby Equity Purchase Agreement (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_StandbyEquityPurchaseAgreementDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StandbyEquityPurchaseAgreementDetailsTable", "presentation": [ "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Standby Equity Purchase Agreement (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Jurisdiction, Domestic State and Local [Member]", "label": "Income Tax Jurisdiction, Domestic State and Local [Member]", "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax." } } }, "auth_ref": [ "r608" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r124", "r256", "r267", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r282", "r284", "r285", "r286", "r294", "r295", "r296", "r297", "r298", "r300", "r301", "r302", "r308", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r397", "r412", "r416", "r424", "r425", "r699", "r702", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1209", "r1212", "r1213", "r1220", "r1333", "r1770", "r1771", "r1772", "r1773", "r1774", "r1775", "r1776", "r1777", "r1778", "r1779", "r1780", "r1781", "r1782", "r1783", "r1784", "r1785", "r1786", "r1787", "r1788", "r1789", "r1790", "r1791", "r1792", "r1793", "r1794", "r1795", "r1796", "r1809", "r1810" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementClassOfStockAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r66", "r141", "r142", "r170", "r171", "r172", "r173", "r174", "r175", "r212", "r216", "r247", "r248", "r250", "r252", "r258", "r259", "r344", "r432", "r435", "r436", "r437", "r441", "r442", "r477", "r478", "r480", "r481", "r483", "r486", "r489", "r490", "r492", "r493", "r494", "r495", "r496", "r497", "r499", "r502", "r506", "r507", "r508", "r509", "r510", "r512", "r513", "r516", "r517", "r518", "r804", "r932", "r933", "r944", "r945", "r946", "r978", "r1044", "r1045", "r1046", "r1047", "r1055", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1068", "r1083", "r1104", "r1126", "r1147", "r1148", "r1149", "r1150", "r1151", "r1366", "r1498", "r1500", "r1516", "r1615", "r1621" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r112", "r113", "r141", "r174", "r175", "r186", "r187", "r188", "r226", "r227", "r228", "r230", "r238", "r241", "r243", "r257", "r345", "r348", "r399", "r400", "r401", "r474", "r506", "r511", "r512", "r513", "r516", "r518", "r521", "r538", "r539", "r541", "r542", "r589", "r627", "r628", "r638", "r639", "r640", "r642", "r708", "r709", "r751", "r752", "r753", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r769", "r806", "r807", "r808", "r809", "r810", "r811", "r816", "r835", "r888", "r932", "r933", "r945", "r946", "r978", "r1000", "r1024", "r1025", "r1026", "r1055", "r1126", "r1621" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "StatementGeographicalAxis", "presentation": [ "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofIncomeLossIncomeTaxesTable" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r69", "r71", "r74", "r76", "r83", "r84", "r85", "r86", "r88", "r89", "r90", "r91", "r92", "r94", "r95", "r96", "r262", "r306", "r307", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r930", "r953", "r954", "r955", "r956", "r1069", "r1070", "r1071", "r1135", "r1137", "r1140", "r1146", "r1155", "r1157", "r1158", "r1159", "r1161", "r1162", "r1163", "r1164", "r1166", "r1167", "r1168", "r1169", "r1170", "r1175", "r1203", "r1231", "r1234", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325", "r1326", "r1332", "r1341", "r1770", "r1771", "r1772", "r1774", "r1775", "r1776", "r1777", "r1778", "r1779", "r1780", "r1781", "r1782", "r1783", "r1784", "r1785", "r1786", "r1787", "r1788", "r1789", "r1790", "r1791", "r1792", "r1793", "r1794", "r1795", "r1796", "r1809", "r1810" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementLineItems", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/IncomeTaxesDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Statement", "terseLabel": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r141", "r142", "r146", "r147", "r155", "r165", "r167", "r170", "r173", "r174", "r175", "r178", "r226", "r227", "r228", "r257", "r477", "r478", "r480", "r483", "r489", "r506", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r518", "r520", "r521", "r530", "r816", "r894", "r932", "r933", "r944", "r945", "r946", "r1042", "r1056", "r1068", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1083", "r1086", "r1087", "r1088", "r1089", "r1090", "r1092", "r1093", "r1094", "r1095", "r1097", "r1098", "r1099", "r1100", "r1101", "r1105", "r1106", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1126", "r1185", "r1198", "r1200", "r1342", "r1814" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOperatingActivitiesSegmentAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable" ], "lang": { "en-us": { "role": { "label": "Operating Activities [Axis]", "documentation": "Information by continuing and discontinuing operations." } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "StatementScenarioAxis", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable0" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r109", "r117", "r119", "r244", "r556", "r1367", "r1372" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementTable", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r121", "r141", "r142", "r146", "r147", "r155", "r165", "r167", "r170", "r173", "r174", "r175", "r178", "r226", "r227", "r228", "r257", "r309", "r477", "r478", "r480", "r483", "r489", "r506", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r518", "r520", "r521", "r530", "r816", "r894", "r932", "r933", "r944", "r945", "r946", "r978", "r1042", "r1056", "r1068", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1083", "r1086", "r1087", "r1088", "r1089", "r1090", "r1092", "r1093", "r1094", "r1095", "r1097", "r1098", "r1099", "r1100", "r1101", "r1105", "r1106", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1126", "r1185", "r1198", "r1200", "r1342", "r1814" ] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued", "verboseLabel": "Estimated the fair value of the shares of common stock issued (in Dollars)", "label": "Stock Issued", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r1494" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares for iDoc acquisition (in Shares)", "verboseLabel": "Shares for iDoc acquisition", "label": "Stock Issued During Period, Shares, Acquisitions", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r1413", "r1428", "r1429", "r1608", "r1612", "r1613", "r1614", "r1617", "r1753", "r1754", "r1760", "r1761" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued on conversion (in Shares)", "verboseLabel": "Conversion of convertible securities", "netLabel": "Shares issued upon conversion (in Shares)", "label": "Conversion of convertible securities (in Shares)", "totalLabel": "Shares issued upon conversion", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r460", "r507", "r1413", "r1428", "r1429", "r1608", "r1612", "r1613", "r1614", "r1617", "r1753", "r1754", "r1760", "r1761" ] }, "vsee_StockIssuedDuringPeriodSharesConversionOfWorkingCapitalFundAdvances": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodSharesConversionOfWorkingCapitalFundAdvances", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon conversion of Working Capital Funds Advances (in Shares)", "verboseLabel": "Number of shares of Common Stock upon the settlement in working capital funds advanced", "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company.", "label": "Stock Issued During Period Shares Conversion Of Working Capital Fund Advances" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesDebtIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodSharesDebtIssuance", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants and commitment shares issued in connection with the September 2024 Note (in Shares)", "verboseLabel": "Warrants and commitment shares issued (in Shares)", "netLabel": "Warrants and commitment shares issued in connection with the September 2024 Note", "documentation": "Number of shares of stock, including warrants and commitment shares, issued during the period pursuant to debt issuance.", "label": "Stock Issued During Period Shares Debt Issuance" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesDebtSettlement": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodSharesDebtSettlement", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued in debt settlement or conversion (in Shares)", "verboseLabel": "Promissory note by issuing shares (in Shares)", "netLabel": "Shares to sponsor debt settlement (in Shares)", "label": "Shares issued in debt settlement or conversion", "documentation": "Number of shares of stock issued during the period pursuant to debt settlement or conversion." } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesEscrowSharesReleasedFromStockPayable": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodSharesEscrowSharesReleasedFromStockPayable", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Escrow shares released from stock payable (in Shares)", "documentation": "Number\r\nof escrow shares issued from stock payable during the period.", "label": "Stock Issued During Period Shares Escrow Shares Released From Stock Payable" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as part of stock grants to vendors (in Shares)", "verboseLabel": "Shares issued for services performed by A.G.P. (in Shares)", "netLabel": "Shares issued as part of stock grants to vendors", "label": "Stock Issued During Period, Shares, Issued for Services", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [ "r1413", "r1428", "r1429", "r1612", "r1613" ] }, "vsee_StockIssuedDuringPeriodSharesIssuedOnTheExerciseOfPrefundedWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodSharesIssuedOnTheExerciseOfPrefundedWarrants", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued on the exercise of pre-funded warrants (in Shares)", "documentation": "Shares issued on the exercise of pre-funded warrants.", "label": "Stock Issued During Period Shares Issued On The Exercise Of Prefunded Warrants" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued during the period (in Shares)", "verboseLabel": "Number of shares issued", "netLabel": "Pre-funded warrants shares issued (in Shares)", "label": "Number of shares issued (in Shares)", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r1044", "r1126", "r1148", "r1413", "r1428", "r1429", "r1608", "r1612", "r1613", "r1614", "r1617", "r1753", "r1754", "r1760", "r1761" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of restricted common stock", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r1413", "r1428", "r1429", "r1608", "r1612", "r1613", "r1614", "r1617" ] }, "vsee_StockIssuedDuringPeriodSharesReverseRecapitalization": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodSharesReverseRecapitalization", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse recapitalization (in Shares)", "documentation": "Number of shares of stock issued during the period pursuant to reverse recapitalization.", "label": "Stock Issued During Period Shares Reverse Recapitalization" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as conversion of iDoc debt as part of the consideration in the acquisition (in Shares)", "documentation": "Number of shares of stock issued as a settlement of debt during the period pursuant to acquisitions.", "label": "Stock Issued During Period Shares Settlement Of Debt As Part Of Consideration In Acquisitions" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation issued shares", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r1413", "r1428", "r1429", "r1608", "r1612", "r1613", "r1614", "r1617", "r1753", "r1754", "r1760", "r1761" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Stock based compensation (in Shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture", "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r1413", "r1428", "r1429", "r1608", "r1612", "r1613" ] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares for iDoc acquisition", "label": "Stock Issued During Period, Value, Acquisitions", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r1413", "r1428", "r1429", "r1608", "r1612", "r1613", "r1614", "r1617", "r1753", "r1754", "r1760", "r1761" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued on conversion", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r1413", "r1428", "r1429", "r1608", "r1612", "r1613", "r1614", "r1617", "r1753", "r1754", "r1760", "r1761" ] }, "vsee_StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvance", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon conversion of Working Capital Funds Advances", "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company.", "label": "Stock Issued During Period Value Conversion Of Working Capital Fund Advance" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvances": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvances", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of stock issued during the period upon the settlement in working capital funds advanced (in Dollars)", "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company.", "label": "Stock Issued During Period Value Conversion Of Working Capital Fund Advances" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvancesTroubledDebtRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvancesTroubledDebtRestructuring", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of stock issued during period upon conversion of certain working capital funds advanced on debt restructuring (in Dollars)", "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company under troubled debt restructuring.", "label": "Stock Issued During Period Value Conversion Of Working Capital Fund Advances Troubled Debt Restructuring" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueDebtSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodValueDebtSettlement", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued in debt settlement or conversion", "documentation": "Value of stock issued pursuant to debt settlement or conversion during the period.", "label": "Stock Issued During Period Value Debt Settlement" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueEscrowSharesReleasedFromStockPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodValueEscrowSharesReleasedFromStockPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Escrow shares released from stock payable", "documentation": "Value of escrow stock issued from stock payable during the period.", "label": "Stock Issued During Period Value Escrow Shares Released From Stock Payable" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as part of stock grants to vendors", "label": "Stock Issued During Period, Value, Issued for Services", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [ "r1413", "r1428", "r1429", "r1612", "r1613" ] }, "vsee_StockIssuedDuringPeriodValueIssuedOnExerciseOfPrefundedWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodValueIssuedOnExerciseOfPrefundedWarrants", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued on the exercise of pre-funded warrants", "documentation": "The amount shares issued on exercise of pre-funded warrants.", "label": "Stock Issued During Period Value Issued On Exercise Of Prefunded Warrants" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued during the period", "verboseLabel": "Stock Issued During Period, Value, New Issues", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r1055", "r1126", "r1148", "r1348", "r1413", "r1428", "r1429", "r1608", "r1612", "r1613", "r1614", "r1617", "r1753", "r1754", "r1760", "r1761" ] }, "vsee_StockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as conversion of iDoc debt as part of the consideration in the acquisition", "documentation": "Value of stock issued to settle debt pursuant to consideration in acquisitions during the period.", "label": "Stock Issued During Period Value Settlement Of Debt As Part Of Consideration In Acquisition" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Stock based compensation", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r16", "r1413", "r1428", "r1429", "r1608", "r1612", "r1613", "r1614", "r1617", "r1753", "r1754", "r1760", "r1761" ] }, "vsee_StockIssuedDuringThePeriodValueReverseRecapitalization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedDuringThePeriodValueReverseRecapitalization", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse recapitalization", "documentation": "Value of stock issued pursuant to reverse recapitalization during the period.", "label": "Stock Issued During The Period Value Reverse Recapitalization" } } }, "auth_ref": [] }, "vsee_StockIssuedEscrowSharesReleasedFromStockPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedEscrowSharesReleasedFromStockPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Escrow shares released from stock payable", "documentation": "The fair value of stock issued relating to escrow shares released from notes payable in a non-cash financing activities.", "label": "Stock Issued Escrow Shares Released From Stock Payable" } } }, "auth_ref": [] }, "vsee_StockIssuedForConversionOfUnderwriterFee": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedForConversionOfUnderwriterFee", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction", "documentation": "The value of stock issued during the period for conversion of underwriter fees in a non-cash financing activities.", "label": "Stock Issued For Conversion Of Underwriter Fee" } } }, "auth_ref": [] }, "vsee_StockIssuedForDebtSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockIssuedForDebtSettlement", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued to settled iDoc debt holders", "documentation": "Value of stock issued to settle the debt in a non-cash financing activities.", "label": "Stock Issued For Debt Settlement" } } }, "auth_ref": [] }, "vsee_StockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "StockOptionsMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Options [Member]", "label": "Stock Options Member" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquityAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "STOCKHOLDERS' EQUITY", "verboseLabel": "STOCKHOLDERS\u2019 EQUITY (DEFICIT)", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r17", "r18", "r20", "r112", "r113", "r175", "r187", "r226", "r227", "r228", "r230", "r238", "r241", "r345", "r348", "r399", "r400", "r401", "r474", "r506", "r512", "r513", "r516", "r518", "r538", "r539", "r541", "r542", "r589", "r627", "r628", "r638", "r639", "r640", "r642", "r708", "r709", "r751", "r752", "r753", "r755", "r756", "r757", "r758", "r759", "r760", "r769", "r806", "r807", "r811", "r835", "r888", "r932", "r933", "r945", "r946", "r1025", "r1026", "r1053", "r1085", "r1102", "r1127", "r1128", "r1152", "r1336", "r1337", "r1348", "r1413", "r1428", "r1496", "r1500", "r1501", "r1550", "r1729", "r1818" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/Equity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r141", "r174", "r175", "r179", "r488", "r491", "r493", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r507", "r512", "r513", "r516", "r518", "r519", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r749", "r766", "r767", "r848", "r1129", "r1131", "r1153" ] }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange ratio", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one." } } }, "auth_ref": [ "r1618", "r1619", "r1620" ] }, "us-gaap_StockholdersEquityReverseStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquityReverseStockSplit", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse stock split", "label": "Stockholders' Equity, Reverse Stock Split", "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements." } } }, "auth_ref": [ "r519", "r523", "r526" ] }, "us-gaap_SubscriptionAndCirculationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubscriptionAndCirculationMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription and Circulation", "verboseLabel": "Subscription fees [Member]", "netLabel": "Subscription and Circulation [Member]", "label": "Subscription and Circulation [Member]", "documentation": "Right to receive or access periodic material for specified period of time." } } }, "auth_ref": [ "r1622", "r1623" ] }, "vsee_SubscriptionFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SubscriptionFeesMember", "presentation": [ "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription fees [Member]", "label": "Subscription Fees Member" } } }, "auth_ref": [] }, "vsee_SubscriptionProfessionalAndTechnicalEngineeringServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SubscriptionProfessionalAndTechnicalEngineeringServicesMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription, Professional And Technical Engineering Services [Member]", "documentation": "Represents the information pertaining to combined member of contract liabilities associated with customer deposits for subscription, professional and technical engineering services.", "label": "Subscription Professional And Technical Engineering Services Member" } } }, "auth_ref": [] }, "vsee_SubscriptionServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SubscriptionServicesMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription Services [Member]", "documentation": "Represents information pertaining to subscription services.", "label": "Subscription Services Member" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventLineItems", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r812", "r846" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Member]", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r812", "r846" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventTable", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r812", "r846" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r812", "r846" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r812", "r846" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://vseehealth.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r845", "r847" ] }, "vsee_SubsequentSettlementAgreementPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SubsequentSettlementAgreementPaid", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent settlement agreement, paid", "documentation": "The value represents subsequent settlement agreement, paid.", "label": "Subsequent Settlement Agreement Paid" } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/StandbyEquityPurchaseAgreementDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "vsee_SummaryOfRecapitalizationAndEquityImpactTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SummaryOfRecapitalizationAndEquityImpactTableTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of the Recapitalization and Net Equity Impact on Business Combination", "documentation": "Tabular disclosure of information relating to the recapitalization and its net equity impact.", "label": "Summary Of Recapitalization And Equity Impact Table Text Block" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Basic and Diluted Earnings Per Share Attributable to Continuing Operations (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Basic and Diluted Earnings Per Share Attributable to Continuing Operations (Details) [Table]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SummaryofSignificantAccountingPoliciesScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SummaryofSignificantAccountingPoliciesScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Table]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofNetLossPerCommonShareDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SummaryofSignificantAccountingPoliciesScheduleofNetLossPerCommonShareDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofNetLossPerCommonShareDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "SummaryofSignificantAccountingPoliciesScheduleofNetLossPerCommonShareDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosure of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Concentration Risk [Member]", "label": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r1520" ] }, "stpr_TX": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2026", "localname": "TX", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "TEXAS", "label": "TEXAS" } } }, "auth_ref": [] }, "us-gaap_TaxPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TaxPeriodAxis", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Axis]", "documentation": "Information by period subject to enacted tax law." } } }, "auth_ref": [ "r1657" ] }, "us-gaap_TaxPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TaxPeriodDomain", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Domain]", "documentation": "Identified tax period." } } }, "auth_ref": [ "r1657" ] }, "us-gaap_TaxYear2017Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TaxYear2017Member", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Year 2017 [Member]", "label": "Tax Year 2017 [Member]", "documentation": "Identified as tax year 2017." } } }, "auth_ref": [ "r1657" ] }, "vsee_TaxYear2030Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TaxYear2030Member", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Year 2030 [Member]", "label": "Tax Year2030 Member" } } }, "auth_ref": [] }, "vsee_TechnicalEngineeringFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TechnicalEngineeringFeesMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofStatementofOperationsDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Technical engineering fees [Member]", "label": "Technical Engineering Fees Member" } } }, "auth_ref": [] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology [Member]", "label": "Technology-Based Intangible Assets [Member]", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r1285", "r1560", "r1561", "r1562", "r1563", "r1564", "r1566", "r1570", "r1571" ] }, "vsee_TechnologySegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TechnologySegmentMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Technology [Member]", "verboseLabel": "Technology Segment [Member]", "documentation": "Represents information pertaining to the technology segment.", "label": "Technology Segment Member" } } }, "auth_ref": [] }, "us-gaap_TechnologyServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TechnologyServiceMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Technology Service", "label": "Technology Service [Member]", "documentation": "Technology assistance, including but not limited to, training, installation, engineering, and software design." } } }, "auth_ref": [ "r1622", "r1623" ] }, "vsee_TelehealthAndInstitutionalServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TelehealthAndInstitutionalServicesMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Telehealth and Institutional Services [Member]", "documentation": "Represents information pertaining to telehealth and institutional services.", "label": "Telehealth And Institutional Services Member" } } }, "auth_ref": [] }, "vsee_TelehealthFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TelehealthFeesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Telehealth fees", "verboseLabel": "Telehealth Fees", "netLabel": "Telehealth Fees [Member]", "label": "Telehealth fees [Member]", "documentation": "Represents fees relating to telehealth services." } } }, "auth_ref": [] }, "vsee_TelehealthSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TelehealthSegmentMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Telehealth [Member]", "verboseLabel": "Telehealth Segment [Member]", "documentation": "Represents information pertaining to the telehealth segment.", "label": "Telehealth Segment Member" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance during the period", "label": "Temporary Equity, Stock Issued During Period, Value, New Issues", "documentation": "Value of new stock classified as temporary equity issued during the period." } } }, "auth_ref": [ "r1414", "r1427", "r1602", "r1604", "r1605", "r1606", "r1753", "r1754", "r1759" ] }, "vsee_ThisAmericanDocIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ThisAmericanDocIncMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "This American Doc", "verboseLabel": "This American Doc, Inc [Member]", "documentation": "Represents the information pertaining to This American Doc, Inc.", "label": "This American Doc Inc Member" } } }, "auth_ref": [] }, "vsee_ThreeCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ThreeCustomersMember", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Three Customers [Member]", "label": "Three Customers Member" } } }, "auth_ref": [] }, "vsee_ThresholdBeneficialOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ThresholdBeneficialOwnershipPercentage", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold beneficial ownership percentage", "documentation": "Represents the threshold percentage of beneficial ownership of the shares of common stock outstanding.", "label": "Threshold Beneficial Ownership Percentage" } } }, "auth_ref": [] }, "vsee_ThresholdGrossProceedsFromCapitalRaisingAsPercentageOfTotalEquityProceedsConsideredForAdjustmentOfExercisePriceOfWarrants": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ThresholdGrossProceedsFromCapitalRaisingAsPercentageOfTotalEquityProceedsConsideredForAdjustmentOfExercisePriceOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold gross proceeds from capital raising as a percentage of total equity proceeds, considered for adjustment of exercise price of warrants", "documentation": "Represents the threshold gross proceeds from capital raising as a percentage of total equity proceeds, considered for adjustments of exercise price of warrants.", "label": "Threshold Gross Proceeds From Capital Raising As Percentage Of Total Equity Proceeds Considered For Adjustment Of Exercise Price Of Warrants" } } }, "auth_ref": [] }, "vsee_ThresholdIssuePriceForCapitalRaisingInConnectionWithClosingOfInitialBusinessCombinationConsideredForAdjustmentOfExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ThresholdIssuePriceForCapitalRaisingInConnectionWithClosingOfInitialBusinessCombinationConsideredForAdjustmentOfExercisePriceOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold issue price for capital raising purposes in connection with the closing of the initial business combination, considered for adjustment of exercise price of warrants (in Dollars per share)", "documentation": "Represents the threshold issue price for capital raising in connection with the closing of a Initial Business Combination, considered for adjustments of exercise price of warrants.", "label": "Threshold Issue Price For Capital Raising In Connection With Closing Of Initial Business Combination Considered For Adjustment Of Exercise Price Of Warrants" } } }, "auth_ref": [] }, "vsee_ThresholdMaximumMarketValuePerShareConsideredForAdjustmentOfExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ThresholdMaximumMarketValuePerShareConsideredForAdjustmentOfExercisePriceOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold maximum market value per share, considered for adjustment of exercise price of warrants (in Dollars per share)", "documentation": "Represents the threshold maximum market value per share, considered for adjustments of exercise price of warrants.", "label": "Threshold Maximum Market Value Per Share Considered For Adjustment Of Exercise Price Of Warrants" } } }, "auth_ref": [] }, "vsee_ThresholdOwnershipPercentageEligibleToVote": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "ThresholdOwnershipPercentageEligibleToVote", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership percentage eligible to vote", "documentation": "Threshold ownership percentage eligible to vote.", "label": "Threshold Ownership Percentage Eligible To Vote" } } }, "auth_ref": [] }, "vsee_TidewaterMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TidewaterMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tidewater [Member]", "documentation": "Represents information pertaining to tidewater.", "label": "Tidewater Member" } } }, "auth_ref": [] }, "vsee_TimingOfRevenueRecognitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TimingOfRevenueRecognitionAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Timing of revenue recognition", "label": "Timing Of Revenue Recognition Abstract" } } }, "auth_ref": [] }, "vsee_TimingOfRevenueRecognitionAbstract0": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TimingOfRevenueRecognitionAbstract0", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Timing of revenue recognition", "label": "Timing Of Revenue Recognition Abstract0" } } }, "auth_ref": [] }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TimingOfTransferOfGoodOrServiceAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable", "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable0" ], "lang": { "en-us": { "role": { "label": "Timing of Transfer of Good or Service [Axis]", "documentation": "Information by timing of transfer of good or service to customer." } } }, "auth_ref": [ "r536", "r1231", "r1238" ] }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TimingOfTransferOfGoodOrServiceDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable", "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable0" ], "lang": { "en-us": { "role": { "label": "Timing of Transfer of Good or Service [Domain]", "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time." } } }, "auth_ref": [ "r536", "r1231", "r1238" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "TitleOfIndividualAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]", "documentation": "Information by title and position of individual or group within organization." } } }, "auth_ref": [ "r1540", "r1743" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Title and Position [Domain]", "documentation": "Title and position of individual or group within organization." } } }, "auth_ref": [] }, "vsee_TotalFinanceCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TotalFinanceCharges", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total finance charges", "documentation": "Total finance charges.", "label": "Total Finance Charges" } } }, "auth_ref": [] }, "vsee_TotalNumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TotalNumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration", "presentation": [ "http://vseehealth.com/role/CommitmentsContingenciesandConcentrationRiskDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total number of deployed telepresence robots (in robot)", "documentation": "Total number of deployed telepresence robots rights considered for calculating percentage of monthly revenue generation.", "label": "Total Number Of Deployed Telepresence Robots Rights Considered For Calculating Percentage Of Monthly Revenue Generation" } } }, "auth_ref": [] }, "us-gaap_TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofBalancesheetDiscontinuedoperationsTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowance for credit losses", "label": "Accounts and Financing Receivables, Held-for-Sale, Not Part of Disposal Group, after Valuation Allowance", "documentation": "Amount, after valuation allowance, of accounts and financing receivables held for sale and not part of disposal group. Excludes loan covered under loss sharing agreement and loan classified as investment in debt security." } } }, "auth_ref": [ "r1541" ] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable and Credit Losses", "label": "Accounts Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r1542", "r1543", "r1545" ] }, "vsee_TransactionRelatedFeesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TransactionRelatedFeesPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction-related fees payable", "documentation": "Transaction-related fees payable.", "label": "Transaction Related Fees Payable" } } }, "auth_ref": [] }, "us-gaap_TransferredAtPointInTimeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TransferredAtPointInTimeMember", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable", "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Transferred at Point in Time [Member]", "label": "Transferred at Point in Time [Member]", "documentation": "Contract with customer in which good or service is transferred at point in time." } } }, "auth_ref": [ "r1231", "r1232", "r1238" ] }, "us-gaap_TransferredOverTimeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TransferredOverTimeMember", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable", "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Transferred over Time [Member]", "label": "Transferred over Time [Member]", "documentation": "Contract with customer in which good or service is transferred over time." } } }, "auth_ref": [ "r1231", "r1232", "r1238" ] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable0" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r351", "r352", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r468", "r505", "r749", "r796", "r803", "r805", "r850", "r851", "r852", "r853", "r854", "r855", "r857", "r858", "r859", "r860", "r862", "r863", "r864", "r865", "r866", "r867", "r869", "r870", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r958", "r959", "r960", "r961", "r962", "r963", "r964", "r965", "r966", "r967", "r968", "r969", "r970", "r971", "r972", "r973", "r974", "r975", "r981", "r1001", "r1300", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1317", "r1386", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1546", "r1547", "r1548", "r1549", "r1708", "r1711", "r1712", "r1713", "r1720", "r1723", "r1725", "r1726" ] }, "vsee_TwoCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TwoCustomersMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Two Customers [Member]", "documentation": "Represents information relating to two customers.", "label": "Two Customers Member" } } }, "auth_ref": [] }, "vsee_TwoVendorsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "TwoVendorsMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Two Vendors [Member]", "label": "Two Vendors Member" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TypeOfArrangementAxis", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r710" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2026", "localname": "US", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeLossIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "UNITED STATES", "label": "UNITED STATES" } } }, "auth_ref": [] }, "vsee_UnallocatedCorporateOverheadExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "UnallocatedCorporateOverheadExpenses", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Unallocated corporate overhead expenses", "documentation": "Unallocated corporate overhead expenses.", "label": "Unallocated Corporate Overhead Expenses" } } }, "auth_ref": [] }, "vsee_UncertainTaxPositionsExpectedToReverseDuration": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "UncertainTaxPositionsExpectedToReverseDuration", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax positions expected to reverse dyration", "documentation": "Uncertain tax positions are expected to reverse.", "label": "Uncertain Tax Positions Expected To Reverse Duration" } } }, "auth_ref": [] }, "vsee_UnpaidNotesAccrueInterestPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "UnpaidNotesAccrueInterestPercentage", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unpaid notes accrue interest percentage", "documentation": "Unpaid notes accrue interest percentage.", "label": "Unpaid Notes Accrue Interest Percentage" } } }, "auth_ref": [] }, "vsee_UnpaidPremiumBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "UnpaidPremiumBalance", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unpaid premium balance", "documentation": "Unpaid premium balance.", "label": "Unpaid Premium Balance" } } }, "auth_ref": [] }, "us-gaap_UnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "UnsecuredDebt", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured promissory note", "label": "Unsecured Debt", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r1416", "r1423", "r1765" ] }, "vsee_UnsecuredPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "UnsecuredPromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured Promissory Note [Member]", "documentation": "Represents the information pertaining to unsecured promissory note.", "label": "Unsecured Promissory Note Member" } } }, "auth_ref": [] }, "vsee_UntilMarch272026Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "UntilMarch272026Member", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Until March 27, 2026 [Member]", "label": "Until March272026 Member" } } }, "auth_ref": [] }, "vsee_UntilSeptember212026Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "UntilSeptember212026Member", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Until September 21, 2026 [Member]", "label": "Until September212026 Member" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "UseOfEstimates", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r59", "r60", "r260", "r263", "r264", "r265", "r953", "r955", "r1204" ] }, "vsee_VSeeLabMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "VSeeLabMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "VSee Lab [Member]", "label": "VSee Lab Member" } } }, "auth_ref": [] }, "vsee_VanquishFundingConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "VanquishFundingConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable3" ], "lang": { "en-us": { "role": { "terseLabel": "Vanquish Funding Convertible Note [Member]", "verboseLabel": "Equity Line of Credit [Member]", "label": "Vanquish Funding Convertible Note Member" } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "VestingAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1624", "r1625", "r1626", "r1627", "r1628", "r1629", "r1630", "r1631", "r1632", "r1633", "r1634", "r1635", "r1636", "r1637", "r1638", "r1639", "r1640", "r1641", "r1642", "r1643", "r1644", "r1646", "r1647", "r1648", "r1649", "r1650" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "VestingDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1624", "r1625", "r1626", "r1627", "r1628", "r1629", "r1630", "r1631", "r1632", "r1633", "r1634", "r1635", "r1636", "r1637", "r1638", "r1639", "r1640", "r1641", "r1642", "r1643", "r1644", "r1646", "r1647", "r1648", "r1649", "r1650" ] }, "vsee_VseeLabIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "VseeLabIncMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "VSee Lab, Inc [Member]", "documentation": "Represents the information pertaining to VSee Lab, Inc.", "label": "Vsee Lab Inc Member" } } }, "auth_ref": [] }, "vsee_VseeLabStockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "VseeLabStockholdersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "VSee Lab Stockholders [Member]", "documentation": "Represents information pertaining to VSee Lab stockholders.", "label": "Vsee Lab Stockholders Member" } } }, "auth_ref": [] }, "vsee_VseeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "VseeNoteMember", "presentation": [ "http://vseehealth.com/role/ConvertiblenotesatfairvalueDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "VSee Note", "verboseLabel": "Vsee Note [Member]", "documentation": "Represents information related to VSee Note.", "label": "Vsee Note Member" } } }, "auth_ref": [] }, "vsee_WarrantExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WarrantExchangeAgreementMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant Exchange Agreement [Member]", "label": "Warrant Exchange Agreement Member" } } }, "auth_ref": [] }, "vsee_WarrantInstrumentsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WarrantInstrumentsPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant Instruments", "documentation": "Disclosure of accounting policy for warrant instruments.", "label": "Warrant Instruments Policy Policy Text Block" } } }, "auth_ref": [] }, "vsee_WarrantPeriodForExerciseAfterClosingOfInitialPublicOffering": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WarrantPeriodForExerciseAfterClosingOfInitialPublicOffering", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant, period for exercise after closing of initial public offering", "documentation": "Represents the period after closing of Initial Public Offering, that the warrants become exercisable.", "label": "Warrant Period For Exercise After Closing Of Initial Public Offering" } } }, "auth_ref": [] }, "vsee_WarrantPeriodForExerciseAfterCompletionOfInitialBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WarrantPeriodForExerciseAfterCompletionOfInitialBusinessCombination", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum notice period for redemption of warrants", "documentation": "Represents the period after completion of Initial Business Combination, that the warrants become exercisable.", "label": "Warrant Period For Exercise After Completion Of Initial Business Combination" } } }, "auth_ref": [] }, "vsee_Warrants1Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "Warrants1Member", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants [Member]", "label": "Warrants1 Member" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WarrantsAndRightsNoteDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise period", "verboseLabel": "Weighted Average remaining life in years", "label": "Warrants and Rights Outstanding, Term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1711", "r1712", "r1713" ] }, "vsee_WarrantsAndRightsOutstandingWeightedAverageRemainingTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WarrantsAndRightsOutstandingWeightedAverageRemainingTerm", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandOutstandingTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Life in Years", "documentation": "Weighted average remaining term of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants And Rights Outstanding Weighted Average Remaining Term" } } }, "auth_ref": [] }, "vsee_WarrantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WarrantsTextBlock", "presentation": [ "http://vseehealth.com/role/Warrants" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants", "documentation": "The entire disclosure of Warrants.", "label": "Warrants Text Block" } } }, "auth_ref": [] }, "vsee_WeightedAverageNumberOfCommonSharesOutstandingBasicDiscontinuedOperationsinS": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WeightedAverageNumberOfCommonSharesOutstandingBasicDiscontinuedOperationsinS", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average number of common shares outstanding, basic - discontinued operations (in Shares)", "documentation": "Weighted average number of common shares outstanding, basic - discontinued operations shares.", "label": "Weighted Average Number Of Common Shares Outstanding Basic Discontinued Operationsin S" } } }, "auth_ref": [] }, "vsee_WeightedAverageNumberOfCommonSharesOutstandingDilutedDiscontinuedOperationsinS": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WeightedAverageNumberOfCommonSharesOutstandingDilutedDiscontinuedOperationsinS", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average number of common shares outstanding, diluted - discontinued operations (in Shares)", "documentation": "Weighted average number of common shares outstanding, diluted - discontinued operations shares.", "label": "Weighted Average Number Of Common Shares Outstanding Diluted Discontinued Operationsin S" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average number of common shares outstanding, basic and diluted - continuing operations (in Shares) (in Shares)", "verboseLabel": "Weighted average shares outstanding \u2013 diluted", "netLabel": "Weighted average shares outstanding diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r246", "r252" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofBasicandDilutedEarningsPerShareAttributabletoContinuingOperationsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares outstanding \u2013 basic", "verboseLabel": "Weighted average number of common shares outstanding, basic and diluted - continuing operations (in Shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r245", "r252" ] }, "vsee_WhackyMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WhackyMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Whacky [Member]", "documentation": "Represents information related to Whacky.", "label": "Whacky Member" } } }, "auth_ref": [] }, "vsee_WorkingCapitalFundsAdvancesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20260630", "localname": "WorkingCapitalFundsAdvancesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Working Capital Funds Advances", "label": "Working Capital Funds Advances Member" } } }, "auth_ref": [] } } }, "vseeex-fee.htm": { "dts": { "inline": { "local": [ "vseeex-fee.htm" ] }, "schema": { "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 0, "hidden": { "total": 6, "http://xbrl.sec.gov/dei/2025": 1, "http://xbrl.sec.gov/ffd/2025": 5 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 107, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/ffd/2025": 21, "http://xbrl.sec.gov/dei/2025": 2 }, "report": { "R136": { "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable", "longName": "995210 - Document - Submission", "shortName": "Submission", "isDefault": "true", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "136", "firstAnchor": { "contextRef": "c_report", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "vseeex-fee.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c_report", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "vseeex-fee.htm", "first": true, "unique": true } }, "R137": { "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "longName": "995211 - Document - Offerings", "shortName": "Offerings", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "137", "firstAnchor": { "contextRef": "c_offering_1", "name": "ffd:PrevslyPdFlg", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "vseeex-fee.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c_offering_1", "name": "ffd:PrevslyPdFlg", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "vseeex-fee.htm", "first": true, "unique": true } }, "R138": { "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable", "longName": "995215 - Document - Fees Summary", "shortName": "Fees Summary", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "138", "firstAnchor": { "contextRef": "c_report", "name": "ffd:TtlOfferingAmt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "vseeex-fee.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c_report", "name": "ffd:TtlOfferingAmt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "vseeex-fee.htm", "first": true, "unique": true } } }, "tag": { "ffd_AggtRedRpPricFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AggtRedRpPricFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year", "terseLabel": "Aggregate Redeemed or Repurchased, FY" } } }, "auth_ref": [ "r1353" ] }, "ffd_AggtRedRpPricPrrFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AggtRedRpPricPrrFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year", "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY" } } }, "auth_ref": [ "r1353" ] }, "ffd_AggtSalesPricFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AggtSalesPricFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Sales Price, Fiscal Year", "terseLabel": "Aggregate Sales Price" } } }, "auth_ref": [ "r1353" ] }, "ffd_AmtRedCdts": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AmtRedCdts", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Amount of Redemption Credits", "terseLabel": "Redemption Credits" } } }, "auth_ref": [ "r1353" ] }, "ffd_AmtSctiesRcvd": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AmtSctiesRcvd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Amount of Securities Received", "terseLabel": "Amount of Securities Received", "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)" } } }, "auth_ref": [ "r1358" ] }, "ffd_AmtSctiesRegd": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "AmtSctiesRegd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Amount of Securities Registered", "terseLabel": "Amount Registered", "documentation": "The amount of securities being registered." } } }, "auth_ref": [ "r1353" ] }, "ffd_CeasedOprsDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CeasedOprsDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Ceased Operations Date", "terseLabel": "Ceased Operations Date" } } }, "auth_ref": [] }, "ffd_CfwdFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CfwdFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Form Type", "terseLabel": "Carry Forward Form Type", "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)." } } }, "auth_ref": [ "r1354" ] }, "ffd_CfwdPrevslyPdFee": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CfwdPrevslyPdFee", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Previously Paid Fee", "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward", "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)." } } }, "auth_ref": [ "r1354" ] }, "ffd_CfwdPrrFctvDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CfwdPrrFctvDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Prior Effective Date", "terseLabel": "Carry Forward Initial Effective Date", "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)." } } }, "auth_ref": [ "r1354" ] }, "ffd_CfwdPrrFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CfwdPrrFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward File Number", "terseLabel": "Carry Forward File Number", "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used." } } }, "auth_ref": [ "r1354" ] }, "ffd_CmbndPrspctsItemAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CmbndPrspctsItemAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus Item [Axis]", "terseLabel": "Combined Prospectus", "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission." } } }, "auth_ref": [ "r1353" ] }, "ffd_CmbndPrspctsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CmbndPrspctsLineItems", "lang": { "en-us": { "role": { "label": "Combined Prospectus [Line Items]", "terseLabel": "Combined Prospectus:" } } }, "auth_ref": [ "r1353" ] }, "ffd_CmbndPrspctsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CmbndPrspctsTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus [Table]", "terseLabel": "Combined Prospectus Table" } } }, "auth_ref": [ "r1353" ] }, "ffd_CombinedProspectusTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CombinedProspectusTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus Table [N/A]", "terseLabel": "Combined Prospectus Table N/A" } } }, "auth_ref": [] }, "ffd_CshPdByRegistrantInTx": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CshPdByRegistrantInTx", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Cash Paid by Registrant in Transaction", "terseLabel": "Cash Consideration Paid", "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)." } } }, "auth_ref": [ "r1364" ] }, "ffd_CshRcvdByRegistrantInTx": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "CshRcvdByRegistrantInTx", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Cash Received by Registrant in Transaction", "terseLabel": "Cash Consideration Received", "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)." } } }, "auth_ref": [ "r1364" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1350" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1350" ] }, "ffd_FeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Amount", "terseLabel": "Amount of Registration Fee", "documentation": "Total amount of registration fee (amount due after offsets)." } } }, "auth_ref": [ "r1353" ] }, "ffd_FeeExhibitTp": { "xbrltype": "feeExhibitTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeExhibitTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Fee Exhibit Type", "terseLabel": "Fee Exhibit Type" } } }, "auth_ref": [] }, "ffd_FeeIntrstAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeIntrstAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Fee Interest Amount", "terseLabel": "Interest Amount" } } }, "auth_ref": [ "r1353" ] }, "ffd_FeeNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Note", "terseLabel": "Fee Note" } } }, "auth_ref": [ "r1353" ] }, "ffd_FeeNoteMaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeNoteMaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Fee Note Maximum Aggregate Offering Price", "terseLabel": "Fee Note MAOP" } } }, "auth_ref": [ "r1353" ] }, "ffd_FeeRate": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeeRate", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Rate", "terseLabel": "Fee Rate", "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission." } } }, "auth_ref": [ "r1353" ] }, "ffd_FeesOthrRuleFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeesOthrRuleFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Fees, Other Rule [Flag]", "terseLabel": "Other Rule", "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due." } } }, "auth_ref": [ "r1353" ] }, "ffd_FeesSummaryLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FeesSummaryLineItems", "lang": { "en-us": { "role": { "label": "Fees Summary [Line Items]", "terseLabel": "Fees Summary:" } } }, "auth_ref": [ "r1353" ] }, "ffd_FnlPrspctsFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FnlPrspctsFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Final Prospectus [Flag]", "terseLabel": "Final Prospectus" } } }, "auth_ref": [ "r1353" ] }, "ffd_FormTp": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "FormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Form Type", "terseLabel": "Form Type" } } }, "auth_ref": [] }, "ffd_GnlInstrIIhiFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "GnlInstrIIhiFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "General Instruction II.H,I [Flag]", "terseLabel": "General Instruction II.H,I" } } }, "auth_ref": [] }, "ffd_IssrBizAdrCity": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrCity", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, City", "terseLabel": "City" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStatOrCtryCd": { "xbrltype": "stateOrCountryCodeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrStatOrCtryCd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, State or Country Code", "terseLabel": "State or Country Code" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStrt1": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrStrt1", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Street 1", "terseLabel": "Street 1" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStrt2": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrStrt2", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Street 2", "terseLabel": "Street 2" } } }, "auth_ref": [] }, "ffd_IssrBizAdrZipCd": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrBizAdrZipCd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Zip Code", "terseLabel": "Zip Code" } } }, "auth_ref": [] }, "ffd_IssrNm": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "IssrNm", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Name", "terseLabel": "Issuer Name" } } }, "auth_ref": [] }, "ffd_MaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "MaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Maximum Aggregate Offering Price", "terseLabel": "Maximum Aggregate Offering Price", "documentation": "The maximum aggregate offering price for the offering that is being registered." } } }, "auth_ref": [ "r1353" ] }, "ffd_MaxOfferingPricPerScty": { "xbrltype": "nonNegativeDecimal4lItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "MaxOfferingPricPerScty", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Maximum Offering Price per Security", "terseLabel": "Proposed Maximum Offering Price per Unit", "documentation": "The maximum offering price per share/unit being registered." } } }, "auth_ref": [ "r1353" ] }, "ffd_NetFeeAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NetFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Net Fee Amount", "terseLabel": "Net Fee" } } }, "auth_ref": [ "r1353" ] }, "ffd_NetSalesAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NetSalesAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Net Sales Amount", "terseLabel": "Net Sales" } } }, "auth_ref": [ "r1353" ] }, "ffd_NrrtvDsclsr": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NrrtvDsclsr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure", "terseLabel": "Narrative Disclosure" } } }, "auth_ref": [ "r1353" ] }, "ffd_NrrtvMaxAggtAmt": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NrrtvMaxAggtAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure, Maximum Aggregate Offering Amount", "terseLabel": "Narrative - Max Aggregate Offering Amount" } } }, "auth_ref": [ "r1353" ] }, "ffd_NrrtvMaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "NrrtvMaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure, Maximum Aggregate Offering Price", "terseLabel": "Narrative - Max Aggregate Offering Price" } } }, "auth_ref": [ "r1353" ] }, "ffd_OfferingAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering [Axis]", "terseLabel": "Offering", "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission." } } }, "auth_ref": [] }, "ffd_OfferingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingLineItems", "lang": { "en-us": { "role": { "label": "Offering [Line Items]", "terseLabel": "Offering:" } } }, "auth_ref": [] }, "ffd_OfferingNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering Note", "terseLabel": "Offering Note" } } }, "auth_ref": [ "r1353" ] }, "ffd_OfferingSctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingSctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Offering Security Title", "terseLabel": "Security Class Title", "documentation": "The title of the class of securities being registered (for each class being registered)." } } }, "auth_ref": [ "r1353" ] }, "ffd_OfferingSctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingSctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering Security Type", "terseLabel": "Security Type", "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\"" } } }, "auth_ref": [ "r1353" ] }, "ffd_OfferingTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering [Table]", "terseLabel": "Offering:" } } }, "auth_ref": [] }, "ffd_OfferingTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OfferingTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Offering Table [N/A]", "terseLabel": "Offering Table N/A" } } }, "auth_ref": [] }, "ffd_OffsetAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset [Axis]", "terseLabel": "Offset", "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission." } } }, "auth_ref": [ "r1353" ] }, "ffd_OffsetClmInitlFilgDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetClmInitlFilgDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claim Initial Filing Date", "terseLabel": "Initial Filing Date", "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetClmdAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetClmdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claimed Amount", "terseLabel": "Fee Offset Claimed", "documentation": "The amount of offsetting fees being claimed." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetClmdInd": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetClmdInd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claimed Indicator", "terseLabel": "Offset Claimed" } } }, "auth_ref": [ "r1353" ] }, "ffd_OffsetExpltnForClmdAmt": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetExpltnForClmdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Explanation for Claimed Amount", "terseLabel": "Explanation for Claimed Amount" } } }, "auth_ref": [ "r1353" ] }, "ffd_OffsetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetLineItems", "lang": { "en-us": { "role": { "terseLabel": "Offset:", "label": "Offset [Line Items]" } } }, "auth_ref": [ "r1353" ] }, "ffd_OffsetNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Note", "terseLabel": "Offset Note" } } }, "auth_ref": [ "r1353" ] }, "ffd_OffsetPrrFeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Fee Amount", "terseLabel": "Fee Paid with Fee Offset Source", "documentation": "The fee previously paid from which an offset is being derived." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetPrrFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior File Number", "terseLabel": "File Number", "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetPrrFilerNm": { "xbrltype": "filerNameItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrFilerNm", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Filer Name", "terseLabel": "Registrant or Filer Name", "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetPrrFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Form Type", "terseLabel": "Form or Filing Type", "documentation": "The Form Type of the offset filing." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetPrrNbOfUnsoldScties": { "xbrltype": "nonNegativeIntegerItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrNbOfUnsoldScties", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Unsold Number of Securities", "terseLabel": "Unsold Securities Associated with Fee Offset Claimed", "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetPrrSctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrSctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Security Title", "terseLabel": "Security Title Associated with Fee Offset Claimed", "documentation": "The title of the class of securities from which offset fees were derived." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetPrrSctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrSctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Security Type", "terseLabel": "Security Type Associated with Fee Offset Claimed", "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\"" } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetPrrUnsoldOfferingAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetPrrUnsoldOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Unsold Offering Amount", "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed", "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetSrcFilgDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetSrcFilgDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Source Filing Date", "terseLabel": "Filing Date", "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset." } } }, "auth_ref": [ "r1357", "r1360" ] }, "ffd_OffsetTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Offset Payment:", "label": "Offset [Table]" } } }, "auth_ref": [ "r1353" ] }, "ffd_OffsetTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "OffsetTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Offset Table [N/A]", "terseLabel": "Offset Table N/A" } } }, "auth_ref": [] }, "ffd_PrevslyPdFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "PrevslyPdFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Previously Paid [Flag]", "terseLabel": "Fee Previously Paid" } } }, "auth_ref": [] }, "ffd_RegnFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "RegnFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Registration File Number", "terseLabel": "Registration File Number" } } }, "auth_ref": [] }, "ffd_RptgFsclYrEndDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "RptgFsclYrEndDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Reporting Fiscal Year End Date", "terseLabel": "Reporting FY End Date" } } }, "auth_ref": [] }, "ffd_Rule011Flg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule011Flg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 0-11 [Flag]", "terseLabel": "Rule 0-11" } } }, "auth_ref": [] }, "ffd_Rule011a2OffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule011a2OffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 0-11(a)(2) Offset", "label": "Rule 0-11(a)(2) Offset [Flag]" } } }, "auth_ref": [] }, "ffd_Rule415a6Flg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule415a6Flg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 415(a)(6) [Flag]", "terseLabel": "Rule 415(a)(6)", "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward." } } }, "auth_ref": [ "r1354" ] }, "ffd_Rule429AggtOfferingAmt": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429AggtOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Aggregate Offering Amount", "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered", "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement." } } }, "auth_ref": [ "r1355" ] }, "ffd_Rule429CmbndPrspctsFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429CmbndPrspctsFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Combined Prospectus [Flag]", "terseLabel": "Rule 429", "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429." } } }, "auth_ref": [ "r1355" ] }, "ffd_Rule429EarlierFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429EarlierFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Earlier File Number", "terseLabel": "File Number", "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429." } } }, "auth_ref": [ "r1355" ] }, "ffd_Rule429EarlierFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429EarlierFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Earlier Form Type", "terseLabel": "Form Type", "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)." } } }, "auth_ref": [ "r1355" ] }, "ffd_Rule429InitlFctvDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429InitlFctvDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Initial Effective Date", "terseLabel": "Initial Effective Date", "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429." } } }, "auth_ref": [ "r1355" ] }, "ffd_Rule429NbOfUnsoldScties": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429NbOfUnsoldScties", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Number Of Unsold Securities", "terseLabel": "Amount of Securities Previously Registered", "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429." } } }, "auth_ref": [ "r1355" ] }, "ffd_Rule429PrspctsNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429PrspctsNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Prospectus Note", "terseLabel": "Combined Prospectus Note" } } }, "auth_ref": [ "r1353" ] }, "ffd_Rule429SctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429SctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Security Title", "terseLabel": "Security Class Title" } } }, "auth_ref": [ "r1353" ] }, "ffd_Rule429SctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule429SctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Security Type", "terseLabel": "Security Type" } } }, "auth_ref": [ "r1353" ] }, "ffd_Rule457aFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457aFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(a) [Flag]", "terseLabel": "Rule 457(a)", "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due." } } }, "auth_ref": [ "r1356" ] }, "ffd_Rule457bOffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457bOffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(b) Offset [Flag]", "terseLabel": "Rule 457(b) Offset", "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)." } } }, "auth_ref": [ "r1357" ] }, "ffd_Rule457fFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457fFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(f) [Flag]", "terseLabel": "Rule 457(f)", "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due." } } }, "auth_ref": [ "r1358" ] }, "ffd_Rule457oFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457oFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(o) [Flag]", "terseLabel": "Rule 457(o)", "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due." } } }, "auth_ref": [ "r1359" ] }, "ffd_Rule457pOffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457pOffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(p) Offset [Flag]", "terseLabel": "Rule 457(p) Offset", "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)." } } }, "auth_ref": [ "r1360" ] }, "ffd_Rule457rFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457rFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(r) [Flag]", "terseLabel": "Rule 457(r)" } } }, "auth_ref": [ "r1361" ] }, "ffd_Rule457sFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457sFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(s) Flag", "terseLabel": "Rule 457(s)" } } }, "auth_ref": [ "r1362" ] }, "ffd_Rule457uFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Rule457uFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(u) [Flag]", "terseLabel": "Rule 457(u)", "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due." } } }, "auth_ref": [ "r1363" ] }, "ffd_Scties424iAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Scties424iAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Securities, 424I [Axis]", "terseLabel": "Securities, 424I" } } }, "auth_ref": [ "r1353" ] }, "ffd_Scties424iLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Scties424iLineItems", "lang": { "en-us": { "role": { "label": "Securities, 424I [Line Items]", "terseLabel": "Securities, 424I:" } } }, "auth_ref": [ "r1353" ] }, "ffd_Scties424iTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Scties424iTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Securities, 424I [Table]", "terseLabel": "Securities, 424I Table" } } }, "auth_ref": [ "r1353" ] }, "ffd_Securities424iTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "Securities424iNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Securities 424I [N/A]", "terseLabel": "Securities 424I N/A" } } }, "auth_ref": [] }, "ffd_SubmissionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "SubmissionLineItems", "lang": { "en-us": { "role": { "label": "Submission [Line Items]", "terseLabel": "Items" } } }, "auth_ref": [] }, "ffd_SubmissnTp": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "SubmissnTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Submission Type", "terseLabel": "Submission Type" } } }, "auth_ref": [] }, "ffd_TermntnCmpltnWdrwl": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TermntnCmpltnWdrwl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Termination / Completion / Withdrawal Statement", "terseLabel": "Termination / Withdrawal Statement" } } }, "auth_ref": [] }, "ffd_TtlFeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Fee Amount", "terseLabel": "Total Fee Amount" } } }, "auth_ref": [ "r1353" ] }, "ffd_TtlFeeAndIntrstAmt": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlFeeAndIntrstAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Fee and Interest Amount", "terseLabel": "Total Fee and Interest Amount" } } }, "auth_ref": [ "r1353" ] }, "ffd_TtlOfferingAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Offering Amount", "terseLabel": "Total Offering" } } }, "auth_ref": [ "r1353" ] }, "ffd_TtlOffsetAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlOffsetAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Offset Amount", "terseLabel": "Total Offset Amount" } } }, "auth_ref": [ "r1353" ] }, "ffd_TtlPrevslyPdAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlPrevslyPdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Previously Paid Amount", "terseLabel": "Previously Paid Amount" } } }, "auth_ref": [ "r1353" ] }, "ffd_TtlTxValtn": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TtlTxValtn", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Transaction Valuation", "terseLabel": "Total Transaction Valuation" } } }, "auth_ref": [ "r1353" ] }, "ffd_TxValtn": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "TxValtn", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Transaction Valuation", "terseLabel": "Transaction Valuation" } } }, "auth_ref": [] }, "ffd_ValSctiesRcvd": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "ValSctiesRcvd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Value of Securities Received", "terseLabel": "Value of Securities Received", "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)" } } }, "auth_ref": [ "r1358" ] }, "ffd_ValSctiesRcvdPerShr": { "xbrltype": "nonNegativeDecimal4lItemType", "nsuri": "http://xbrl.sec.gov/ffd/2025", "localname": "ValSctiesRcvdPerShr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Value of Securities Received, Per Share", "terseLabel": "Value of Securities Received, Per Share", "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation." } } }, "auth_ref": [ "r1358" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 5.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479836/810-10-S99-5" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column C", "Footnote": "5", "Publisher": "SEC" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column C", "Footnote": "4", "Publisher": "SEC" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(a)", "Footnote": "4", "Publisher": "SEC" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "4", "Publisher": "SEC" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column C", "Footnote": "2", "Publisher": "SEC" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column F", "Footnote": "7", "Publisher": "SEC" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column A", "Publisher": "SEC" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column B", "Publisher": "SEC" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column C", "Publisher": "SEC" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column D", "Publisher": "SEC" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column E", "Publisher": "SEC" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column F", "Publisher": "SEC" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Footnote": "4", "Publisher": "SEC" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column A", "Footnote": "3", "Publisher": "SEC" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column A", "Footnote": "4", "Publisher": "SEC" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column B", "Publisher": "SEC" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column C", "Publisher": "SEC" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(C)", "Publisher": "SEC" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "m", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "m", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "L", "Publisher": "SEC" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "M", "Paragraph": "Question 2", "Publisher": "SEC" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 4", "Publisher": "SEC" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.4-03(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SAB Topic 1.B.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205-20/tableOfContent" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480868/205-20-S45-2" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480837/205-20-S50-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.Z.5.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480781/205-20-S99-2" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480781/205-20-S99-3" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-11" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-13" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-4" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-5" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-6" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-8" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-9" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-9" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "36", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-20" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3C" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3D" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-6" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-5" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-13" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-14" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480204/360-10-S45-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481679/480-10-45-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(24)(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480125/505-10-S35-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-3" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-4" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-8" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-6" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SAB Topic 5.Q.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-7" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S25", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-3" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 1.D.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479921/505-20-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.1.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477349/740-270-45-3" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805-10/tableOfContent" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-4" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-5" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805-20/tableOfContent" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-3" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805-30/tableOfContent" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-3" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479326/805-40-45-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2AG", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AG" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/815/tableOfContent" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8C" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479693/815-10-S50-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-3" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "45", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480865/815-45-50-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2G", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2G" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479092/842-20-40-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 1.B.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480148/855-10-S99-1" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480088/860-10-S50-1" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(cc)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4D" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-5" }, "r889": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r890": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11" }, "r891": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1" }, "r892": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1" }, "r893": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4" }, "r894": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r895": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r896": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r897": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1" }, "r898": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r899": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r900": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r901": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19" }, "r902": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20" }, "r903": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20" }, "r904": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r905": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r906": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r907": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r908": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r909": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r910": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28" }, "r911": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28" }, "r912": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r913": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r914": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r915": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r916": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r917": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r918": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r919": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r920": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r921": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r922": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r923": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r924": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6" }, "r925": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7" }, "r926": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r927": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r928": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r929": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "280", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1" }, "r930": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1" }, "r931": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r932": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477657/942-210-S45-1" }, "r933": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478478/942-210-S50-1" }, "r934": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r935": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r936": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r937": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13)(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r938": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r939": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r940": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r941": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r942": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r943": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r944": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r945": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r946": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r947": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r948": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r949": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7)(e)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r950": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7)(e)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r951": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r952": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r953": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1" }, "r954": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r955": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r956": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r957": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.9-06)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2" }, "r958": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r959": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r960": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r961": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r962": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r963": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(ff)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r964": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(fff)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r965": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2" }, "r966": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r967": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r968": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r969": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r970": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3" }, "r971": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r972": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r973": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r974": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r975": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A" }, "r976": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478443/942-360-45-1" }, "r977": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r978": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2" }, "r979": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r980": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1" }, "r981": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r982": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r983": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r984": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r985": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r986": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r987": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r988": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r989": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r990": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r991": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r992": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r993": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r994": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r995": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r996": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r997": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r998": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r999": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r1000": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r1001": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r1002": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r1003": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r1004": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1005": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1006": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1007": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1008": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1009": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1010": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1011": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1012": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1013": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1014": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r1015": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r1016": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r1017": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r1018": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r1019": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r1020": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r1021": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r1022": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1023": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1024": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1025": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1026": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1027": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1028": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1029": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1030": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1031": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1032": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1033": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1034": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r1035": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1" }, "r1036": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "805", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1" }, "r1037": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r1038": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r1039": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r1040": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r1041": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3" }, "r1042": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r1043": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r1044": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r1045": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r1046": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r1047": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r1048": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r1049": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r1050": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r1051": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r1052": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r1053": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r1054": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r1055": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1056": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6" }, "r1057": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r1058": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r1059": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r1060": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r1061": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r1062": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r1063": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r1064": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r1065": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r1066": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r1067": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21" }, "r1068": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r1069": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r1070": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2" }, "r1071": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1072": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1073": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1074": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1075": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1076": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1077": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1078": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1079": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1080": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1081": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1082": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1083": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1084": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1085": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1086": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1087": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1088": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1089": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1090": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1091": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1092": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1093": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1094": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1095": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1096": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1097": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1098": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1099": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r1102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r1103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r1104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r1105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r1130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r1131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r1132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r1133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r1134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r1135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r1136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r1137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r1138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r1142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r1143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r1144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r1145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r1146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r1147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r1148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r1149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r1150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r1151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r1152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r1153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r1154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477011/948-310-45-1" }, "r1155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2" }, "r1156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r1157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r1158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r1159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r1160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r1161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r1171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r1172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r1173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r1174": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r1175": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r1176": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r1177": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A" }, "r1178": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r1179": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r1180": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r1181": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r1182": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483474/205-20-55-102" }, "r1183": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483474/205-20-55-103" }, "r1184": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r1185": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r1186": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8" }, "r1187": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8" }, "r1188": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-9" }, "r1189": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1190": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-15" }, "r1191": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r1192": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21" }, "r1193": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r1194": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12" }, "r1195": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11" }, "r1196": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14" }, "r1197": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18" }, "r1198": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21" }, "r1199": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24" }, "r1200": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4" }, "r1201": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r1202": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r1203": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18" }, "r1204": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6" }, "r1205": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1206": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r1207": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1208": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1209": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1210": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1211": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1212": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r1213": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r1214": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1215": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1216": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1217": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1218": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r1219": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8" }, "r1220": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r1221": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3" }, "r1222": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3" }, "r1223": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3" }, "r1224": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3" }, "r1225": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1226": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r1227": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r1228": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r1229": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r1230": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "64", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64" }, "r1231": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1232": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7" }, "r1233": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1234": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1235": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1236": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1237": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1238": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1239": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1240": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r1241": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r1242": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r1243": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r1244": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r1245": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r1246": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r1247": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r1248": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1249": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r1250": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482630/740-20-55-7" }, "r1251": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8" }, "r1252": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29" }, "r1253": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29" }, "r1254": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-38" }, "r1255": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "39", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39" }, "r1256": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41" }, "r1257": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-42" }, "r1258": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "43", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43" }, "r1259": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "45", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-45" }, "r1260": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "46", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-46" }, "r1261": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47" }, "r1262": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-49" }, "r1263": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-50" }, "r1264": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1265": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1266": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1267": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1268": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1269": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r1270": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r1271": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r1272": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r1273": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29" }, "r1274": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29" }, "r1275": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1276": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1277": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1278": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1279": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1280": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1281": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1282": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1283": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1284": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1285": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1286": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1287": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1288": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1289": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1290": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1291": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r1292": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r1293": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479299/805-40-55-10" }, "r1294": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13" }, "r1295": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r1296": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r1297": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1298": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "181", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181" }, "r1299": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182" }, "r1300": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1301": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1302": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1303": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r1304": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r1305": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1306": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1307": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1308": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1309": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1310": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1311": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10" }, "r1312": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12" }, "r1313": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r1314": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r1315": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r1316": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "108", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481296/860-20-55-108" }, "r1317": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4" }, "r1318": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-2" }, "r1319": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17" }, "r1320": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21" }, "r1321": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29" }, "r1322": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3" }, "r1323": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2" }, "r1324": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4" }, "r1325": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5" }, "r1326": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6" }, "r1327": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r1328": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r1329": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29E" }, "r1330": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r1331": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1332": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1333": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1334": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1335": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r1336": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11" }, "r1337": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14" }, "r1338": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r1339": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r1340": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1341": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r1342": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r1343": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r1344": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r1345": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1346": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r1347": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r1348": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r1349": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r1350": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1351": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r1352": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r1353": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230" }, "r1354": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "415", "Subsection": "a" }, "r1355": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "429" }, "r1356": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457" }, "r1357": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "b" }, "r1358": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "f" }, "r1359": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "o" }, "r1360": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "p" }, "r1361": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "r" }, "r1362": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "s" }, "r1363": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "u" }, "r1364": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Subsection": "f", "Section": "457" }, "r1365": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r1366": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r1367": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r1368": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1369": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1370": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1371": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-11" }, "r1372": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r1373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r1374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r1375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r1376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r1377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r1378": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r1379": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r1380": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r1381": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1382": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1383": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1384": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(6))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org/705/tableOfContent" }, "r1386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r1387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r1388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(2)", "Publisher": "SEC" }, "r1389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "SEC" }, "r1390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r1391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r1392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r1393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r1394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r1395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(ii)", "Publisher": "SEC" }, "r1396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)", "Publisher": "SEC" }, "r1397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "6", "Subsection": "04", "Paragraph": "12", "Subparagraph": "(b)(1)", "Publisher": "SEC" }, "r1400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r1401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11" }, "r1402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A" }, "r1403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B" }, "r1404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r1405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A" }, "r1406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r1407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r1408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r1409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r1410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C" }, "r1411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r1412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r1413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-11" }, "r1414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-13" }, "r1415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-8" }, "r1416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-9" }, "r1417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1420": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1421": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1422": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1423": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1424": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1425": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1426": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1427": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1428": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1429": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1430": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1431": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1432": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1433": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1434": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1435": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1436": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1437": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1438": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1439": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r1440": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12" }, "r1441": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r1442": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1443": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1444": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1445": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1446": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1447": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1448": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1449": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1450": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1451": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1452": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1453": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1454": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1455": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1456": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1457": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(m)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1458": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1459": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1460": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1461": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1462": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1463": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1464": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1465": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1466": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1467": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1468": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1469": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1470": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(m)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1471": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1472": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1473": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1474": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1475": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(r)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1476": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(s)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1477": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(t)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1478": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(u)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1479": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30" }, "r1480": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31" }, "r1481": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32" }, "r1482": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33" }, "r1483": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1484": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1485": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1486": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1487": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1488": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r1489": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r1490": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r1491": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1492": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1493": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r1494": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r1495": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r1496": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r1497": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4" }, "r1498": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1499": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1500": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1501": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1502": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1503": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1504": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r1505": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r1506": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r1507": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r1508": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r1509": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12" }, "r1510": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r1511": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r1512": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r1513": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r1514": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r1515": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r1516": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r1517": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r1518": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r1519": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1520": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1521": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1522": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1523": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1524": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r1525": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r1526": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r1527": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r1528": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r1529": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r1530": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r1531": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1532": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1533": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1534": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1535": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r1536": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1537": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1538": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1539": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r1540": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r1541": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r1542": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r1543": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r1544": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-3" }, "r1545": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1" }, "r1546": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r1547": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1548": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1549": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1550": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r1551": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r1552": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r1553": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r1554": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r1555": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r1556": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1557": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1558": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r1559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r1560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r1561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482558/350-40-50-1" }, "r1573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482222/360-10-30-2" }, "r1574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482190/360-10-35-3" }, "r1575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-14" }, "r1576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4" }, "r1577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r1578": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r1579": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r1580": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r1581": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r1582": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r1583": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1584": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r1587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r1588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r1589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r1592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r1593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r1598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r1600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r1601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481648/480-10-50-2" }, "r1602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2" }, "r1603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1" }, "r1604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2" }, "r1605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r1606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r1607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r1608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r1609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r1610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4" }, "r1611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r1612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-2" }, "r1613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-3" }, "r1614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-1" }, "r1615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-2" }, "r1616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-6" }, "r1617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r1618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4" }, "r1619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-2" }, "r1620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-2" }, "r1621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r1622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4" }, "r1653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1" }, "r1654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r1655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r1656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r1657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r1658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r1659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r1660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6" }, "r1661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r1664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23" }, "r1669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-9" }, "r1670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r1671": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r1672": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7" }, "r1673": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8" }, "r1674": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-42" }, "r1675": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r1676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r1677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r1678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2" }, "r1679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r1681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r1682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r1683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3" }, "r1684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r1689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r1690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r1691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r1692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r1693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r1694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r1695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r1696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r1697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r1698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r1699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC" }, "r1700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r1701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A" }, "r1702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "15", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481116/815-15-25-1" }, "r1706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r1709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r1721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r1724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1" }, "r1725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r1726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r1727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r1728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r1731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r1733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r1735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-2" }, "r1736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r1738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r1739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r1740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r1741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r1742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r1743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r1744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r1745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-2" }, "r1746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r1749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-8" }, "r1750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-8" }, "r1751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-2" }, "r1752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "905", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478704/905-360-25-4" }, "r1753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477657/942-210-S45-1" }, "r1754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478478/942-210-S50-1" }, "r1755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r1756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r1757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r1758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r1759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r1760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r1761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r1762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r1763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.9-06)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2" }, "r1764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r1769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r1770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1" }, "r1808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "970", "SubTopic": "810", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477383/970-810-45-1" }, "r1821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-1" }, "r1822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-1" }, "r1823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-1" } } }